eHDSI Terminologies
0.1.0 - ci-build
eHDSI Terminologies, published by HL7 Europe. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/EHDSI-Terminology-package/ and changes regularly. See the Directory of published versions
| Official URL: http://hl7europe.org/fhir/terminology/ehdsi/ValueSet/eHDSIActiveIngredient | Version: 0.1.0 | |||
| Draft as of 2024-11-03 | Computable Name: eHDSIActiveIngredient | |||
| Other Identifiers: UUID:eHDSIActiveIngredient | ||||
nan
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet eHDSIActiveIngredient
http://www.whocc.no/atc| Code | Display |
| A01AA03 | olaflur |
| A01AB12 | hexetidine |
| A01AD | Other agents for local oral treatment |
| A01AD08 | becaplermin |
| A02AA | Magnesium compounds |
| A02AB02 | algeldrate |
| A02AB10 | combinations |
| A02AG | Antacids with antispasmodics |
| A02AH | Antacids with sodium bicarbonate |
| A02BA06 | roxatidine |
| A02BB02 | enprostil |
| A02BC | Proton pump inhibitors |
| A02BD11 | pantoprazole, amoxicillin, clarithromycin and metronidazole |
| A02BX01 | carbenoxolone |
| A02BX06 | proglumide |
| A02BX07 | gefarnate |
| A02BX09 | acetoxolone |
| A02BX11 | troxipide |
| A02X | OTHER DRUGS FOR ACID RELATED DISORDERS |
| A03AB13 | bevonium |
| A03AB15 | diphemanil |
| A03AB18 | prifinium bromide |
| A03AD01 | papaverine |
| A03AE03 | cilansetron |
| A03AX | Other drugs for functional gastrointestinal disorders |
| A03AX01 | fenpiprane |
| A03AX06 | idanpramine |
| A03AX10 | isometheptene |
| A03BA03 | hyoscyamine |
| A03BB02 | methylatropine |
| A03BB06 | homatropine methylbromide |
| A03CA05 | glycopyrronium bromide and psycholeptics |
| A03CB03 | atropine and psycholeptics |
| A03CB04 | homatropine methylbromide and psycholeptics |
| A03FA02 | cisapride |
| A03FA03 | domperidone |
| A03FA06 | clebopride |
| A04AA | Serotonin (5HT3) antagonists |
| A05AA03 | cholic acid |
| A05AX | Other drugs for bile therapy |
| A06AA01 | liquid paraffin |
| A06AB05 | castor oil |
| A06AB53 | dantron, combinations |
| A06AD02 | magnesium oxide |
| A06AD21 | sodium tartrate |
| A06AG01 | sodium phosphate |
| A06AG02 | bisacodyl |
| A06AG04 | glycerol |
| A06AH | Peripheral opioid receptor antagonists |
| A07A | INTESTINAL ANTIINFECTIVES |
| A07AA04 | streptomycin |
| A07AA06 | paromomycin |
| A07AA08 | kanamycin |
| A07AA09 | vancomycin |
| A07BA | Charcoal preparations |
| A07BC05 | diosmectite |
| A07DA05 | loperamide oxide |
| A07EB | Antiallergic agents, excl. corticosteroids |
| A07EC02 | mesalazine |
| A07XA01 | albumin tannate |
| A08AX01 | rimonabant |
| A09AB02 | betaine hydrochloride |
| A09AB04 | citric acid |
| A10AB04 | insulin lispro |
| A10AD02 | insulin (beef) |
| A10AE01 | insulin (human) |
| A10AE05 | insulin detemir |
| A10AE07 | insulin icodec |
| A10BB01 | glibenclamide |
| A10BB02 | chlorpropamide |
| A10BD11 | metformin and linagliptin |
| A10BF | Alpha glucosidase inhibitors |
| A10BF03 | voglibose |
| A10BX06 | benfluorex |
| A10BX15 | imeglimin |
| A11AA02 | multivitamins and calcium |
| A11AA04 | multivitamins and trace elements |
| A11CA02 | betacarotene |
| A11CC | Vitamin D and analogues |
| A11DA | Vitamin B1, plain |
| A11DA03 | benfotiamine |
| A11GA01 | ascorbic acid (vit C) |
| A11HA31 | calcium pantothenate |
| A12AA05 | calcium lactate |
| A12AA08 | calcium glycerylphosphate |
| A12AA10 | calcium glucoheptonate |
| A12AX | Calcium, combinations with vitamin D and/or other drugs |
| A12CA02 | sodium sulfate |
| A12CC02 | magnesium sulfate |
| A12CD02 | sodium monofluorophosphate |
| A12CE | Selenium |
| A14AA | Androstan derivatives |
| A16AB04 | agalsidase beta |
| A16AB20 | pegunigalsidase alfa |
| A16AB27 | pabinafusp alfa |
| A16AX | Various alimentary tract and metabolism products |
| A16AX09 | glycerol phenylbutyrate |
| A16AX15 | telotristat |
| A16AX19 | fosdenopterin |
| B01AA03 | warfarin |
| B01AB51 | heparin, combinations |
| B01AC15 | aloxiprin |
| B01AC19 | beraprost |
| B01AD01 | streptokinase |
| B01AD03 | anistreplase |
| B01AD12 | protein C |
| B01AE | Direct thrombin inhibitors |
| B01AF02 | apixaban |
| B01AX | Other antithrombotic agents |
| B02BC01 | absorbable gelatin sponge |
| B02BD07 | coagulation factor XIII |
| B02BD16 | etranacogene dezaparvovec |
| B03AC | Iron, parenteral preparations |
| B03AD04 | ferric oxide polymaltose complexes and folic acid |
| B03AE | Iron in other combinations |
| B03AE01 | iron, vitamin B12 and folic acid |
| B03AE03 | iron and multivitamins |
| B03BA | Vitamin B12 (cyanocobalamin and analogues) |
| B03BB | Folic acid and derivatives |
| B03XA07 | daprodustat |
| B05BA02 | fat emulsions |
| B05BA04 | protein hydrolysates |
| B05BA10 | combinations |
| B05CA01 | cetylpyridinium |
| B05CA10 | combinations |
| B05CB10 | combinations |
| B05CX04 | mannitol |
| B05XB01 | arginine hydrochloride |
| B05Z | HEMODIALYTICS AND HEMOFILTRATES |
| B05ZA | Hemodialytics, concentrates |
| B06AA03 | hyaluronidase |
| B06AA04 | chymotrypsin |
| B06AB | Heme products |
| B06AC | Drugs used in hereditary angioedema |
| B06AC06 | berotralstat |
| C01A | CARDIAC GLYCOSIDES |
| C01AA07 | deslanoside |
| C01AA08 | metildigoxin |
| C01AA52 | acetyldigoxin, combinations |
| C01AB51 | proscillaridin, combinations |
| C01B | ANTIARRHYTHMICS, CLASS I AND III |
| C01BA71 | quinidine, combinations with psycholeptics |
| C01CA | Adrenergic and dopaminergic agents |
| C01CA05 | norfenefrine |
| C01CA09 | metaraminol |
| C01CE | Phosphodiesterase inhibitors |
| C01CE03 | enoximone |
| C01CX | Other cardiac stimulants |
| C01DA55 | pentaerithrityl tetranitrate, combinations |
| C01DX11 | trapidil |
| C01DX15 | cloridarol |
| C01EB10 | adenosine |
| C01EB15 | trimetazidine |
| C01EX | Other cardiac combination products |
| C02AA53 | combinations of rauwolfia alkoloids, combinations |
| C02AC | Imidazoline receptor agonists |
| C02AC01 | clonidine |
| C02CC03 | guanoxan |
| C02CC06 | guanazodine |
| C02DA01 | diazoxide |
| C02KB01 | metirosine |
| C02KN01 | aprocitentan |
| C02KX | Antihypertensives for pulmonary arterial hypertension |
| C02KX03 | sitaxentan |
| C02KX04 | macitentan |
| C02LA71 | reserpine and diuretics, combinations with psycholeptics |
| C02LC | Imidazoline receptor agonists in combination with diuretics |
| C02LE01 | prazosin and diuretics |
| C02LG03 | picodralazine and diuretics |
| C02LG51 | dihydralazine and diuretics, combinations with other drugs |
| C03AB01 | bendroflumethiazide and potassium |
| C03AB05 | polythiazide and potassium |
| C03AX01 | hydrochlorothiazide, combinations |
| C03BB | Sulfonamides and potassium in combination |
| C03BB07 | clofenamide and potassium |
| C03C | HIGH-CEILING DIURETICS |
| C03CB01 | furosemide and potassium |
| C03CD | Pyrazolone derivatives |
| C03EA02 | trichlormethiazide and potassium-sparing agents |
| C03EA06 | chlortalidone and potassium-sparing agents |
| C03XA01 | tolvaptan |
| C04AA | 2-amino-1-phenylethanol derivatives |
| C04AD04 | etofylline nicotinate |
| C04AE01 | ergoloid mesylates |
| C04AE04 | dihydroergocristine |
| C04AX01 | cyclandelate |
| C04AX19 | suloctidil |
| C04AX21 | naftidrofuryl |
| C05AE03 | diltiazem |
| C05AX04 | zinc preparations |
| C05BB01 | monoethanolamine oleate |
| C05BX01 | calcium dobesilate |
| C07AA02 | oxprenolol |
| C07AA03 | pindolol |
| C07AA27 | cloranolol |
| C07AB02 | metoprolol |
| C07AB03 | atenolol |
| C07AB08 | celiprolol |
| C07BA05 | propranolol and thiazides |
| C07BG01 | labetalol and thiazides |
| C07FB07 | bisoprolol and amlodipine |
| C07FX01 | propranolol and other combinations |
| C08 | CALCIUM CHANNEL BLOCKERS |
| C08CA02 | felodipine |
| C08CA17 | levamlodipine |
| C08CA55 | nifedipine, combinations |
| C08CX | Other selective calcium channel blockers with mainly vascular effects |
| C08DA01 | verapamil |
| C08DA02 | gallopamil |
| C08EA | Phenylalkylamine derivatives |
| C08GA01 | nifedipine and diuretics |
| C09A | ACE INHIBITORS, PLAIN |
| C09AA | ACE inhibitors, plain |
| C09AA16 | imidapril |
| C09BA06 | quinapril and diuretics |
| C09BB02 | enalapril and lercanidipine |
| C09BB04 | perindopril and amlodipine |
| C09BX07 | zofenopril and nebivolol |
| C09CA08 | olmesartan medoxomil |
| C09DA04 | irbesartan and diuretics |
| C09DB07 | candesartan and amlodipine |
| C09XA52 | aliskiren and hydrochlorothiazide |
| C09XA54 | aliskiren, amlodipine and hydrochlorothiazide |
| C10AC01 | colestyramine |
| C10AD02 | nicotinic acid |
| C10AD05 | nicotinyl alcohol (pyridylcarbinol) |
| C10AX15 | bempedoic acid |
| C10BA | Combinations of various lipid modifying agents |
| C10BA02 | simvastatin and ezetimibe |
| C10BA04 | simvastatin and fenofibrate |
| C10BA06 | rosuvastatin and ezetimibe |
| C10BX05 | rosuvastatin and acetylsalicylic acid |
| D01AA03 | hachimycin |
| D01AA20 | combinations |
| D01AC04 | chlormidazole |
| D01AC15 | fluconazole |
| D01AC18 | luliconazole |
| D01AE10 | ethyl hydroxybenzoate |
| D01AE14 | ciclopirox |
| D01AE19 | tolciclate |
| D01AE22 | naftifine |
| D01AE54 | undecylenic acid, combinations |
| D01BA01 | griseofulvin |
| D02 | EMOLLIENTS AND PROTECTIVES |
| D02AF | Salicylic acid preparations |
| D02B | PROTECTIVES AGAINST UV-RADIATION |
| D02BA | Protectives against UV-radiation for topical use |
| D03AA | Cod-liver oil ointments |
| D03AX09 | crilanomer |
| D03AX14 | Centella asiatica herba, incl. combinations |
| D04AA10 | promethazine |
| D04AB06 | tetracaine |
| D04AX | Other antipruritics |
| D04AX01 | doxepin |
| D05 | ANTIPSORIATICS |
| D05AD02 | methoxsalen |
| D05AX03 | calcitriol |
| D05B | ANTIPSORIATICS FOR SYSTEMIC USE |
| D06AA | Tetracycline and derivatives |
| D06BA01 | silver sulfadiazine |
| D07A | CORTICOSTEROIDS, PLAIN |
| D07BA01 | prednisolone and antiseptics |
| D07BA04 | hydrocortisone and antiseptics |
| D07BB01 | flumetasone and antiseptics |
| D07CC01 | betamethasone and antibiotics |
| D07CD01 | clobetasol and antibiotics |
| D07XB02 | triamcinolone |
| D07XB04 | fluorometholone |
| D07XB05 | dexamethasone |
| D07XD | Corticosteroids, very potent, other combinations |
| D08AA01 | ethacridine lactate |
| D08AB | Aluminium agents |
| D08AC02 | chlorhexidine |
| D08AC05 | polihexanide |
| D08AD | Boric acid products |
| D08AG01 | iodine/octylphenoxypolyglycolether |
| D08AH03 | oxyquinoline |
| D08AJ05 | benzoxonium chloride |
| D08AK06 | thiomersal |
| D08AL01 | silver nitrate |
| D08AX | Other antiseptics and disinfectants |
| D08AX02 | eosin |
| D08AX06 | potassium permanganate |
| D08AX07 | sodium hypochlorite |
| D08AX53 | propanol, combinations |
| D09AA02 | fusidic acid |
| D09AA04 | phenylmercuric nitrate |
| D09AA11 | benzalkonium |
| D09AB | Zinc bandages |
| D10AE | Peroxides |
| D10BA01 | isotretinoin |
| D10BX | Other anti-acne preparations for systemic use |
| D11AC01 | cetrimide |
| D11AC09 | xenysalate |
| D11AH04 | alitretinoin |
| D11AX08 | tiratricol |
| D11AX16 | eflornithine |
| D11AX26 | caffeine |
| G01AA04 | candicidin |
| G01AA05 | chloramphenicol |
| G01AC | Quinoline derivatives |
| G01AD | Organic acids |
| G01AF15 | butoconazole |
| G01AG | Triazole derivatives |
| G01AX66 | octenidine, combinations |
| G01BC | Quinoline derivatives and corticosteroids |
| G02B | CONTRACEPTIVES FOR TOPICAL USE |
| G03 | SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM |
| G03A | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| G03BA01 | fluoxymesterone |
| G03BB02 | androstanolone |
| G03CA | Natural and semisynthetic estrogens, plain |
| G03CB03 | methallenestril |
| G03CC05 | diethylstilbestrol |
| G03CC06 | estriol |
| G03D | PROGESTOGENS |
| G03DB01 | dydrogesterone |
| G03DB03 | medrogestone |
| G03DC01 | allylestrenol |
| G03FA05 | methylnortestosterone and estrogen |
| G03FA08 | megestrol and estrogen |
| G03FA10 | norgestrel and estrogen |
| G03FA13 | norgestimate and estrogen |
| G03FA14 | dydrogesterone and estrogen |
| G03G | GONADOTROPINS AND OTHER OVULATION STIMULANTS |
| G03GA05 | follitropin alfa |
| G03GA09 | corifollitropin alfa |
| G03XA | Antigonadotropins and similar agents |
| G03XB02 | ulipristal |
| G03XB51 | mifepristone, combinations |
| G03XX | Other sex hormones and modulators of the genital system |
| G04BD06 | propiverine |
| G04BE01 | alprostadil |
| G04BE06 | moxisylyte |
| G04BE08 | tadalafil |
| G04BX03 | acetohydroxamic acid |
| G04BX11 | collagen |
| G04CA51 | alfuzosin and finasteride |
| G04CB | Testosterone-5-alpha reductase inhibitors |
| G04CX | Other drugs used in benign prostatic hypertrophy |
| H01AA01 | corticotropin |
| H01AA02 | tetracosactide |
| H01AB01 | thyrotropin alfa |
| H01AC05 | mecasermin rinfabate |
| H01AX01 | pegvisomant |
| H01BA04 | terlipressin |
| H01BB03 | carbetocin |
| H01CB03 | lanreotide |
| H02AB01 | betamethasone |
| H02AB04 | methylprednisolone |
| H02AB13 | deflazacort |
| H02BX | Corticosteroids for systemic use, combinations |
| H03AA04 | tiratricol |
| H03AA05 | thyroid gland preparations |
| H03B | ANTITHYROID PREPARATIONS |
| H03BC01 | potassium perchlorate |
| H03C | IODINE THERAPY |
| H05A | PARATHYROID HORMONES AND ANALOGUES |
| H05BX01 | cinacalcet |
| J | ANTIINFECTIVES FOR SYSTEMIC USE |
| J01AA02 | doxycycline |
| J01AA03 | chlortetracycline |
| J01AA04 | lymecycline |
| J01AA12 | tigecycline |
| J01AA13 | eravacycline |
| J01BA01 | chloramphenicol |
| J01CA07 | epicillin |
| J01CA12 | piperacillin |
| J01CA17 | temocillin |
| J01CA18 | hetacillin |
| J01CA20 | combinations |
| J01CA51 | ampicillin, combinations |
| J01CE10 | benzathine phenoxymethylpenicillin |
| J01DC05 | cefotetan |
| J01DC12 | cefminox |
| J01DC13 | cefbuperazone |
| J01DD13 | cefpodoxime |
| J01DD64 | cefpodoxime and beta-lactamase inhibitor |
| J01DH02 | meropenem |
| J01DH56 | imipenem, cilastatin and relebactam |
| J01DI02 | ceftaroline fosamil |
| J01E | SULFONAMIDES AND TRIMETHOPRIM |
| J01EC03 | sulfamoxole |
| J01ED20 | combinations |
| J01EE03 | sulfametrole and trimethoprim |
| J01EE05 | sulfadimidine and trimethoprim |
| J01FA08 | troleandomycin |
| J01GA02 | streptoduocin |
| J01GB10 | ribostamycin |
| J01M | QUINOLONE ANTIBACTERIALS |
| J01MA02 | ciprofloxacin |
| J01RA08 | tetracycline and oleandomycin |
| J01RA09 | ofloxacin and ornidazole |
| J01XA | Glycopeptide antibacterials |
| J01XA03 | telavancin |
| J01XA05 | oritavancin |
| J01XC | Steroid antibacterials |
| J01XE03 | furazidin |
| J01XX10 | bacitracin |
| J01XX12 | lefamulin |
| J02 | ANTIMYCOTICS FOR SYSTEMIC USE |
| J02AC04 | posaconazole |
| J02AX | Other antimycotics for systemic use |
| J02AX05 | micafungin |
| J02AX07 | ibrexafungerp |
| J04AA02 | sodium aminosalicylate |
| J04AB01 | cycloserine |
| J04AB03 | rifamycin |
| J04AK | Other drugs for treatment of tuberculosis |
| J04AM | Combinations of drugs for treatment of tuberculosis |
| J04AM01 | streptomycin and isoniazid |
| J04BA02 | dapsone |
| J05AB11 | valaciclovir |
| J05AD02 | fosfonet |
| J05AE01 | saquinavir |
| J05AE30 | nirmatrelvir and ritonavir |
| J05AF04 | stavudine |
| J05AF12 | clevudine |
| J05AH04 | laninamivir |
| J05AJ01 | raltegravir |
| J05AP11 | grazoprevir |
| J05AP55 | sofosbuvir and velpatasvir |
| J05AR03 | tenofovir disoproxil and emtricitabine |
| J05AR16 | lamivudine and raltegravir |
| J05AR21 | dolutegravir and rilpivirine |
| J05AX10 | maribavir |
| J05AX19 | tilorone |
| J06 | IMMUNE SERA AND IMMUNOGLOBULINS |
| J06BC01 | nebacumab |
| J06BD03 | tixagevimab and cilgavimab |
| J07AE51 | cholera, combinations with typhoid vaccine, inactivated, whole cell |
| J07AH01 | meningococcus A, purified polysaccharides antigen |
| J07AH06 | meningococcus B, outer membrane vesicle vaccine |
| J07BB03 | influenza, live attenuated |
| J07BC01 | hepatitis B, purified antigen |
| J07BD | Measles vaccines |
| J07BJ | Rubella vaccines |
| J07BJ01 | rubella, live attenuated |
| J07BX05 | respiratory syncytial virus vaccines |
| J07CA01 | diphtheria-poliomyelitis-tetanus |
| J07CA06 | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus |
| J07XA01 | malaria vaccines |
| L01AA01 | cyclophosphamide |
| L01AA08 | prednimustine |
| L01AD07 | ranimustine |
| L01AD08 | uramustine |
| L01BA04 | pemetrexed |
| L01BC06 | capecitabine |
| L01CA01 | vinblastine |
| L01CA06 | vintafolide |
| L01CD01 | paclitaxel |
| L01CD04 | cabazitaxel |
| L01CE01 | topotecan |
| L01EB03 | afatinib |
| L01EB06 | olmutinib |
| L01EB08 | icotinib |
| L01ED02 | ceritinib |
| L01EE03 | binimetinib |
| L01EG02 | everolimus |
| L01EX24 | surufatinib |
| L01F | MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
| L01FD | HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors |
| L01FD04 | trastuzumab deruxtecan |
| L01FE03 | necitumumab |
| L01FG02 | ramucirumab |
| L01FX04 | ipilimumab |
| L01FY | Combinations of monoclonal antibodies and antibody drug conjugates |
| L01XF02 | alitretinoin |
| L01XJ02 | sonidegib |
| L01XK01 | olaparib |
| L01XL01 | sitimagene ceradenovec |
| L01XX | Other antineoplastic agents |
| L01XX07 | lonidamine |
| L01XX27 | arsenic trioxide |
| L01XX53 | vosaroxin |
| L02AA01 | diethylstilbestrol |
| L02AB01 | megestrol |
| L02AB02 | medroxyprogesterone |
| L02AE04 | triptorelin |
| L02AE05 | histrelin |
| L02B | HORMONE ANTAGONISTS AND RELATED AGENTS |
| L02BA | Anti-estrogens |
| L02BA02 | toremifene |
| L02BB02 | nilutamide |
| L02BB06 | darolutamide |
| L02BG03 | anastrozole |
| L02BX04 | relugolix |
| L02BX53 | abiraterone and prednisolone |
| L03AA16 | empegfilgrastim |
| L03AB02 | interferon beta natural |
| L03AB15 | ropeginterferon alfa-2b |
| L03AC01 | aldesleukin |
| L03AX | Other immunostimulants |
| L03AX10 | immunocyanin |
| L04AA06 | mycophenolic acid |
| L04AB | Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| L04AB02 | infliximab |
| L04AB03 | afelimomab |
| L04AB05 | certolizumab pegol |
| L04AC02 | basiliximab |
| L04AC17 | tildrakizumab |
| L04AF | Janus-associated kinase (JAK) inhibitors |
| L04AG06 | alemtuzumab |
| L04AG15 | divozilimab |
| L04AJ02 | ravulizumab |
| L04AK02 | teriflunomide |
| M01AA | Butylpyrazolidines |
| M01AB15 | ketorolac |
| M01AE08 | pirprofen |
| M01AE16 | alminoprofen |
| M01AX05 | glucosamine |
| M01AX21 | diacerein |
| M01CA | Quinolines |
| M01CB03 | auranofin |
| M01CB05 | aurotioprol |
| M02A | TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN |
| M02AA07 | piroxicam |
| M02AA12 | naproxen |
| M02AA13 | ibuprofen |
| M02AA14 | fentiazac |
| M02AA21 | tolmetin |
| M02AA23 | indometacin |
| M02AA24 | nifenazone |
| M02AC | Preparations with salicylic acid derivatives |
| M03AC01 | pancuronium |
| M03AX01 | botulinum toxin |
| M03BB53 | chlorzoxazone, combinations excl. psycholeptics |
| M03BX02 | tizanidine |
| M03BX09 | eperisone |
| M04A | ANTIGOUT PREPARATIONS |
| M04AA02 | tisopurine |
| M04AB02 | sulfinpyrazone |
| M05 | DRUGS FOR TREATMENT OF BONE DISEASES |
| M05BA06 | ibandronic acid |
| M05BB01 | etidronic acid and calcium, sequential |
| M05BB02 | risedronic acid and calcium, sequential |
| M05BB03 | alendronic acid and colecalciferol |
| M05BX02 | aluminium chlorohydrate |
| M05BX04 | denosumab |
| M05BX05 | burosumab |
| M05BX53 | strontium ranelate and colecalciferol |
| M09AB | Enzymes |
| M09AB03 | bromelains |
| M09AX05 | aceneuramic acid |
| M09AX11 | palovarotene |
| M09AX12 | viltolarsen |
| N01AB01 | halothane |
| N01AB04 | enflurane |
| N01AB06 | isoflurane |
| N01AB08 | sevoflurane |
| N01AF02 | hexobarbital |
| N01AH | Opioid anesthetics |
| N01AX07 | etomidate |
| N01AX10 | propofol |
| N01BA04 | chloroprocaine |
| N01BB04 | prilocaine |
| N01BB58 | articaine, combinations |
| N01BX04 | capsaicin |
| N02AA05 | oxycodone |
| N02AB52 | pethidine, combinations excl. psycholeptics |
| N02AC05 | bezitramide |
| N02AD01 | pentazocine |
| N02AD02 | phenazocine |
| N02AE | Oripavine derivatives |
| N02AG03 | pethidine and antispasmodics |
| N02AJ06 | codeine and paracetamol |
| N02BA16 | imidazole salicylate |
| N02BA77 | ethenzamide, combinations with psycholeptics |
| N02BB51 | phenazone, combinations excl. psycholeptics |
| N02BB71 | phenazone, combinations with psycholeptics |
| N02BE74 | bucetin, combinations with psycholeptics |
| N02BF | Gabapentinoids |
| N02BG | Other analgesics and antipyretics |
| N02BG03 | glafenine |
| N02CB01 | flumedroxone |
| N02CD04 | ubrogepant |
| N02CX | Other antimigraine preparations |
| N02CX01 | pizotifen |
| N03 | ANTIEPILEPTICS |
| N03AC02 | trimethadione |
| N03AF04 | eslicarbazepine |
| N03AX15 | zonisamide |
| N03AX17 | stiripentol |
| N03AX26 | fenfluramine |
| N04AA | Tertiary amines |
| N04AC | Ethers of tropine or tropine derivatives |
| N04BA | Dopa and dopa derivatives |
| N04BA01 | levodopa |
| N04BA02 | levodopa and decarboxylase inhibitor |
| N04BC09 | rotigotine |
| N04BX | Other dopaminergic agents |
| N05AC01 | periciazine |
| N05AD | Butyrophenone derivatives |
| N05AD06 | bromperidol |
| N05BA01 | diazepam |
| N05BA05 | potassium clorazepate |
| N05BA15 | camazepam |
| N05BA17 | fludiazepam |
| N05BA24 | bentazepam |
| N05BA25 | mexazolam |
| N05BC51 | meprobamate, combinations |
| N05C | HYPNOTICS AND SEDATIVES |
| N05CA07 | talbutal |
| N05CA16 | hexobarbital |
| N05CA20 | etallobarbital |
| N05CC01 | chloral hydrate |
| N05CC02 | chloralodol |
| N05CF04 | eszopiclone |
| N05CJ02 | lemborexant |
| N05CM05 | scopolamine |
| N05CM18 | dexmedetomidine |
| N05CX01 | meprobamate, combinations |
| N05CX03 | methylpentynol, combinations |
| N05CX04 | clomethiazole, combinations |
| N06AA02 | imipramine |
| N06AA15 | butriptyline |
| N06AB10 | escitalopram |
| N06AX10 | oxaflozane |
| N06AX15 | pivagabine |
| N06AX16 | venlafaxine |
| N06AX26 | vortioxetine |
| N06AX28 | levomilnacipran |
| N06BA06 | fencamfamin |
| N06BA07 | modafinil |
| N06BA11 | dexmethylphenidate |
| N06BX11 | aniracetam |
| N06BX16 | pramiracetam |
| N06DX03 | aducanumab |
| N07AA03 | distigmine |
| N07AX01 | pilocarpine |
| N07AX03 | cevimeline |
| N07BA01 | nicotine |
| N07BB04 | naltrexone |
| N07BC02 | methadone |
| N07BC03 | levacetylmethadol |
| N07XX04 | sodium oxybate |
| N07XX13 | valbenazine |
| N07XX18 | vutrisiran |
| P01AB07 | secnidazole |
| P01AX07 | trimetrexate |
| P01AX11 | nitazoxanide |
| P01B | ANTIMALARIALS |
| P01BE04 | artemotil |
| P01BF02 | artesunate and mefloquine |
| P01BF07 | artemisinin and piperaquine |
| P01BX01 | halofantrine |
| P01C | AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS |
| P02C | ANTINEMATODAL AGENTS |
| P02CA | Benzimidazole derivatives |
| P02CA06 | fenbendazole |
| P03AC01 | pyrethrum |
| P03AX01 | benzyl benzoate |
| P03BX | Other insecticides and repellents |
| R | RESPIRATORY SYSTEM |
| R01AA03 | ephedrine |
| R01AA06 | tetryzoline |
| R01AA09 | tramazoline |
| R01AC08 | olopatadine |
| R01AD01 | beclometasone |
| R02AA05 | chlorhexidine |
| R02AA12 | hexylresorcinol |
| R02AA21 | octenidine |
| R02AB | Antibiotics |
| R03AC03 | terbutaline |
| R03AC05 | rimiterol |
| R03AC08 | pirbuterol |
| R03AC10 | carbuterol |
| R03AK10 | vilanterol and fluticasone furoate |
| R03CC05 | hexoprenaline |
| R03CC09 | tretoquinol |
| R03CC11 | tulobuterol |
| R03DA04 | theophylline |
| R03DA08 | bamifylline |
| R03DC02 | pranlukast |
| R03DX09 | mepolizumab |
| R03DX10 | benralizumab |
| R05CA02 | potassium iodide |
| R05CA07 | antimony pentasulfide |
| R05CA11 | levoverbenone |
| R05DA06 | normethadone |
| R05DA07 | noscapine |
| R05DA12 | acetyldihydrocodeine |
| R05DB03 | clobutinol |
| R05DB09 | oxeladin |
| R05DB16 | dibunate |
| R05DB18 | prenoxdiazine |
| R05DB29 | gefapixant |
| R05FA01 | opium derivatives and mucolytics |
| R06AA08 | carbinoxamine |
| R06AA09 | doxylamine |
| R06AA10 | trimethobenzamide |
| R06AB01 | brompheniramine |
| R06AB56 | dexbrompheniramine, combinations |
| R06AE07 | cetirizine |
| R06AX | Other antihistamines for systemic use |
| R06AX05 | antazoline |
| R06AX09 | azatadine |
| R06AX11 | astemizole |
| R06AX15 | mebhydrolin |
| R06AX19 | azelastine |
| R06AX58 | pyrrobutamine, combinations |
| R07AA02 | natural phospholipids |
| R07AB02 | nikethamide |
| R07AB07 | almitrine |
| S01AA17 | erythromycin |
| S01AA19 | ampicillin |
| S01AB03 | sulfadicramide |
| S01AB05 | sulfafenazol |
| S01AD09 | ganciclovir |
| S01AE03 | ciprofloxacin |
| S01AE06 | gatifloxacin |
| S01BA03 | cortisone |
| S01CA03 | hydrocortisone and antiinfectives |
| S01CA06 | fludrocortisone and antiinfectives |
| S01CB | Corticosteroids/antiinfectives/mydriatics in combination |
| S01EA01 | epinephrine |
| S01EA04 | clonidine |
| S01EB07 | fluostigmine |
| S01EB10 | paraoxon |
| S01ED | Beta blocking agents |
| S01ED03 | levobunolol |
| S01ED54 | metipranolol, combinations |
| S01ED55 | carteolol, combinations |
| S01EX02 | dapiprazole |
| S01EX07 | ripasudil |
| S01F | MYDRIATICS AND CYCLOPLEGICS |
| S01FB03 | ibopamine |
| S01GA04 | oxymetazoline |
| S01GA51 | naphazoline, combinations |
| S01GX01 | cromoglicic acid |
| S01GX04 | nedocromil |
| S01GX08 | ketotifen |
| S01GX11 | alcaftadine |
| S01GX12 | cetirizine |
| S01HA04 | proxymetacaine |
| S01HA08 | chloroprocaine |
| S01JA02 | rose bengal sodium |
| S01LA01 | verteporfin |
| S01LA02 | anecortave |
| S01XA09 | iodoheparinate |
| S01XA20 | artificial tears and other indifferent preparations |
| S01XA26 | riboflavin |
| S01XA31 | pegcetacoplan |
| S02 | OTOLOGICALS |
| S02AA04 | aluminium acetotartrate |
| S02AA13 | miconazole |
| S02C | CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION |
| S02CA05 | fluocinolone acetonide and antiinfectives |
| S02DA30 | combinations |
| S03AA | Antiinfectives |
| S03AA03 | polymyxin B |
| S03AA07 | ciprofloxacin |
| S03BA01 | dexamethasone |
| S03BA02 | prednisolone |
| V | VARIOUS |
| V01AA11 | animals |
| V03A | ALL OTHER THERAPEUTIC PRODUCTS |
| V03AB01 | ipecacuanha |
| V03AB24 | digitalis antitoxin |
| V03AC03 | deferasirox |
| V03AE07 | calcium acetate |
| V03AF | Detoxifying agents for antineoplastic treatment |
| V03AF06 | sodium folinate |
| V03AK | Tissue adhesives |
| V03AN03 | helium |
| V04B | URINE TESTS |
| V04CA | Tests for diabetes |
| V04CG02 | betazole |
| V04CX02 | folic acid |
| V04CX05 | 13C-urea |
| V04CX07 | edrophonium |
| V06A | DIET FORMULATIONS FOR TREATMENT OF OBESITY |
| V06DA | Carbohydrates/proteins/minerals/vitamins, combinations |
| V08A | X-RAY CONTRAST MEDIA, IODINATED |
| V08AA01 | diatrizoic acid |
| V08AB08 | iopentol |
| V08AC06 | iopanoic acid |
| V08BA01 | barium sulfate with suspending agents |
| V08CB01 | ferumoxsil |
| V08CB02 | ferristene |
| V08DA | Ultrasound contrast media |
| V09AB01 | iodine iofetamine (123I) |
| V09BA01 | technetium (99mTc) oxidronic acid |
| V09CA06 | technetium (99mTc) ethylenedicysteine |
| V09D | HEPATIC AND RETICULO ENDOTHELIAL SYSTEM |
| V09DA | Technetium (99mTc) compounds |
| V09EA01 | technetium (99mTc) pentetic acid |
| V09EA02 | technetium (99mTc) technegas |
| V09FX04 | sodium iodide (124I) |
| V09HA02 | technetium (99mTc) exametazime labelled cells |
| V09IA09 | technetium (99mTc) tilmanocept |
| V09IB | Indium (111In) compounds |
| V09IB04 | indium (111In) capromab pendetide |
| V09IX02 | iobenguane (131I) |
| V09IX09 | gallium (68Ga) edotreotide |
| V09IX12 | fluciclovine (18F) |
| V09X | OTHER DIAGNOSTIC RADIOPHARMACEUTICALS |
| V10AA03 | yttrium (90Y) silicate colloid |
| V10AX05 | rhenium (186Re) sulfide colloid |
| V10BX01 | strontium (89Sr) chloride |
| V10BX02 | samarium (153Sm) lexidronam |
| V10XX04 | lutetium (177Lu) oxodotreotide |
| V10XX05 | lutetium (177Lu) vipivotide tetraxetan |
| A01AB14 | benzoxonium chloride |
| A02AA05 | magnesium silicate |
| A02AC10 | combinations |
| A02BA08 | lafutidine |
| A02BC02 | pantoprazole |
| A02BC05 | esomeprazole |
| A02BD02 | lansoprazole, tetracycline and metronidazole |
| A02BD13 | rabeprazole, amoxicillin and metronidazole |
| A02BX02 | sucralfate |
| A02BX04 | methiosulfonium chloride |
| A02BX16 | irsogladine |
| A03 | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| A03AA | Synthetic anticholinergics, esters with tertiary amino group |
| A03AA30 | piperidolate |
| A03AB10 | hexocyclium |
| A03AB12 | mepenzolate |
| A03AX12 | phloroglucinol |
| A03BB03 | methylscopolamine |
| A03CB01 | methylscopolamine and psycholeptics |
| A03CC | Other antispasmodics in combination with psycholeptics |
| A03D | ANTISPASMODICS IN COMBINATION WITH ANALGESICS |
| A03DA01 | tropenzilone and analgesics |
| A03DA06 | trospium and analgesics |
| A03E | ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS |
| A03FA | Propulsives |
| A03FA01 | metoclopramide |
| A03FA05 | alizapride |
| A04AD05 | metopimazine |
| A05A | BILE THERAPY |
| A05AA04 | obeticholic acid |
| A06AA02 | docusate sodium |
| A06AB06 | senna glycosides |
| A06AB52 | bisacodyl, combinations |
| A06AC01 | ispaghula (psylla seeds) |
| A06AC06 | methylcellulose |
| A06AC07 | triticum (wheat fibre) |
| A06AD | Osmotically acting laxatives |
| A06AD61 | lactulose, combinations |
| A07AC01 | miconazole |
| A07BA51 | medicinal charcoal, combinations |
| A07BC | Other intestinal adsorbents |
| A07BC01 | pectin |
| A07BC03 | crospovidone |
| A07DA06 | eluxadoline |
| A07EA01 | prednisolone |
| A08AA01 | phentermine |
| A08AA08 | clobenzorex |
| A08AA56 | ephedrine, combinations |
| A10AB01 | insulin (human) |
| A10AB03 | insulin (pork) |
| A10AC01 | insulin (human) |
| A10AE06 | insulin degludec |
| A10AE56 | insulin degludec and liraglutide |
| A10BA | Biguanides |
| A10BA02 | metformin |
| A10BB09 | gliclazide |
| A10BB31 | acetohexamide |
| A10BD03 | metformin and rosiglitazone |
| A10BD18 | metformin and gemigliptin |
| A10BD21 | saxagliptin and dapagliflozin |
| A10BD23 | metformin and ertugliflozin |
| A10BH | Dipeptidyl peptidase 4 (DPP-4) inhibitors |
| A10BH01 | sitagliptin |
| A10BH03 | saxagliptin |
| A10BH05 | linagliptin |
| A10BH07 | evogliptin |
| A10BH08 | teneligliptin |
| A10BH51 | sitagliptin and simvastatin |
| A10BJ01 | exenatide |
| A10BK08 | bexagliflozin |
| A10BX16 | tirzepatide |
| A10X | OTHER DRUGS USED IN DIABETES |
| A10XA01 | tolrestat |
| A11CA01 | retinol (vit A) |
| A11CC05 | colecalciferol |
| A11ED | Vitamin B-complex with anabolic steroids |
| A11HA04 | riboflavin (vit B2) |
| A11HA06 | pyridoxal phosphate |
| A11J | OTHER VITAMIN PRODUCTS, COMBINATIONS |
| A12AA01 | calcium phosphate |
| A12AA06 | calcium lactate gluconate |
| A12BA30 | potassium (different salts in combination) |
| A12CA | Sodium |
| A12CC07 | magnesium levulinate |
| A12CC09 | magnesium orotate |
| A12CD | Fluoride |
| A13 | TONICS |
| A13A | TONICS |
| A14AA03 | metandienone |
| A14AA04 | metenolone |
| A14AA07 | prasterone |
| A14AA08 | oxandrolone |
| A16AA01 | levocarnitine |
| A16AA03 | glutamine |
| A16AB | Enzymes |
| A16AB01 | alglucerase |
| A16AB05 | laronidase |
| A16AB13 | asfotase alfa |
| A16AB23 | cipaglucosidase alfa |
| A16AB24 | pegzilarginase |
| A16AX02 | anethole trithione |
| B | BLOOD AND BLOOD FORMING ORGANS |
| B01A | ANTITHROMBOTIC AGENTS |
| B01AA04 | phenprocoumon |
| B01AA10 | diphenadione |
| B01AC01 | ditazole |
| B01AC03 | picotamide |
| B01AC05 | ticlopidine |
| B01AC13 | abciximab |
| B01AC17 | tirofiban |
| B01AC24 | ticagrelor |
| B01AD | Enzymes |
| B01AE07 | dabigatran etexilate |
| B02AB01 | aprotinin |
| B02BA | Vitamin K |
| B02BA01 | phytomenadione |
| B02BC08 | calcium alginate |
| B02BX | Other systemic hemostatics |
| B02BX03 | batroxobin |
| B02BX05 | eltrombopag |
| B02BX06 | emicizumab |
| B03AA05 | ferrous chloride |
| B03AA11 | ferrous iodine |
| B03AB | Iron trivalent, oral preparations |
| B03AB04 | ferric hydroxide |
| B03BA53 | hydroxocobalamin, combinations |
| B03BB51 | folic acid, combinations |
| B03X | OTHER ANTIANEMIC PREPARATIONS |
| B03XA01 | erythropoietin |
| B03XA05 | roxadustat |
| B05AA01 | albumin |
| B05AA10 | hemoglobin glutamer (bovine) |
| B05AX02 | thrombocytes |
| B05AX04 | stem cells from umbilical cord blood |
| B05BB03 | trometamol |
| B05BC01 | mannitol |
| B05CA03 | nitrofural |
| B05CB | Salt solutions |
| B05CX03 | glycine |
| B05XB02 | alanyl glutamine |
| B05XX02 | trometamol |
| B06AA10 | desoxyribonuclease |
| B06AA55 | streptokinase, combinations |
| C01 | CARDIAC THERAPY |
| C01AA01 | acetyldigitoxin |
| C01AA02 | acetyldigoxin |
| C01AA06 | lanatoside C |
| C01AC03 | cymarin |
| C01BA02 | procainamide |
| C01BA03 | disopyramide |
| C01BA12 | lorajmine |
| C01BB03 | tocainide |
| C01BB04 | aprindine |
| C01BC04 | flecainide |
| C01BC09 | ethacizine |
| C01BD02 | bretylium tosilate |
| C01CA08 | oxedrine |
| C01CA13 | prenalterol |
| C01CA14 | dopexamine |
| C01CA26 | ephedrine |
| C01CA51 | etilefrine, combinations |
| C01CX07 | xamoterol |
| C01DB | Quinolone vasodilators |
| C01DB01 | flosequinan |
| C01DX04 | benziodarone |
| C01DX14 | cinepazet |
| C01DX52 | prenylamine, combinations |
| C01EA01 | alprostadil |
| C01EB04 | crataegus glycosides |
| C01EB09 | ubidecarenone |
| C02AA07 | bietaserpine |
| C02AB | Methyldopa |
| C02AC02 | guanfacine |
| C02B | ANTIADRENERGIC AGENTS, GANGLION-BLOCKING |
| C02BA01 | trimetaphan |
| C02BB01 | mecamylamine |
| C02CA | Alpha-adrenoreceptor antagonists |
| C02CC07 | guanoxabenz |
| C02DA | Thiazide derivatives |
| C02DC | Pyrimidine derivatives |
| C02DG | Guanidine derivatives |
| C02LA09 | syrosingopine and diuretics |
| C03AA | Thiazides, plain |
| C03AA06 | trichlormethiazide |
| C03AA07 | cyclopenthiazide |
| C03AB07 | cyclopenthiazide and potassium |
| C03AB09 | cyclothiazide and potassium |
| C03AH01 | chlorothiazide, combinations |
| C03AH02 | hydroflumethiazide, combinations |
| C03B | LOW-CEILING DIURETICS, EXCL. THIAZIDES |
| C03BA03 | clopamide |
| C03BA08 | metolazone |
| C03BA12 | clorexolone |
| C03BD01 | theobromine |
| C03CA | Sulfonamides, plain |
| C03CB02 | bumetanide and potassium |
| C03D | ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS |
| C03EA04 | altizide and potassium-sparing agents |
| C04AC03 | inositol nicotinate |
| C04AC07 | ciclonicate |
| C04AE | Ergot alkaloids |
| C04AX | Other peripheral vasodilators |
| C04AX17 | vinburnine |
| C04AX30 | azapetine |
| C05AA09 | dexamethasone |
| C05AA11 | fluocinonide |
| C05AD | Local anesthetics |
| C05AE01 | glyceryl trinitrate |
| C05CA05 | hidrosmin |
| C07AA | Beta blocking agents, non-selective |
| C07AB | Beta blocking agents, selective |
| C07AG01 | labetalol |
| C07B | BETA BLOCKING AGENTS AND THIAZIDES |
| C07BB12 | nebivolol and thiazides |
| C07CA02 | oxprenolol and other diuretics |
| C07DA06 | timolol, thiazides and other diuretics |
| C07FB | Beta blocking agents and calcium channel blockers |
| C08CA01 | amlodipine |
| C08CA51 | amlodipine and celecoxib |
| C08EX | Other non-selective calcium channel blockers |
| C09AA10 | trandolapril |
| C09AA12 | delapril |
| C09AA13 | moexipril |
| C09BA | ACE inhibitors and diuretics |
| C09BA01 | captopril and diuretics |
| C09BA05 | ramipril and diuretics |
| C09BA08 | cilazapril and diuretics |
| C09BA15 | zofenopril and diuretics |
| C09BX01 | perindopril, amlodipine and indapamide |
| C09BX02 | perindopril and bisoprolol |
| C09BX04 | perindopril, bisoprolol and amlodipine |
| C09C | ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN |
| C09CA05 | tasosartan |
| C09CA10 | fimasartan |
| C09DA06 | candesartan and diuretics |
| C09DB04 | telmisartan and amlodipine |
| C09DX03 | olmesartan medoxomil, amlodipine and hydrochlorothiazide |
| C09XA02 | aliskiren |
| C10 | LIPID MODIFYING AGENTS |
| C10AB01 | clofibrate |
| C10AB06 | simfibrate |
| C10AD01 | niceritrol |
| C10AD03 | nicofuranose |
| C10AX | Other lipid modifying agents |
| C10AX07 | magnesium pyridoxal 5-phosphate glutamate |
| C10AX11 | mipomersen |
| C10AX17 | evinacumab |
| C10AX18 | volanesorsen |
| C10BA10 | bempedoic acid and ezetimibe |
| C10BX02 | pravastatin and acetylsalicylic acid |
| C10BX07 | rosuvastatin, amlodipine and lisinopril |
| C10BX11 | atorvastatin, amlodipine and perindopril |
| C10BX17 | rosuvastatin and ramipril |
| D01AA04 | pecilocin |
| D01AC02 | miconazole |
| D01AC06 | tiabendazole |
| D01AC13 | omoconazole |
| D01AC52 | miconazole, combinations |
| D01AE15 | terbinafine |
| D02AA | Silicone products |
| D02AC | Soft paraffin and fat products |
| D02BB | Protectives against UV-radiation for systemic use |
| D03AX12 | trolamine |
| D03AX16 | beremagene geperpavec |
| D04AB07 | pramocaine |
| D05AX | Other antipsoriatics for topical use |
| D05AX06 | roflumilast |
| D05BA02 | methoxsalen |
| D06AX01 | fusidic acid |
| D06BA05 | sulfanilamide |
| D06BB02 | tromantadine |
| D06BB03 | aciclovir |
| D06BB11 | docosanol |
| D06BX | Other chemotherapeutics |
| D07AA03 | prednisolone |
| D07AB01 | clobetasone |
| D07AB02 | hydrocortisone butyrate |
| D07AB03 | flumetasone |
| D07AB05 | fluperolone |
| D07AC21 | ulobetasol |
| D07BB03 | triamcinolone and antiseptics |
| D07CC03 | fludroxycortide and antibiotics |
| D07CC06 | fluocortolone and antibiotics |
| D08AA03 | euflavine |
| D08AE03 | phenol |
| D08AE04 | triclosan |
| D08AG03 | iodine |
| D08AJ | Quaternary ammonium compounds |
| D08AX01 | hydrogen peroxide |
| D08AX03 | propanol |
| D09A | MEDICATED DRESSINGS |
| D09AA | Medicated dressings with antiinfectives |
| D09AA01 | framycetin |
| D09AA05 | benzododecinium |
| D09AA06 | triclosan |
| D09AB02 | zinc bandage with supplements |
| D10AB05 | mesulfen |
| D10AD05 | motretinide |
| D10AF04 | meclocycline |
| D10AF52 | erythromycin, combinations |
| D11AC | Medicated shampoos |
| D11AC03 | selenium compounds |
| D11AH07 | tralokinumab |
| D11AH08 | abrocitinib |
| D11AH10 | lebrikizumab |
| D11AH12 | nemolizumab |
| D11AX03 | calcium gluconate |
| D11AX27 | oxymetazoline |
| G01AA01 | nystatin |
| G01AA02 | natamycin |
| G01AC02 | clioquinol |
| G01AF12 | fenticonazole |
| G01AF18 | flutrimazole |
| G01AF20 | combinations of imidazole derivatives |
| G01AX06 | furazolidone |
| G01AX12 | ciclopirox |
| G02AC | Ergot alkaloids and oxytocin incl. analogues, in combination |
| G02BA01 | plastic IUD |
| G02CC | Antiinflammatory products for vaginal administration |
| G02CC02 | naproxen |
| G02CC03 | benzydamine |
| G02CX05 | bremelanotide |
| G03AA | Progestogens and estrogens, fixed combinations |
| G03AA04 | megestrol and ethinylestradiol |
| G03AA05 | norethisterone and ethinylestradiol |
| G03AA12 | drospirenone and ethinylestradiol |
| G03AA17 | medroxyprogesterone and estradiol |
| G03AB | Progestogens and estrogens, sequential preparations |
| G03AB06 | gestodene and ethinylestradiol |
| G03AC05 | megestrol |
| G03AC07 | norgestrienone |
| G03AC08 | etonogestrel |
| G03BA02 | methyltestosterone |
| G03BB | 5-androstanon (3) derivatives |
| G03C | ESTROGENS |
| G03CB04 | moxestrol |
| G03CC07 | conjugated estrogens and bazedoxifene |
| G03DB06 | chlormadinone |
| G03DC | Estren derivatives |
| G03EA01 | methyltestosterone and estrogen |
| G03FA | Progestogens and estrogens, fixed combinations |
| G03FA07 | lynestrenol and estrogen |
| G03FA09 | noretynodrel and estrogen |
| G03FA11 | levonorgestrel and estrogen |
| G03FA15 | dienogest and estrogen |
| G03FA16 | trimegestone and estrogen |
| G03FA17 | drospirenone and estrogen |
| G03FB | Progestogens and estrogens, sequential preparations |
| G03FB07 | medrogestone and estrogen |
| G03GA08 | choriogonadotropin alfa |
| G03GB01 | cyclofenil |
| G03GB02 | clomifene |
| G04BA01 | ammonium chloride |
| G04BD | Drugs for urinary frequency and incontinence |
| G04BD11 | fesoterodine |
| G04BE52 | papaverine, combinations |
| G04BX13 | dimethyl sulfoxide |
| G04BX16 | tiopronin |
| G04CA02 | tamsulosin |
| G04CB01 | finasteride |
| G04CX02 | Sabalis serrulatae fructus |
| H01AA | ACTH |
| H01AC | Somatropin and somatropin agonists |
| H01AC01 | somatropin |
| H01BA01 | vasopressin (argipressin) |
| H01BA05 | ornipressin |
| H01BB01 | demoxytocin |
| H01CB02 | octreotide |
| H01CC04 | linzagolix |
| H02AB | Glucocorticoids |
| H02AB06 | prednisolone |
| H02AB09 | hydrocortisone |
| H02AB17 | cortivazol |
| H02B | CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS |
| H03AA02 | liothyronine sodium |
| H03AA03 | combinations of levothyroxine and liothyronine |
| H03BB | Sulfur-containing imidazole derivatives |
| H03BC | Perchlorates |
| H05AA01 | parathyroid gland extract |
| H05AA03 | parathyroid hormone |
| H05BA02 | calcitonin (pork natural) |
| H05BX | Other anti-parathyroid agents |
| J01AA05 | metacycline |
| J01AA07 | tetracycline |
| J01AA09 | rolitetracycline |
| J01AA14 | sarecycline |
| J01BA | Amphenicols |
| J01C | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| J01CA | Penicillins with extended spectrum |
| J01CA14 | metampicillin |
| J01CE04 | azidocillin |
| J01CE06 | penamecillin |
| J01CR05 | piperacillin and beta-lactamase inhibitor |
| J01D | OTHER BETA-LACTAM ANTIBACTERIALS |
| J01DB02 | cefaloridine |
| J01DC02 | cefuroxime |
| J01DD03 | cefsulodin |
| J01DD06 | latamoxef |
| J01DI04 | cefiderocol |
| J01EB20 | combinations |
| J01ED02 | sulfalene |
| J01ED05 | sulfamethoxypyridazine |
| J01ED08 | sulfaphenazole |
| J01ED09 | sulfamazone |
| J01EE01 | sulfamethoxazole and trimethoprim |
| J01FA06 | roxithromycin |
| J01FA11 | miocamycin |
| J01GA | Streptomycins |
| J01GB | Other aminoglycosides |
| J01GB07 | netilmicin |
| J01GB09 | dibekacin |
| J01MA07 | lomefloxacin |
| J01MA12 | levofloxacin |
| J01MA21 | sitafloxacin |
| J01MB04 | pipemidic acid |
| J01XE51 | nitrofurantoin, combinations |
| J01XX04 | spectinomycin |
| J01XX09 | daptomycin |
| J02A | ANTIMYCOTICS FOR SYSTEMIC USE |
| J04AB06 | enviomycin |
| J04AB30 | capreomycin |
| J04AC01 | isoniazid |
| J04AK06 | delamanid |
| J04AM02 | rifampicin and isoniazid |
| J04AM06 | rifampicin, pyrazinamide, ethambutol and isoniazid |
| J05 | ANTIVIRALS FOR SYSTEMIC USE |
| J05AB03 | vidarabine |
| J05AC02 | rimantadine |
| J05AE03 | ritonavir |
| J05AE09 | tipranavir |
| J05AE10 | darunavir |
| J05AF05 | lamivudine |
| J05AF06 | abacavir |
| J05AF09 | emtricitabine |
| J05AG02 | delavirdine |
| J05AG04 | etravirine |
| J05AG06 | doravirine |
| J05AH02 | oseltamivir |
| J05AH03 | peramivir |
| J05AJ02 | elvitegravir |
| J05AP04 | faldaprevir |
| J05AP51 | sofosbuvir and ledipasvir |
| J05AR06 | emtricitabine, tenofovir disoproxil and efavirenz |
| J05AR07 | stavudine, lamivudine and nevirapine |
| J05AR10 | lopinavir and ritonavir |
| J05AR11 | lamivudine, tenofovir disoproxil and efavirenz |
| J05AR17 | emtricitabine and tenofovir alafenamide |
| J05AR24 | lamivudine, tenofovir disoproxil and doravirine |
| J05AR25 | lamivudine and dolutegravir |
| J05AX | Other antivirals |
| J05AX06 | pleconaril |
| J05AX25 | baloxavir marboxil |
| J05AX28 | bulevirtide |
| J06AA01 | diphtheria antitoxin |
| J06AA03 | snake venom antiserum |
| J06BA | Immunoglobulins, normal human |
| J06BB02 | tetanus immunoglobulin |
| J06BB11 | hepatitis A immunoglobulin |
| J06BB12 | encephalitis, tick borne immunoglobulin |
| J06BC03 | bezlotoxumab |
| J06BD04 | ansuvimab |
| J06BD06 | regdanvimab |
| J07AE02 | cholera, live attenuated |
| J07AG51 | haemophilus influenzae B, combinations with toxoids |
| J07AH07 | meningococcus C, purified polysaccharides antigen conjugated |
| J07AH09 | meningococcus B, multicomponent vaccine |
| J07AP10 | typhoid, combinations with paratyphi types |
| J07BA | Encephalitis vaccines |
| J07BA03 | encephalitis, Japanese, live attenuated |
| J07BE | Mumps vaccines |
| J07BL | Yellow fever vaccines |
| J07BM01 | papillomavirus (human types 6, 11, 16, 18) |
| J07BN05 | covid-19, virus-like particles |
| J07BX | Other viral vaccines |
| J07CA03 | diphtheria-rubella-tetanus |
| J07CA07 | diphtheria-hepatitis B-tetanus |
| J07CA09 | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B |
| L01AA07 | trofosfamide |
| L01AA09 | bendamustine |
| L01AB02 | treosulfan |
| L01AC | Ethylene imines |
| L01AD03 | semustine |
| L01AG | Epoxides |
| L01BA05 | pralatrexate |
| L01BB07 | nelarabine |
| L01BC04 | carmofur |
| L01BC08 | decitabine |
| L01BC59 | trifluridine, combinations |
| L01CA05 | vinflunine |
| L01CD | Taxanes |
| L01CE | Topoisomerase 1 (TOP1) inhibitors |
| L01CX | Other plant alkaloids and natural products |
| L01D | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
| L01DB01 | doxorubicin |
| L01DB05 | zorubicin |
| L01DB09 | valrubicin |
| L01DC01 | bleomycin |
| L01EB | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors |
| L01EB05 | rociletinib |
| L01EC03 | encorafenib |
| L01ED | Anaplastic lymphoma kinase (ALK) inhibitors |
| L01ED03 | alectinib |
| L01EF | Cyclin-dependent kinase (CDK) inhibitors |
| L01EF02 | ribociclib |
| L01EH | Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors |
| L01EL04 | orelabrutinib |
| L01EL05 | pirtobrutinib |
| L01EX | Other protein kinase inhibitors |
| L01EX01 | sunitinib |
| L01EX12 | larotrectinib |
| L01EX17 | capmatinib |
| L01FA02 | ofatumumab |
| L01FF02 | pembrolizumab |
| L01FF08 | prolgolimab |
| L01FF09 | tislelizumab |
| L01FG01 | bevacizumab |
| L01FX10 | olaratumab |
| L01FX14 | polatuzumab vedotin |
| L01FX15 | belantamab mafodotin |
| L01FX20 | tremelimumab |
| L01FX28 | glofitamab |
| L01XD01 | porfimer sodium |
| L01XD04 | aminolevulinic acid |
| L01XD06 | efaproxiral |
| L01XH04 | belinostat |
| L01XX23 | mitotane |
| L01XX44 | aflibercept |
| L01XX52 | venetoclax |
| L01XX77 | adagrasib |
| L01XX78 | navitoclax |
| L01XX80 | imetelstat |
| L02AE01 | buserelin |
| L02BB05 | apalutamide |
| L02BG04 | letrozole |
| L02BX03 | abiraterone |
| L03AA14 | lipegfilgrastim |
| L03AB03 | interferon gamma |
| L03AX21 | elapegademase |
| L04AB06 | golimumab |
| L04AC | Interleukin inhibitors |
| L04AC22 | spesolimab |
| L04AJ01 | eculizumab |
| L04AK | Dihydroorotate dehydrogenase (DHODH) inhibitors |
| L04AX09 | diroximel fumarate |
| M01AB08 | etodolac |
| M01AC02 | tenoxicam |
| M01AC05 | lornoxicam |
| M01AE11 | tiaprofenic acid |
| M01AE17 | dexketoprofen |
| M01AG03 | flufenamic acid |
| M01AH02 | rofecoxib |
| M01AH06 | lumiracoxib |
| M01BA02 | dipyrocetyl and corticosteroids |
| M01BA03 | acetylsalicylic acid and corticosteroids |
| M01BX | Other antiinflammatory/antirheumatic agents in combination with other drugs |
| M02AA | Antiinflammatory preparations, non-steroids for topical use |
| M02AA04 | oxyphenbutazone |
| M02AA09 | bufexamac |
| M02AA16 | feprazone |
| M02AA22 | suxibuzone |
| M02AB01 | capsaicin |
| M03AA | Curare alkaloids |
| M03AC03 | vecuronium |
| M03AC06 | pipecuronium bromide |
| M03AC10 | mivacurium chloride |
| M03AC11 | cisatracurium |
| M03BA73 | methocarbamol, combinations with psycholeptics |
| M03BC01 | orphenadrine (citrate) |
| M03BX04 | tolperisone |
| M03BX30 | fenyramidol |
| M04AA01 | allopurinol |
| M05BA04 | alendronic acid |
| M05BA05 | tiludronic acid |
| M05BX03 | strontium ranelate |
| M09AB01 | chymopapain |
| N01AA02 | vinyl ether |
| N01AB02 | chloroform |
| N01AF03 | thiopental |
| N01AG | Barbiturates in combination with other drugs |
| N01AH04 | phenoperidine |
| N01AX11 | sodium oxybate |
| N01AX13 | nitrous oxide |
| N01BA02 | procaine |
| N01BB01 | bupivacaine |
| N01BB03 | mepivacaine |
| N01BB51 | bupivacaine, combinations |
| N01BB52 | lidocaine, combinations |
| N02AA03 | hydromorphone |
| N02AA55 | oxycodone and naloxone |
| N02AA79 | codeine, combinations with psycholeptics |
| N02AC | Diphenylpropylamine derivatives |
| N02AC52 | methadone, combinations excl. psycholeptics |
| N02AJ02 | dihydrocodeine and acetylsalicylic acid |
| N02AJ08 | codeine and ibuprofen |
| N02AJ16 | tramadol and celecoxib |
| N02AJ18 | oxycodone and acetylsalicylic acid |
| N02AX | Other opioids |
| N02BA12 | potassium salicylate |
| N02BA59 | dipyrocetyl, combinations excl. psycholeptics |
| N02BB52 | metamizole sodium, combinations excl. psycholeptics |
| N02BB73 | aminophenazone, combinations with psycholeptics |
| N02BE01 | paracetamol |
| N02CA01 | dihydroergotamine |
| N02CC04 | rizatriptan |
| N02CC07 | frovatriptan |
| N02CD01 | erenumab |
| N02CD05 | eptinezumab |
| N02CX05 | dimetotiazine |
| N03AB01 | ethotoin |
| N03AB04 | mephenytoin |
| N03AD01 | ethosuximide |
| N03AF01 | carbamazepine |
| N03AG04 | vigabatrin |
| N03AX07 | phenacemide |
| N03AX09 | lamotrigine |
| N03AX14 | levetiracetam |
| N03AX22 | perampanel |
| N03AX25 | cenobamate |
| N04AA01 | trihexyphenidyl |
| N04AA02 | biperiden |
| N04AB | Ethers chemically close to antihistamines |
| N04BA06 | etilevodopa and decarboxylase inhibitor |
| N04BC02 | pergolide |
| N04BC05 | pramipexole |
| N04BX02 | entacapone |
| N04BX04 | opicapone |
| N04C | OTHER ANTIPARKINSON DRUGS |
| N05AA05 | triflupromazine |
| N05AA07 | chlorproethazine |
| N05AB01 | dixyrazine |
| N05AB02 | fluphenazine |
| N05AB06 | trifluoperazine |
| N05AF01 | flupentixol |
| N05AG03 | penfluridol |
| N05AH | Diazepines, oxazepines, thiazepines and oxepines |
| N05AH04 | quetiapine |
| N05AL02 | sultopride |
| N05AL04 | remoxipride |
| N05BA | Benzodiazepine derivatives |
| N05BA08 | bromazepam |
| N05BA11 | prazepam |
| N05BA23 | tofisopam |
| N05BX02 | gedocarnil |
| N05CA06 | secobarbital |
| N05CB | Barbiturates, combinations |
| N05CB02 | barbiturates in combination with other drugs |
| N05CD02 | nitrazepam |
| N05CD11 | loprazolam |
| N05CE | Piperidinedione derivatives |
| N05CH02 | ramelteon |
| N05CM04 | carbromal |
| N05CM16 | niaprazine |
| N06AA05 | opipramol |
| N06AA13 | iprindole |
| N06AB03 | fluoxetine |
| N06AF | Monoamine oxidase inhibitors, non-selective |
| N06AF01 | isocarboxazid |
| N06AG | Monoamine oxidase A inhibitors |
| N06AX04 | nomifensine |
| N06AX18 | reboxetine |
| N06AX19 | gepirone |
| N06AX21 | duloxetine |
| N06AX62 | bupropion and dextromethorphan |
| N06BA02 | dexamfetamine |
| N06BA03 | metamfetamine |
| N06BA10 | fenetylline |
| N06BA13 | armodafinil |
| N06BC | Xanthine derivatives |
| N06BC02 | propentofylline |
| N06BX | Other psychostimulants and nootropics |
| N06BX06 | citicoline |
| N06BX15 | pipradrol |
| N06CA01 | amitriptyline and psycholeptics |
| N06DA03 | rivastigmine |
| N06DX | Other anti-dementia drugs |
| N06DX01 | memantine |
| N06DX05 | donanemab |
| N07 | OTHER NERVOUS SYSTEM DRUGS |
| N07AA02 | pyridostigmine |
| N07AA51 | neostigmine, combinations |
| N07BC | Drugs used in opioid dependence |
| N07BC06 | diamorphine |
| N07BC51 | buprenorphine, combinations |
| N07CA01 | betahistine |
| N07XX19 | sodium phenylbutyrate and ursodoxicoltaurine |
| P01AA | Hydroxyquinoline derivatives |
| P01AB01 | metronidazole |
| P01AB02 | tinidazole |
| P01BB | Biguanides |
| P01BD | Diaminopyrimidines |
| P01BE | Artemisinin and derivatives, plain |
| P01BF01 | artemether and lumefantrine |
| P01BX02 | arterolane and piperaquine |
| P02BA02 | oxamniquine |
| P02BX | Other antitrematodal agents |
| P02CA05 | flubendazole |
| P02CC | Tetrahydropyrimidine derivatives |
| P02CX01 | pyrvinium |
| P02DX02 | dichlorophen |
| P03AB02 | lindane |
| P03AC53 | phenothrin, combinations |
| P03B | INSECTICIDES AND REPELLENTS |
| P03BX05 | dimethylcarbate |
| P03BX06 | etohexadiol |
| R01 | NASAL PREPARATIONS |
| R01AA12 | fenoxazoline |
| R01AC05 | spaglumic acid |
| R01AC07 | nedocromil |
| R01AC51 | cromoglicic acid, combinations |
| R01AD | Corticosteroids |
| R01AD60 | hydrocortisone, combinations |
| R01AX10 | various |
| R02AB04 | bacitracin |
| R02AB30 | gramicidin |
| R02AD01 | benzocaine |
| R02AD04 | dyclonine |
| R02AX02 | ibuprofen |
| R03AB | Non-selective beta-adrenoreceptor agonists |
| R03AC06 | hexoprenaline |
| R03AC11 | tulobuterol |
| R03AK09 | formoterol and mometasone |
| R03AL03 | vilanterol and umeclidinium bromide |
| R03AL12 | indacaterol, glycopyrronium bromide and mometasone |
| R03B | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| R03BB04 | tiotropium bromide |
| R03BB05 | aclidinium bromide |
| R03BB08 | revefenacin |
| R03BX | Other drugs for obstructive airway diseases, inhalants |
| R03CA | Alpha- and beta-adrenoreceptor agonists |
| R03CB | Non-selective beta-adrenoreceptor agonists |
| R03CB03 | orciprenaline |
| R03CC | Selective beta-2-adrenoreceptor agonists |
| R03CC08 | procaterol |
| R03DA09 | acefylline piperazine |
| R03DA12 | mepyramine theophyllinacetate |
| R03DA20 | combinations of xanthines |
| R05CB | Mucolytics |
| R05CB13 | dornase alfa (desoxyribonuclease) |
| R05DA09 | dextromethorphan |
| R05DB11 | pipazetate |
| R05DB22 | meprotixol |
| R05DB23 | piperidione |
| R05DB27 | levodropropizine |
| R05DB28 | dimethoxanate |
| R06AA11 | dimenhydrinate |
| R06AA59 | doxylamine, combinations |
| R06AB04 | chlorphenamine |
| R06AB51 | brompheniramine, combinations |
| R06AC02 | histapyrrodine |
| R06AC03 | chloropyramine |
| R06AD01 | alimemazine |
| R06AD02 | promethazine |
| R06AD52 | promethazine, combinations |
| R06AD55 | hydroxyethylpromethazine, combinations |
| R06AE | Piperazine derivatives |
| R06AE53 | cyclizine, combinations |
| R06AX01 | bamipine |
| R06AX02 | cyproheptadine |
| R06AX12 | terfenadine |
| R06AX18 | acrivastine |
| R07AA30 | combinations |
| R07AB | Respiratory stimulants |
| R07AX30 | ivacaftor and lumacaftor |
| S01A | ANTIINFECTIVES |
| S01AA | Antibiotics |
| S01AA10 | natamycin |
| S01AA15 | dihydrostreptomycin |
| S01AA24 | kanamycin |
| S01AA25 | azidamfenicol |
| S01AA31 | cefmenoxime |
| S01AA32 | bacitracin |
| S01AD08 | fomivirsen |
| S01AE01 | ofloxacin |
| S01AE05 | levofloxacin |
| S01AX06 | resorcinol |
| S01AX09 | chlorhexidine |
| S01BA10 | alclometasone |
| S01BB01 | hydrocortisone and mydriatics |
| S01BC03 | diclofenac |
| S01BC11 | bromfenac |
| S01CB04 | betamethasone |
| S01CC01 | diclofenac and antiinfectives |
| S01EB02 | carbachol |
| S01EB06 | neostigmine |
| S01EB51 | pilocarpine, combinations |
| S01ED02 | betaxolol |
| S01FA05 | homatropine |
| S01GA05 | phenylephrine |
| S01GA07 | brimonidine |
| S01GX02 | levocabastine |
| S01GX06 | emedastine |
| S01GX09 | olopatadine |
| S01L | OCULAR VASCULAR DISORDER AGENTS |
| S01XA08 | acetylcysteine |
| S01XA19 | limbal stem cells, autologous |
| S02AA10 | acetic acid |
| S02AA12 | rifamycin |
| S02BA | Corticosteroids |
| S02DA04 | cinchocaine |
| S03AA05 | hexamidine |
| S03AA08 | chloramphenicol |
| V01AA04 | mould fungus and yeast fungus |
| V01AA09 | textiles |
| V01AA10 | flowers |
| V03AB02 | nalorphine |
| V03AB13 | obidoxime |
| V03AB36 | phentolamine |
| V03AB37 | idarucizumab |
| V03AC01 | deferoxamine |
| V03AF02 | dexrazoxane |
| V03AN05 | medical air |
| V03AX03 | cobicistat |
| V04CD04 | corticorelin |
| V04CE | Tests for liver functional capacity |
| V04CE01 | galactose |
| V04CH03 | phenolsulfonphthalein |
| V04CH30 | aminohippuric acid |
| V04CJ02 | protirelin |
| V04CK01 | secretin |
| V04CX08 | carbon monoxide |
| V06DC | Carbohydrates |
| V06DE | Amino acids/carbohydrates/minerals/vitamins, combinations |
| V06DX | Other combinations of nutrients |
| V07A | ALL OTHER NON-THERAPEUTIC PRODUCTS |
| V07AN | Incontinence equipment |
| V08AA04 | iotalamic acid |
| V08AA06 | ioglicic acid |
| V08AC04 | adipiodone |
| V08BA02 | barium sulfate without suspending agents |
| V08CA07 | ferric ammonium citrate |
| V08CB03 | iron oxide, nanoparticles |
| V08DA01 | perflutren, human albumin microspheres |
| V08DA02 | microparticles of galactose |
| V09AX03 | iodine (124I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane |
| V09C | RENAL SYSTEM |
| V09CA | Technetium (99mTc) compounds |
| V09CX | Other renal system diagnostic radiopharmaceuticals |
| V09DX01 | selenium (75Se) tauroselcholic acid |
| V09FX | Various thyroid diagnostic radiopharmaceuticals |
| V09G | CARDIOVASCULAR SYSTEM |
| V09H | INFLAMMATION AND INFECTION DETECTION |
| V09HA03 | technetium (99mTc) antigranulocyte antibody |
| V09HB | Indium (111In) compounds |
| V09IA07 | technetium (99mTc) hynic-octreotide |
| V09IA08 | technetium (99mTc) etarfolatide |
| V09IB02 | indium (111In) satumomab pendetide |
| V09IX | Other diagnostic radiopharmaceuticals for tumour detection |
| V09IX06 | sodium fluoride (18F) |
| V09IX08 | fluoroethylcholine (18F) |
| V10A | ANTIINFLAMMATORY AGENTS |
| V10B | PAIN PALLIATION (BONE SEEKING AGENTS) |
| V10XX01 | sodium phosphate (32P) |
| A01AA04 | stannous fluoride |
| A01AB | Antiinfectives and antiseptics for local oral treatment |
| A01AB03 | chlorhexidine |
| A01AB21 | chlortetracycline |
| A01AB23 | minocycline |
| A01AC | Corticosteroids for local oral treatment |
| A01AC01 | triamcinolone |
| A01AD11 | various |
| A02A | ANTACIDS |
| A02AC | Calcium compounds |
| A02AD | Combinations and complexes of aluminium, calcium and magnesium compounds |
| A02AF02 | ordinary salt combinations and antiflatulents |
| A02BA03 | famotidine |
| A02BC04 | rabeprazole |
| A02BC07 | dexrabeprazole |
| A02BC54 | rabeprazole, combinations |
| A02BD04 | pantoprazole, amoxicillin and clarithromycin |
| A02BD15 | vonoprazan, amoxicillin and metronidazole |
| A03AB02 | glycopyrronium bromide |
| A03AB21 | fenpiverinium |
| A03AC | Synthetic antispasmodics, amides with tertiary amines |
| A03AD30 | moxaverine |
| A03AE | Serotonin receptor antagonists |
| A03AX02 | diisopromine |
| A03AX11 | caroverine |
| A03CA | Synthetic anticholinergic agents in combination with psycholeptics |
| A03CA07 | ambutonium and psycholeptics |
| A04AA05 | palonosetron |
| A04AD04 | chlorobutanol |
| A04AD11 | nabilone |
| A04AD14 | rolapitant |
| A05AA01 | chenodeoxycholic acid |
| A05AA02 | ursodeoxycholic acid |
| A05AX03 | cyclobutyrol |
| A05BA06 | ornithine oxoglurate |
| A05BA07 | tidiacic arginine |
| A06AA51 | liquid paraffin, combinations |
| A06AB | Contact laxatives |
| A06AB20 | contact laxatives in combination |
| A06AC | Bulk-forming laxatives |
| A06AD04 | magnesium sulfate |
| A06AD14 | pentaerithrityl |
| A06AX03 | lubiprostone |
| A06AX07 | plecanatide |
| A06AX08 | tenapanor |
| A07AA | Antibiotics |
| A07AA10 | colistin |
| A07AA11 | rifaximin |
| A07AA54 | streptomycin, combinations |
| A07AX01 | broxyquinoline |
| A07DA01 | diphenoxylate |
| A07DA03 | loperamide |
| A07FA | Antidiarrheal microorganisms |
| A07FA02 | saccharomyces boulardii |
| A09AB01 | glutamic acid hydrochloride |
| A10AC03 | insulin (pork) |
| A10AC30 | combinations |
| A10AE03 | insulin (pork) |
| A10AE30 | combinations |
| A10AE54 | insulin glargine and lixisenatide |
| A10BA03 | buformin |
| A10BB | Sulfonylureas |
| A10BB05 | tolazamide |
| A10BB06 | carbutamide |
| A10BC | Sulfonamides (heterocyclic) |
| A10BD | Combinations of oral blood glucose lowering drugs |
| A10BD09 | pioglitazone and alogliptin |
| A10BD10 | metformin and saxagliptin |
| A10BD27 | metformin, linagliptin and empagliflozin |
| A10BD29 | sitagliptin and dapagliflozin |
| A10BJ06 | semaglutide |
| A10BK02 | canagliflozin |
| A10BX17 | carfloglitazar |
| A10XA | Aldose reductase inhibitors |
| A11AA03 | multivitamins and other minerals, incl. combinations |
| A11AB | Multivitamins, other combinations |
| A11CA | Vitamin A, plain |
| A11CC01 | ergocalciferol |
| A11CC02 | dihydrotachysterol |
| A11G | ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS |
| A11HA07 | inositol |
| A12AA13 | calcium citrate |
| A12AA30 | calcium laevulate |
| A12BA02 | potassium citrate |
| A12BA51 | potassium chloride, combinations |
| A12CC06 | magnesium lactate |
| A12CC10 | magnesium oxide |
| A12CD01 | sodium fluoride |
| A12CE01 | sodium selenate |
| A14AA05 | oxymetholone |
| A14AB | Estren derivatives |
| A16AA02 | ademetionine |
| A16AA04 | mercaptamine |
| A16AB02 | imiglucerase |
| A16AB09 | idursulfase |
| A16AB11 | taliglucerase alfa |
| A16AB26 | eladocagene exuparvovec |
| A16AX05 | zinc acetate |
| A16AX07 | sapropterin |
| A16AX11 | sodium benzoate |
| A16AX16 | givosiran |
| B01AA02 | phenindione |
| B01AB02 | antithrombin III |
| B01AB05 | enoxaparin |
| B01AB12 | bemiparin |
| B01AC04 | clopidogrel |
| B01AD02 | alteplase |
| B01AD09 | ancrod |
| B01AF03 | edoxaban |
| B02AA | Amino acids |
| B02BC30 | combinations |
| B02BD | Blood coagulation factors |
| B02BD05 | coagulation factor VII |
| B02BD13 | coagulation factor X |
| B03AD05 | ferrous gluconate and folic acid |
| B03AE04 | iron, multivitamins and minerals |
| B03BA02 | cyanocobalamin tannin complex |
| B03BA03 | hydroxocobalamin |
| B03BB01 | folic acid |
| B03XA06 | luspatercept |
| B03XA08 | vadadustat |
| B05A | BLOOD AND RELATED PRODUCTS |
| B05AA | Blood substitutes and plasma protein fractions |
| B05AA07 | hydroxyethylstarch |
| B05BA03 | carbohydrates |
| B05BB04 | electrolytes in combination with other drugs |
| B05C | IRRIGATING SOLUTIONS |
| B05CA02 | chlorhexidine |
| B05D | PERITONEAL DIALYTICS |
| B05XA05 | magnesium sulfate |
| B05XA07 | calcium chloride |
| B05XA08 | sodium acetate |
| B05XA11 | magnesium chloride |
| B05XA17 | potassium acetate |
| B05XB03 | lysine |
| B06AA07 | trypsin |
| B06AC02 | icatibant |
| B06AC03 | ecallantide |
| B06AX | Other hematological agents |
| B06AX02 | betibeglogene autotemcel |
| C01AA04 | digitoxin |
| C01AA05 | digoxin |
| C01AA09 | gitoformate |
| C01AB01 | proscillaridin |
| C01BB | Antiarrhythmics, class Ib |
| C01BB01 | lidocaine |
| C01BD07 | dronedarone |
| C01BG | Other antiarrhythmics, class I and III |
| C01CA10 | methoxamine |
| C01CA19 | fenoldopam |
| C01CA21 | cafedrine |
| C01CE04 | bucladesine |
| C01CX08 | levosimendan |
| C01DA08 | isosorbide dinitrate |
| C01DA09 | trolnitrate |
| C01DA13 | eritrityl tetranitrate |
| C01DA38 | tenitramine |
| C01DA63 | eritrityl tetranitrate, combinations |
| C01DX01 | itramin tosilate |
| C01DX02 | prenylamine |
| C01DX05 | carbocromen |
| C01DX08 | heptaminol |
| C01DX18 | linsidomine |
| C01EB07 | fructose 1,6-diphosphate |
| C01EB17 | ivabradine |
| C01EB23 | tiazotic acid |
| C02AB02 | methyldopa (racemic) |
| C02AC04 | tolonidine |
| C02CC | Guanidine derivatives |
| C02CC01 | betanidine |
| C02DB03 | endralazine |
| C02KX02 | ambrisentan |
| C02KX05 | riociguat |
| C02LA03 | deserpidine and diuretics |
| C02LB | Methyldopa and diuretics in combination |
| C02LC01 | clonidine and diuretics |
| C03AA13 | mebutizide |
| C03BA05 | mefruside |
| C03BA13 | fenquizone |
| C03CC | Aryloxyacetic acid derivatives |
| C03CC02 | tienilic acid |
| C03DA | Aldosterone antagonists |
| C03DA05 | finerenone |
| C03EA05 | mebutizide and potassium-sparing agents |
| C03EB | High-ceiling diuretics and potassium-sparing agents |
| C04AC01 | nicotinic acid |
| C04AX20 | buflomedil |
| C04AX26 | cetiedil |
| C05AA01 | hydrocortisone |
| C05AA08 | fluocortolone |
| C05AD02 | tetracaine |
| C05AD04 | cinchocaine |
| C05AD06 | oxetacaine |
| C05AX | Other agents for treatment of hemorrhoids and anal fissures for topical use |
| C05AX02 | bismuth preparations, combinations |
| C05BA | Heparins or heparinoids for topical use |
| C05BA02 | sodium apolate |
| C05CA01 | rutoside |
| C05CA02 | monoxerutin |
| C05CA53 | diosmin, combinations |
| C07AA14 | mepindolol |
| C07AA15 | carteolol |
| C07AB06 | bevantolol |
| C07AB07 | bisoprolol |
| C07BB04 | acebutolol and thiazides |
| C07CA23 | penbutolol and other diuretics |
| C07CB | Beta blocking agents, selective, and other diuretics |
| C07CB53 | atenolol and other diuretics, combinations |
| C07CG | Alpha and beta blocking agents and other diuretics |
| C07FX | Beta blocking agents, other combinations |
| C07FX05 | metoprolol and ivabradine |
| C07FX06 | carvedilol and ivabradine |
| C08C | SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS |
| C08CA08 | nitrendipine |
| C08DB | Benzothiazepine derivatives |
| C08G | CALCIUM CHANNEL BLOCKERS AND DIURETICS |
| C09AA01 | captopril |
| C09AA05 | ramipril |
| C09AA14 | temocapril |
| C09BB | ACE inhibitors and calcium channel blockers |
| C09BB05 | ramipril and felodipine |
| C09BB07 | ramipril and amlodipine |
| C09BX | ACE inhibitors, other combinations |
| C09BX06 | perindopril, bisoprolol, amlodipine and indapamide |
| C09CA | Angiotensin II receptor blockers (ARBs), plain |
| C09DA02 | eprosartan and diuretics |
| C09DA07 | telmisartan and diuretics |
| C09DB08 | valsartan and lercanidipine |
| C09DX01 | valsartan, amlodipine and hydrochlorothiazide |
| C10AA06 | cerivastatin |
| C10AB04 | gemfibrozil |
| C10AC | Bile acid sequestrants |
| C10AD52 | nicotinic acid, combinations |
| C10AX08 | policosanol |
| C10BA09 | rosuvastatin and fenofibrate |
| C10BX03 | atorvastatin and amlodipine |
| C10BX10 | rosuvastatin and valsartan |
| D01AA01 | nystatin |
| D01AC05 | isoconazole |
| D01AC07 | tioconazole |
| D01AC08 | ketoconazole |
| D01AC09 | sulconazole |
| D01AC17 | eberconazole |
| D01AC19 | efinaconazole |
| D01BA03 | fosravuconazole |
| D03A | CICATRIZANTS |
| D03AX02 | dextranomer |
| D03AX13 | Betulae cortex |
| D03BA02 | collagenase |
| D05A | ANTIPSORIATICS FOR TOPICAL USE |
| D05AC01 | dithranol |
| D05AX52 | calcipotriol, combinations |
| D05BA01 | trioxysalen |
| D05BB01 | etretinate |
| D05BX51 | fumaric acid derivatives, combinations |
| D06AA04 | tetracycline |
| D06AX04 | neomycin |
| D06AX10 | virginiamycin |
| D06AX15 | rifamycin |
| D07AC03 | desoximetasone |
| D07AC08 | fluocinonide |
| D07AC18 | prednicarbate |
| D07AD02 | halcinonide |
| D07BA | Corticosteroids, weak, combinations with antiseptics |
| D07BC03 | fluocortolone and antiseptics |
| D07C | CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS |
| D07CC | Corticosteroids, potent, combinations with antibiotics |
| D07CC02 | fluocinolone acetonide and antibiotics |
| D07XA | Corticosteroids, weak, other combinations |
| D07XC02 | desoximetasone |
| D08AE02 | policresulen |
| D08AG | Iodine products |
| D08AH30 | clioquinol |
| D08AK30 | mercuric iodide |
| D09AA07 | cetylpyridinium |
| D09AA10 | clioquinol |
| D10AF02 | erythromycin |
| D10AF03 | chloramphenicol |
| D10AX | Other anti-acne preparations for topical use |
| D10AX01 | aluminium chloride |
| D10AX02 | resorcinol |
| D10AX04 | aluminium oxide |
| D10AX06 | clascoterone |
| D10B | ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE |
| D11AA01 | glycopyrronium |
| D11AC08 | sulfur compounds |
| D11AF | Wart and anti-corn preparations |
| D11AH05 | dupilumab |
| D11AX06 | mequinol |
| D11AX09 | oxaceprol |
| D11AX11 | hydroquinone |
| G01AA | Antibiotics |
| G01AC06 | broxyquinoline |
| G01AX11 | povidone-iodine |
| G02AB01 | methylergometrine |
| G02AB02 | ergot alkaloids |
| G02BB | Intravaginal contraceptives |
| G02CX | Other gynecologicals |
| G03AA08 | medroxyprogesterone and ethinylestradiol |
| G03AA18 | drospirenone and estetrol |
| G03AB01 | megestrol and ethinylestradiol |
| G03AC09 | desogestrel |
| G03AD02 | ulipristal |
| G03CA06 | chlorotrianisene |
| G03CA07 | estrone |
| G03CB01 | dienestrol |
| G03CC03 | methallenestril |
| G03DA03 | hydroxyprogesterone |
| G03DA04 | progesterone |
| G03E | ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION |
| G03FA04 | progesterone and estrogen |
| G03FB03 | chlormadinone and estrogen |
| G03FB12 | nomegestrol and estrogen |
| G04BA03 | calcium chloride |
| G04BC | Urinary concrement solvents |
| G04BD01 | emepronium |
| G04BD07 | tolterodine |
| G04BD12 | mirabegron |
| G04BD15 | vibegron |
| G04BE02 | papaverine |
| G04BE07 | apomorphine |
| G04BE09 | vardenafil |
| G04BX01 | magnesium hydroxide |
| G04CA03 | terazosin |
| G04CB51 | finasteride and tadalafil |
| G04CX03 | mepartricin |
| H01AC03 | mecasermin |
| H01CC53 | elagolix, estradiol and norethisterone |
| H02 | CORTICOSTEROIDS FOR SYSTEMIC USE |
| H02AB15 | meprednisone |
| H02AB18 | vamorolone |
| H03BB02 | thiamazole |
| H03BX | Other antithyroid preparations |
| H04AA02 | dasiglucagon |
| H05 | CALCIUM HOMEOSTASIS |
| H05AA04 | abaloparatide |
| H05BA | Calcitonin preparations |
| H05BX05 | calcifediol |
| J01A | TETRACYCLINES |
| J01AA01 | demeclocycline |
| J01AA06 | oxytetracycline |
| J01AA15 | omadacycline |
| J01AA56 | oxytetracycline, combinations |
| J01CA03 | carbenicillin |
| J01CA15 | talampicillin |
| J01CE01 | benzylpenicillin |
| J01CE05 | pheneticillin |
| J01CE30 | combinations |
| J01DB04 | cefazolin |
| J01DB05 | cefadroxil |
| J01DB06 | cefazedone |
| J01DB07 | cefatrizine |
| J01DB08 | cefapirin |
| J01DB12 | ceftezole |
| J01DD01 | cefotaxime |
| J01DD54 | ceftriaxone, combinations |
| J01DH51 | imipenem and cilastatin |
| J01DI54 | ceftolozane and beta-lactamase inhibitor |
| J01EA01 | trimethoprim |
| J01EA02 | brodimoprim |
| J01EA03 | iclaprim |
| J01EC20 | combinations |
| J01ED04 | sulfametoxydiazine |
| J01FA01 | erythromycin |
| J01FA07 | josamycin |
| J01FA12 | rokitamycin |
| J01FG01 | pristinamycin |
| J01GB05 | neomycin |
| J01GB06 | amikacin |
| J01GB13 | bekanamycin |
| J01MA04 | enoxacin |
| J01MA10 | rufloxacin |
| J01MA16 | gatifloxacin |
| J01MA22 | tosufloxacin |
| J01MB02 | nalidixic acid |
| J01RA05 | levofloxacin and ornidazole |
| J01RA06 | cefepime and amikacin |
| J01RA14 | norfloxacin and metronidazole |
| J01XA04 | dalbavancin |
| J01XD03 | ornidazole |
| J01XX01 | fosfomycin |
| J01XX03 | clofoctol |
| J01XX05 | methenamine |
| J01XX08 | linezolid |
| J01XX11 | tedizolid |
| J02AB | Imidazole derivatives |
| J02AB02 | ketoconazole |
| J04AC51 | isoniazid, combinations |
| J04AD02 | tiocarlide |
| J04AK08 | pretomanid |
| J04AM04 | thioacetazone and isoniazid |
| J04AM07 | rifampicin, ethambutol and isoniazid |
| J05AC03 | tromantadine |
| J05AF11 | telbivudine |
| J05AG | Non-nucleoside reverse transcriptase inhibitors |
| J05AG03 | efavirenz |
| J05AJ | Integrase inhibitors |
| J05AP09 | dasabuvir |
| J05AP10 | elbasvir |
| J05AR13 | lamivudine, abacavir and dolutegravir |
| J05AR20 | emtricitabine, tenofovir alafenamide and bictegravir |
| J05AR28 | stavudine and lamivudine |
| J05AX02 | lysozyme |
| J05AX17 | enisamium iodide |
| J05AX27 | favipiravir |
| J06AA02 | tetanus antitoxin |
| J06AA06 | rabies serum |
| J06BB08 | staphylococcus immunoglobulin |
| J06BB09 | cytomegalovirus immunoglobulin |
| J06BB30 | combinations |
| J06BD | Antiviral monoclonal antibodies |
| J07A | BACTERIAL VACCINES |
| J07AH05 | other meningococcal polyvalent purified polysaccharides antigen |
| J07AH08 | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated |
| J07AH10 | meningococcus A, purified polysaccharides antigen conjugated |
| J07AP02 | typhoid, inactivated, whole cell |
| J07AX | Other bacterial vaccines |
| J07BD53 | measles, combinations with rubella, live attenuated |
| J07BD54 | measles, combinations with mumps, rubella and varicella, live attenuated |
| J07BF | Poliomyelitis vaccines |
| J07BF01 | poliomyelitis oral, monovalent, live attenuated |
| J07BF04 | poliomyelitis oral, bivalent, live attenuated |
| J07BG | Rabies vaccines |
| J07BH | Rota virus diarrhea vaccines |
| J07BH01 | rota virus, live attenuated |
| J07BM | Papillomavirus vaccines |
| J07BN | Covid-19 vaccines |
| J07BN03 | covid-19, inactivated virus |
| J07CA05 | diphtheria-hepatitis B-pertussis-tetanus |
| J07XA | Parasitic vaccines |
| L01AA | Nitrogen mustard analogues |
| L01AD06 | nimustine |
| L01BA | Folic acid analogues |
| L01BB04 | cladribine |
| L01BC | Pyrimidine analogues |
| L01C | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| L01CA04 | vinorelbine |
| L01CC01 | demecolcine |
| L01CD02 | docetaxel |
| L01CD51 | paclitaxel and encequidar |
| L01DB07 | mitoxantrone |
| L01DC03 | mitomycin |
| L01EA02 | dasatinib |
| L01EA04 | bosutinib |
| L01ED05 | lorlatinib |
| L01EF03 | abemaciclib |
| L01EG04 | sirolimus |
| L01EJ04 | momelotinib |
| L01EK01 | axitinib |
| L01EM02 | copanlisib |
| L01EM03 | alpelisib |
| L01EN03 | infigratinib |
| L01EX11 | quizartinib |
| L01EX26 | sitravatinib |
| L01FB01 | inotuzumab ozogamicin |
| L01FC01 | daratumumab |
| L01FD01 | trastuzumab |
| L01FF04 | avelumab |
| L01FX03 | catumaxomab |
| L01FX05 | brentuximab vedotin |
| L01FX06 | dinutuximab beta |
| L01FX07 | blinatumomab |
| L01FX13 | enfortumab vedotin |
| L01FX27 | epcoritamab |
| L01FY01 | pertuzumab and trastuzumab |
| L01XA03 | oxaliplatin |
| L01XA05 | polyplatillen |
| L01XJ01 | vismodegib |
| L01XK | Poly (ADP-ribose) polymerase (PARP) inhibitors |
| L01XK03 | rucaparib |
| L01XK52 | niraparib and abiraterone |
| L01XL06 | brexucabtagene autoleucel |
| L01XX02 | asparaginase |
| L01XX03 | altretamine |
| L01XX74 | belzutifan |
| L02AA | Estrogens |
| L02AA04 | fosfestrol |
| L02AE03 | goserelin |
| L02BA03 | fulvestrant |
| L02BG | Aromatase inhibitors |
| L02BG05 | vorozole |
| L03AA02 | filgrastim |
| L03AA15 | balugrastim |
| L03AA19 | eflapegrastim |
| L03AB07 | interferon beta-1a |
| L03AX02 | roquinimex |
| L03AX04 | pegademase |
| L03AX07 | poly I:C |
| L04 | IMMUNOSUPPRESSANTS |
| L04AA28 | belatacept |
| L04AB01 | etanercept |
| L04AC05 | ustekinumab |
| L04AC08 | canakinumab |
| L04AD01 | ciclosporin |
| L04AH01 | sirolimus |
| L04AJ07 | crovalimab |
| L04AJ08 | iptacopan |
| L04AK01 | leflunomide |
| L04AX | Other immunosuppressants |
| L04AX02 | thalidomide |
| L04AX03 | methotrexate |
| L04AX06 | pomalidomide |
| L04AX07 | dimethyl fumarate |
| M | MUSCULO-SKELETAL SYSTEM |
| M01AA06 | kebuzone |
| M01AB11 | acemetacin |
| M01AB12 | difenpiramide |
| M01AC04 | droxicam |
| M01AC06 | meloxicam |
| M01AE | Propionic acid derivatives |
| M01AE06 | benoxaprofen |
| M01AE53 | ketoprofen, combinations |
| M01AE57 | naproxen and diphenhydramine |
| M01AG01 | mefenamic acid |
| M01AG02 | tolfenamic acid |
| M01AH | Coxibs |
| M01AX07 | benzydamine |
| M01AX13 | proquazone |
| M01AX18 | feprazone |
| M01AX68 | feprazone, combinations |
| M01CA03 | oxycinchophen |
| M01CB | Gold preparations |
| M01CX | Other specific antirheumatic agents |
| M02AA03 | clofezone |
| M02AA05 | benzydamine |
| M02AA17 | niflumic acid |
| M03 | MUSCLE RELAXANTS |
| M03A | MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
| M03AC02 | gallamine |
| M03AC05 | hexafluronium |
| M03BA02 | carisoprodol |
| M03BA04 | styramate |
| M03BA72 | carisoprodol, combinations with psycholeptics |
| M03BB | Oxazol, thiazine, and triazine derivatives |
| M03BB72 | chlormezanone, combinations with psycholeptics |
| M03BC | Ethers, chemically close to antihistamines |
| M03C | MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
| M04 | ANTIGOUT PREPARATIONS |
| M05B | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| M05BA02 | clodronic acid |
| M05BB09 | ibandronic acid and colecalciferol |
| M05BX01 | ipriflavone |
| M09AX07 | nusinersen |
| N01AH02 | alfentanil |
| N01AX | Other general anesthetics |
| N01BB02 | lidocaine |
| N01BB05 | butanilicaine |
| N01BB20 | combinations |
| N01BX | Other local anesthetics |
| N01BX03 | phenol |
| N02 | ANALGESICS |
| N02AA11 | oxymorphone |
| N02AA53 | hydromorphone and naloxone |
| N02AA56 | oxycodone and naltrexone |
| N02AB02 | pethidine |
| N02AD | Benzomorphan derivatives |
| N02AD51 | pentazocine and naloxone |
| N02AE01 | buprenorphine |
| N02AG02 | ketobemidone and antispasmodics |
| N02AJ | Opioids in combination with non-opioid analgesics |
| N02AJ01 | dihydrocodeine and paracetamol |
| N02AJ07 | codeine and acetylsalicylic acid |
| N02AJ15 | tramadol and other non-opioid analgesics |
| N02AJ22 | hydrocodone and paracetamol |
| N02AJ23 | hydrocodone and ibuprofen |
| N02AX02 | tramadol |
| N02AX05 | meptazinol |
| N02BA06 | salsalate |
| N02BA51 | acetylsalicylic acid, combinations excl. psycholeptics |
| N02BA65 | carbasalate calcium combinations excl. psycholeptics |
| N02BB03 | aminophenazone |
| N02BE04 | bucetin |
| N02BE71 | paracetamol, combinations with psycholeptics |
| N02BF02 | pregabalin |
| N02BG05 | viminol |
| N02CA02 | ergotamine |
| N02CA52 | ergotamine, combinations excl. psycholeptics |
| N02CD06 | rimegepant |
| N03AA03 | primidone |
| N03AA04 | barbexaclone |
| N03AC | Oxazolidine derivatives |
| N03AG06 | tiagabine |
| N03AX10 | felbamate |
| N03AX11 | topiramate |
| N04A | ANTICHOLINERGIC AGENTS |
| N04BA03 | levodopa, decarboxylase inhibitor and COMT inhibitor |
| N04BA05 | melevodopa and decarboxylase inhibitor |
| N04BC03 | dihydroergocryptine mesylate |
| N04BC04 | ropinirole |
| N04BC07 | apomorphine |
| N04BD03 | safinamide |
| N05 | PSYCHOLEPTICS |
| N05AE02 | molindone |
| N05AH01 | loxapine |
| N05AL06 | veralipride |
| N05AX08 | risperidone |
| N05AX11 | zotepine |
| N05AX12 | aripiprazole |
| N05AX15 | cariprazine |
| N05AX16 | brexpiprazole |
| N05AX17 | pimavanserin |
| N05BA10 | ketazolam |
| N05BA16 | nordazepam |
| N05BA22 | cloxazolam |
| N05BA56 | lorazepam, combinations |
| N05BD01 | benzoctamine |
| N05BX05 | Lavandulae aetheroleum |
| N05CA02 | amobarbital |
| N05CA10 | cyclobarbital |
| N05CA11 | heptabarbital |
| N05CC03 | acetylglycinamide chloral hydrate |
| N05CD04 | estazolam |
| N05CD10 | quazepam |
| N05CD12 | doxefazepam |
| N05CE01 | glutethimide |
| N05CH | Melatonin receptor agonists |
| N05CH01 | melatonin |
| N05CM07 | triclofos |
| N05CM13 | valnoctamide |
| N05CX02 | methaqualone, combinations |
| N06A | ANTIDEPRESSANTS |
| N06AA08 | dibenzepin |
| N06AA11 | protriptyline |
| N06AA18 | dimetacrine |
| N06AB09 | etoperidone |
| N06AF02 | nialamide |
| N06AF04 | tranylcypromine |
| N06AX09 | viloxazine |
| N06AX14 | tianeptine |
| N06AX27 | esketamine |
| N06BA | Centrally acting sympathomimetics |
| N06BA14 | solriamfetol |
| N06BX04 | deanol |
| N06BX08 | pirisudanol |
| N06CA03 | fluoxetine and psycholeptics |
| N06D | ANTI-DEMENTIA DRUGS |
| N06DA01 | tacrine |
| N06DA04 | galantamine |
| N06DX04 | lecanemab |
| N07AA | Anticholinesterases |
| N07AB01 | carbachol |
| N07AB02 | bethanechol |
| N07AX | Other parasympathomimetics |
| N07BB03 | acamprosate |
| N07BC01 | buprenorphine |
| N07CA03 | flunarizine |
| N07CA52 | cinnarizine, combinations |
| N07XX10 | laquinimod |
| N07XX17 | arimoclomol |
| N07XX22 | tofersen |
| N07XX59 | dextromethorphan, combinations |
| P01AB06 | nimorazole |
| P01AR01 | arsthinol |
| P01AX01 | chiniofon |
| P01AX04 | phanquinone |
| P01AX05 | mepacrine |
| P01AX10 | fumagillin |
| P01BA06 | amodiaquine |
| P01BB01 | proguanil |
| P01BF | Artemisinin and derivatives, combinations |
| P01BF08 | artemisinin and naphthoquine |
| P01CA | Nitroimidazole derivatives |
| P01CA02 | benznidazole |
| P01CD01 | melarsoprol |
| P01CD02 | acetarsol |
| P02BB | Organophosphorous compounds |
| P03AA54 | disulfiram, combinations |
| P03AB01 | clofenotane |
| P03AB51 | clofenotane, combinations |
| P03AC52 | bioallethrin, combinations |
| P03AX06 | benzyl alcohol |
| P03BX01 | diethyltoluamide |
| R01AA10 | metizoline |
| R01AA14 | epinephrine |
| R01AB07 | oxymetazoline |
| R01AC01 | cromoglicic acid |
| R01AC04 | antazoline |
| R01AD03 | dexamethasone |
| R01AD07 | tixocortol |
| R01AD09 | mometasone |
| R01AD12 | fluticasone furoate |
| R01AD52 | prednisolone, combinations |
| R01AD57 | tixocortol, combinations |
| R01AX02 | retinol |
| R01AX05 | ritiometan |
| R01AX06 | mupirocin |
| R01BA | Sympathomimetics |
| R01BA53 | phenylephrine, combinations |
| R02AA01 | ambazone |
| R02AA03 | dichlorobenzyl alcohol |
| R02AA18 | hexamidine |
| R02AB01 | neomycin |
| R02AX | Other throat preparations |
| R03AA01 | epinephrine |
| R03AC12 | salmeterol |
| R03AC13 | formoterol |
| R03AC18 | indacaterol |
| R03AC19 | olodaterol |
| R03AK01 | epinephrine and other drugs for obstructive airway diseases |
| R03AK06 | salmeterol and fluticasone |
| R03AK12 | salmeterol and budesonide |
| R03AL02 | salbutamol and ipratropium bromide |
| R03BA04 | betamethasone |
| R03BA05 | fluticasone |
| R03BA07 | mometasone |
| R03BB01 | ipratropium bromide |
| R03BC01 | cromoglicic acid |
| R03BC03 | nedocromil |
| R03CA02 | ephedrine |
| R03CB01 | isoprenaline |
| R03CC07 | pirbuterol |
| R03CC12 | bambuterol |
| R03CC14 | reproterol |
| R03CK | Adrenergics and other drugs for obstructive airway diseases |
| R03D | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| R03DA01 | diprophylline |
| R03DA05 | aminophylline |
| R03DA07 | theobromine |
| R03DA54 | theophylline, combinations excl. psycholeptics |
| R03DX | Other systemic drugs for obstructive airway diseases |
| R03DX06 | seratrodast |
| R05CA04 | ipecacuanha |
| R05CA13 | cineole |
| R05CB02 | bromhexine |
| R05DA11 | dimemorfan |
| R05DA20 | combinations |
| R05DB05 | pentoxyverine |
| R05DB10 | clofedanol |
| R05DB17 | droxypropine |
| R05DB21 | cloperastine |
| R06AA | Aminoalkyl ethers |
| R06AA56 | chlorphenoxamine, combinations |
| R06AA57 | diphenylpyraline, combinations |
| R06AB05 | pheniramine |
| R06AC | Substituted ethylene diamines |
| R06AC01 | mepyramine |
| R06AC05 | methapyrilene |
| R06AC06 | thonzylamine |
| R06AD09 | isothipendyl |
| R06AX26 | fexofenadine |
| R07AB04 | etamivan |
| R07AB06 | prethcamide |
| S | SENSORY ORGANS |
| S01 | OPHTHALMOLOGICALS |
| S01AA13 | fusidic acid |
| S01AA26 | azithromycin |
| S01AB01 | sulfamethizole |
| S01AD03 | aciclovir |
| S01AE | Fluoroquinolones |
| S01BA08 | medrysone |
| S01CA12 | loteprednol and antiinfectives |
| S01CB02 | prednisolone |
| S01EA51 | epinephrine, combinations |
| S01EB58 | aceclidine, combinations |
| S01EC | Carbonic anhydrase inhibitors |
| S01ED51 | timolol, combinations |
| S01EE02 | unoprostone |
| S01FA06 | tropicamide |
| S01GA53 | xylometazoline, combinations |
| S01GA55 | phenylephrine, combinations |
| S01GX03 | spaglumic acid |
| S01GX10 | epinastine |
| S01HA06 | cinchocaine |
| S01JA01 | fluorescein |
| S01JA51 | fluorescein, combinations |
| S01LA | Antineovascularisation agents |
| S01LA04 | ranibizumab |
| S01LA09 | faricimab |
| S01X | OTHER OPHTHALMOLOGICALS |
| S01XA12 | dexpanthenol |
| S01XA28 | varenicline |
| S02AA08 | tetracycline |
| S02AA16 | ofloxacin |
| S02AA30 | antiinfectives, combinations |
| S02BA06 | dexamethasone |
| S02CA | Corticosteroids and antiinfectives in combination |
| S02D | OTHER OTOLOGICALS |
| S03BA03 | betamethasone |
| S03C | CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION |
| S03CA05 | fludrocortisone and antiinfectives |
| V01 | ALLERGENS |
| V01AA07 | insects |
| V03AB03 | edetates |
| V03AB05 | prednisolone and promethazine |
| V03AB15 | naloxone |
| V03AB21 | potassium iodide |
| V03AB23 | acetylcysteine |
| V03AB25 | flumazenil |
| V03AC02 | deferiprone |
| V03AF09 | glucarpidase |
| V03AN01 | oxygen |
| V04CB | Tests for fat absorption |
| V04CB01 | vitamin A concentrates |
| V04CC | Tests for bile duct patency |
| V04CD03 | sermorelin |
| V04CG | Tests for gastric secretion |
| V04CG04 | pentagastrin |
| V04CG05 | methylthioninium chloride |
| V04CG30 | caffeine and sodium benzoate |
| V04CX01 | indocyanine green |
| V04CX09 | patent blue |
| V06DD | Amino acids, incl. combinations with polypeptides |
| V07AR | Sensitivity tests, discs and tablets |
| V08AA03 | iodamide |
| V08AA09 | methiodal |
| V08AB04 | iopamidol |
| V08AB06 | iotrolan |
| V08AC01 | iodoxamic acid |
| V08AC02 | iotroxic acid |
| V08AC03 | ioglycamic acid |
| V08AD | Non-watersoluble X-ray contrast media |
| V08AD02 | iopydol |
| V08AD03 | propyliodone |
| V08C | MAGNETIC RESONANCE IMAGING CONTRAST MEDIA |
| V08CA02 | gadoteric acid |
| V08CA12 | gadopiclenol |
| V08CB | Superparamagnetic contrast media |
| V09AB02 | iodine iolopride (123I) |
| V09CX04 | chromium (51Cr) edetate |
| V09DA03 | technetium (99mTc) lidofenin |
| V09DB04 | technetium (99mTc) tin colloid |
| V09DB05 | technetium (99mTc) sulfur colloid |
| V09EA03 | technetium (99mTc) nanocolloid |
| V09F | THYROID |
| V09FX01 | technetium (99mTc) pertechnetate |
| V09FX03 | sodium iodide (131I) |
| V09GA | Technetium (99mTc) compounds |
| V09GA05 | technetium (99mTc) furifosmin |
| V09GA07 | technetium (99mTc) apcitide |
| V09HA01 | technetium (99mTc) human immunoglobulin |
| V09I | TUMOUR DETECTION |
| V09IA10 | technetium (99mTc)trofolastat chloride |
| V09XX01 | cobalt (57Co) cyanocobalamine |
| V09XX03 | selenium (75Se) norcholesterol |
| V10XA | Iodine (131I) compounds |
| A01AA | Caries prophylactic agents |
| A01AA01 | sodium fluoride |
| A01AB08 | neomycin |
| A01AB09 | miconazole |
| A01AD02 | benzydamine |
| A02AA01 | magnesium carbonate |
| A02AA02 | magnesium oxide |
| A02AA10 | combinations |
| A02AB05 | aluminium acetoacetate |
| A02AB07 | aluminium glycinate |
| A02AD02 | magaldrate |
| A02AD03 | almagate |
| A02AD04 | hydrotalcite |
| A02AF01 | magaldrate and antiflatulents |
| A02BA02 | ranitidine |
| A02BA07 | ranitidine bismuth citrate |
| A02BB | Prostaglandins |
| A02BC01 | omeprazole |
| A02BC09 | tegoprazan |
| A02BC51 | omeprazole, combinations |
| A02BC53 | lansoprazole, combinations |
| A02BD03 | lansoprazole, amoxicillin and metronidazole |
| A02BD05 | omeprazole, amoxicillin and clarithromycin |
| A02BD06 | esomeprazole, amoxicillin and clarithromycin |
| A02BD08 | bismuth subcitrate, tetracycline and metronidazole |
| A02BD16 | omeprazole, amoxicillin and rifabutin |
| A02BX03 | pirenzepine |
| A02BX51 | carbenoxolone, combinations excl. psycholeptics |
| A03AA03 | camylofin |
| A03AA05 | trimebutine |
| A03AA06 | rociverine |
| A03AB09 | isopropamide |
| A03AB53 | oxyphenonium, combinations |
| A03AC04 | nicofetamide |
| A03AE01 | alosetron |
| A03BA | Belladonna alkaloids, tertiary amines |
| A03CA02 | clidinium and psycholeptics |
| A03CA06 | bevonium and psycholeptics |
| A03CA09 | pipenzolate and psycholeptics |
| A03DA04 | ciclonium and analgesics |
| A03FA07 | itopride |
| A04AA02 | granisetron |
| A04AA03 | tropisetron |
| A04AD10 | dronabinol |
| A05AX05 | odevixibat |
| A05BA04 | citiolone |
| A06 | DRUGS FOR CONSTIPATION |
| A06A | DRUGS FOR CONSTIPATION |
| A06AB08 | sodium picosulfate |
| A06AB58 | sodium picosulfate, combinations |
| A06AC51 | ispaghula, combinations |
| A06AC55 | linseed, combinations |
| A06AD03 | magnesium peroxide |
| A06AD11 | lactulose |
| A06AD12 | lactitol |
| A06AG07 | sorbitol |
| A06AG20 | combinations |
| A06AH04 | naloxone |
| A06AX01 | glycerol |
| A07AA01 | neomycin |
| A07AA05 | polymyxin B |
| A07AB03 | sulfaguanidine |
| A07AX | Other intestinal antiinfectives |
| A07BB | Bismuth preparations |
| A07BC30 | combinations |
| A07C | ELECTROLYTES WITH CARBOHYDRATES |
| A07EA02 | hydrocortisone |
| A07FA01 | lactic acid producing organisms |
| A07FA51 | lactic acid producing organisms, combinations |
| A08AA04 | dexfenfluramine |
| A08AA07 | cathine |
| A08AA12 | setmelanotide |
| A08AB | Peripherally acting antiobesity products |
| A09 | DIGESTIVES, INCL. ENZYMES |
| A09AA | Enzyme preparations |
| A09AB | Acid preparations |
| A10AB05 | insulin aspart |
| A10AD01 | insulin (human) |
| A10AD04 | insulin lispro |
| A10AD06 | insulin degludec and insulin aspart |
| A10AD30 | combinations |
| A10BB03 | tolbutamide |
| A10BB04 | glibornuride |
| A10BB08 | gliquidone |
| A10BC01 | glymidine |
| A10BD12 | pioglitazone and sitagliptin |
| A10BD24 | sitagliptin and ertugliflozin |
| A10BF01 | acarbose |
| A10BG04 | lobeglitazone |
| A10BH04 | alogliptin |
| A10BH06 | gemigliptin |
| A10BJ07 | beinaglutide |
| A10BK01 | dapagliflozin |
| A11B | MULTIVITAMINS, PLAIN |
| A11DA02 | sulbutiamine |
| A11EA | Vitamin B-complex, plain |
| A11EC | Vitamin B-complex with minerals |
| A11HA32 | pantethine |
| A12AA | Calcium |
| A12BA04 | potassium hydrogencarbonate |
| A12BA05 | potassium gluconate |
| A12CC03 | magnesium gluconate |
| A12CC08 | magnesium pidolate |
| A12CC30 | magnesium (different salts in combination) |
| A12CD51 | fluoride, combinations |
| A12CX | Other mineral products |
| A14AB01 | nandrolone |
| A16AA06 | betaine |
| A16AB14 | sebelipase alfa |
| A16AB17 | cerliponase alfa |
| A16AB18 | vestronidase alfa |
| A16AX03 | sodium phenylbutyrate |
| A16AX04 | nitisinone |
| B01AB | Heparin group |
| B01AC02 | cloricromen |
| B01AC06 | acetylsalicylic acid |
| B01AC10 | indobufen |
| B01AC56 | acetylsalicylic acid, combinations with proton pump inhibitors |
| B01AD04 | urokinase |
| B01AD05 | fibrinolysin |
| B01AD06 | brinase |
| B01AE05 | ximelagatran |
| B02A | ANTIFIBRINOLYTICS |
| B02AA01 | aminocaproic acid |
| B02AB | Proteinase inhibitors |
| B02AB04 | camostat |
| B02BA02 | menadione |
| B02BB | Fibrinogen |
| B02BC | Local hemostatics |
| B02BC05 | adrenalone |
| B02BD04 | coagulation factor IX |
| B02BX01 | etamsylate |
| B02BX02 | carbazochrome |
| B02BX04 | romiplostim |
| B03AA04 | ferrous carbonate |
| B03AA09 | ferrous aspartate |
| B03AA12 | ferrous sodium citrate |
| B03AB07 | chondroitin sulfate-iron complex |
| B03AD | Iron in combination with folic acid |
| B03AD03 | ferrous sulfate and folic acid |
| B03AE10 | various combinations |
| B05AA05 | dextran |
| B05AX01 | erythrocytes |
| B05CA09 | neomycin |
| B05CB01 | sodium chloride |
| B05X | I.V. SOLUTION ADDITIVES |
| B05XA | Electrolyte solutions |
| B05XA13 | hydrochloric acid |
| B05XA14 | sodium glycerophosphate |
| B05XA16 | cardioplegia solutions |
| B06AA | Enzymes |
| B06AC01 | c1-inhibitor, plasma derived |
| C01BA01 | quinidine |
| C01BA08 | prajmaline |
| C01BC03 | propafenone |
| C01BG07 | cibenzoline |
| C01C | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| C01CA11 | mephentermine |
| C01CA17 | midodrine |
| C01CA22 | arbutamine |
| C01CA23 | theodrenaline |
| C01CA27 | droxidopa |
| C01CE02 | milrinone |
| C01CX10 | omecamtiv mecarbil |
| C01DA | Organic nitrates |
| C01DA05 | pentaerithrityl tetranitrate |
| C01DA07 | propatylnitrate |
| C01DA14 | isosorbide mononitrate |
| C01DA20 | organic nitrates in combination |
| C01DX09 | imolamine |
| C01DX10 | dilazep |
| C01DX13 | efloxate |
| C01DX53 | oxyfedrine, combinations |
| C01EB02 | camphora |
| C01EB16 | ibuprofen |
| C01EB18 | ranolazine |
| C01EB21 | regadenoson |
| C02AA | Rauwolfia alkaloids |
| C02AA57 | bietaserpine, combinations |
| C02C | ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING |
| C02CC02 | guanethidine |
| C02DB | Hydrazinophthalazine derivatives |
| C02DB04 | cadralazine |
| C02KN | Other antihypertensives |
| C02KX52 | ambrisentan and tadalafil |
| C02KX54 | macitentan and tadalafil |
| C02LK01 | veratrum and diuretics |
| C02LL01 | pargyline and diuretics |
| C02LN | Serotonin antagonists and diuretics |
| C02LX | Other antihypertensives and diuretics |
| C03A | LOW-CEILING DIURETICS, THIAZIDES |
| C03BA82 | clorexolone, combinations with psycholeptics |
| C03BB05 | mefruside and potassium |
| C03BC01 | mersalyl |
| C03BX03 | cicletanine |
| C03CA02 | bumetanide |
| C03DB02 | triamterene |
| C03E | DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION |
| C03EA03 | epitizide and potassium-sparing agents |
| C04 | PERIPHERAL VASODILATORS |
| C04AB01 | phentolamine |
| C04AD01 | pentifylline |
| C04AD03 | pentoxifylline |
| C04AF01 | kallidinogenase |
| C04AX07 | vincamine |
| C04AX11 | bencyclane |
| C04AX24 | visnadine |
| C05 | VASOPROTECTIVES |
| C05AA06 | fluorometholone |
| C05AE02 | isosorbide dinitrate |
| C05BA01 | organo-heparinoid |
| C05BA53 | heparin, combinations |
| C05CX | Other capillary stabilizing agents |
| C05X | OTHER VASOPROTECTIVES |
| C05XX | Other vasoprotectives |
| C07AA07 | sotalol |
| C07AA12 | nadolol |
| C07AB04 | acebutolol |
| C07AB05 | betaxolol |
| C07AB09 | esmolol |
| C07AB12 | nebivolol |
| C07BB02 | metoprolol and thiazides |
| C07BB06 | bevantolol and thiazides |
| C07CG01 | labetalol and other diuretics |
| C07F | BETA BLOCKING AGENTS, OTHER COMBINATIONS |
| C07FB12 | nebivolol and amlodipine |
| C08CA | Dihydropyridine derivatives |
| C08CA03 | isradipine |
| C08CA14 | cilnidipine |
| C08CX01 | mibefradil |
| C08DA | Phenylalkylamine derivatives |
| C08DA51 | verapamil, combinations |
| C08EX01 | lidoflazine |
| C09AA03 | lisinopril |
| C09AA06 | quinapril |
| C09AA11 | spirapril |
| C09BB13 | benazepril and amlodipine |
| C09DA | Angiotensin II receptor blockers (ARBs) and diuretics |
| C09DA08 | olmesartan medoxomil and diuretics |
| C09DB02 | olmesartan medoxomil and amlodipine |
| C09DX | Angiotensin II receptor blockers (ARBs), other combinations |
| C09DX02 | valsartan and aliskiren |
| C09DX08 | telmisartan, amlodipine and hydrochlorothiazide |
| C09XA | Renin-inhibitors |
| C10AA | HMG CoA reductase inhibitors |
| C10AA03 | pravastatin |
| C10AA04 | fluvastatin |
| C10AX10 | alipogene tiparvovec |
| C10AX13 | evolocumab |
| C10BA08 | atorvastatin and omega-3 fatty acids |
| C10BX01 | simvastatin and acetylsalicylic acid |
| C10BX08 | atorvastatin and acetylsalicylic acid |
| C10BX18 | atorvastatin, amlodipine and ramipril |
| D01 | ANTIFUNGALS FOR DERMATOLOGICAL USE |
| D01AC | Imidazole and triazole derivatives |
| D01AC03 | econazole |
| D01AC10 | bifonazole |
| D01AE05 | polynoxylin |
| D01AE08 | ticlatone |
| D02AD | Liquid plasters |
| D02AE | Carbamide products |
| D02AE01 | carbamide |
| D02BA02 | octinoxate |
| D03B | ENZYMES |
| D04 | ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. |
| D04AA | Antihistamines for topical use |
| D04AB01 | lidocaine |
| D05AC | Antracen derivatives |
| D05AC51 | dithranol, combinations |
| D05AX01 | fumaric acid |
| D05AX07 | tapinarof |
| D05BX | Other antipsoriatics for systemic use |
| D06 | ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE |
| D06AA01 | demeclocycline |
| D06AX05 | bacitracin |
| D06AX08 | tyrothricin |
| D06AX12 | amikacin |
| D06BA03 | mafenide |
| D06BB05 | inosine |
| D07AB04 | fluocortin |
| D07AB06 | fluorometholone |
| D07AB21 | clocortolone |
| D07AC | Corticosteroids, potent (group III) |
| D07AC04 | fluocinolone acetonide |
| D07AD | Corticosteroids, very potent (group IV) |
| D07BC04 | diflucortolone and antiseptics |
| D08 | ANTISEPTICS AND DISINFECTANTS |
| D08AC03 | propamidine |
| D08AE | Phenol and derivatives |
| D08AE05 | chloroxylenol |
| D08AG02 | povidone-iodine |
| D08AH | Quinoline derivatives |
| D08AJ02 | cetrimonium |
| D08AJ08 | benzethonium chloride |
| D08AJ58 | benzethonium chloride, combinations |
| D08AJ59 | dodeclonium bromide, combinations |
| D08AK01 | mercuric amidochloride |
| D08AK03 | mercuric chloride |
| D08AX04 | tosylchloramide sodium |
| D09AA08 | aluminium chlorohydrate |
| D09AA09 | povidone-iodine |
| D09AA13 | iodoform |
| D10AA01 | fluorometholone |
| D10AD01 | tretinoin |
| D10AF01 | clindamycin |
| D10AF06 | sulfacetamide |
| D11A | OTHER DERMATOLOGICAL PREPARATIONS |
| D11AA | Antihidrotics |
| D11AC06 | povidone-iodine |
| D11AH03 | cromoglicic acid |
| D11AH06 | crisaborole |
| D11AX10 | finasteride |
| D11AX13 | monobenzone |
| G01AA03 | amphotericin B |
| G01AA07 | oxytetracycline |
| G01AC03 | chlorquinaldol |
| G01AC30 | oxyquinoline |
| G01AE10 | combinations of sulfonamides |
| G01AF13 | azanidazole |
| G01AF16 | omoconazole |
| G01AG02 | terconazole |
| G01AX03 | policresulen |
| G02AB | Ergot alkaloids |
| G02AD | Prostaglandins |
| G02BB02 | vaginal ring with progestogen |
| G02CA01 | ritodrine |
| G02CX03 | Agni casti fructus |
| G03AA01 | etynodiol and ethinylestradiol |
| G03AA03 | lynestrenol and ethinylestradiol |
| G03AA06 | norgestrel and ethinylestradiol |
| G03AA09 | desogestrel and ethinylestradiol |
| G03AA14 | nomegestrol and estradiol |
| G03AB04 | norethisterone and ethinylestradiol |
| G03AC01 | norethisterone |
| G03AD | Emergency contraceptives |
| G03CA03 | estradiol |
| G03CA04 | estriol |
| G03CB | Synthetic estrogens, plain |
| G03DA02 | medroxyprogesterone |
| G03DB04 | nomegestrol |
| G03DB08 | dienogest |
| G03DC03 | lynestrenol |
| G03EA | Androgens and estrogens |
| G03EA02 | testosterone and estrogen |
| G03EB | Androgen, progestogen and estrogen in combination |
| G03FA12 | medroxyprogesterone and estrogen |
| G03FB01 | norgestrel and estrogen |
| G03FB02 | lynestrenol and estrogen |
| G03FB06 | medroxyprogesterone and estrogen |
| G03FB10 | desogestrel and estrogen |
| G03GA | Gonadotropins |
| G03GA30 | combinations |
| G03GB03 | epimestrol |
| G03H | ANTIANDROGENS |
| G03HB01 | cyproterone and estrogen |
| G03XB | Progesterone receptor modulators |
| G03XC01 | raloxifene |
| G03XC02 | bazedoxifene |
| G03XX01 | prasterone |
| G04BD14 | imidafenacin |
| G04BE03 | sildenafil |
| G04BE30 | combinations |
| G04CA53 | tamsulosin and solifenacin |
| H01A | ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES |
| H01AB | Thyrotropin |
| H01AC08 | somatrogon |
| H01CB01 | somatostatin |
| H02AA02 | fludrocortisone |
| H02AB07 | prednisone |
| H02AB12 | rimexolone |
| H02C | ANTIADRENAL PREPARATIONS |
| H02CA | Anticorticosteroids |
| H03AA51 | levothyroxine sodium and iodine compounds |
| H03BA02 | propylthiouracil |
| H03BX02 | dibromotyrosine |
| H03CA | Iodine therapy |
| J01AA08 | minocycline |
| J01AA11 | clomocycline |
| J01BA02 | thiamphenicol |
| J01CA09 | azlocillin |
| J01CA11 | mecillinam |
| J01CA13 | ticarcillin |
| J01CA16 | sulbenicillin |
| J01CA19 | aspoxicillin |
| J01CG02 | tazobactam |
| J01DB09 | cefradine |
| J01DC01 | cefoxitin |
| J01DC04 | cefaclor |
| J01DC52 | cefuroxime and beta-lactamase inhibitor |
| J01DD12 | cefoperazone |
| J01DD17 | cefcapene |
| J01DD18 | cefteram |
| J01DD51 | cefotaxime and beta-lactamase inhibitor |
| J01DD58 | cefixime and beta-lactamase inhibitor |
| J01DH05 | biapenem |
| J01DI03 | faropenem |
| J01EB02 | sulfamethizole |
| J01EB06 | sulfanilamide |
| J01EB08 | sulfathiourea |
| J01ED03 | sulfametomidine |
| J01ED06 | sulfaperin |
| J01ED07 | sulfamerazine |
| J01FA15 | telithromycin |
| J01FA16 | solithromycin |
| J01FG02 | quinupristin/dalfopristin |
| J01GB11 | isepamicin |
| J01MA18 | pazufloxacin |
| J01MB | Other quinolones |
| J01MB05 | oxolinic acid |
| J01MB06 | cinoxacin |
| J01R | COMBINATIONS OF ANTIBACTERIALS |
| J01RA15 | cefixime and ornidazole |
| J01XC01 | fusidic acid |
| J01XE02 | nifurtoinol |
| J01XX06 | mandelic acid |
| J02AC | Triazole and tetrazole derivatives |
| J02AC01 | fluconazole |
| J02AC02 | itraconazole |
| J04A | DRUGS FOR TREATMENT OF TUBERCULOSIS |
| J04AA01 | 4-aminosalicylic acid |
| J04AK02 | ethambutol |
| J04BA01 | clofazimine |
| J05AB17 | brincidofovir |
| J05AF07 | tenofovir disoproxil |
| J05AP01 | ribavirin |
| J05AP05 | simeprevir |
| J05AP53 | ombitasvir, paritaprevir and ritonavir |
| J05AP56 | sofosbuvir, velpatasvir and voxilaprevir |
| J05AR01 | zidovudine and lamivudine |
| J05AR05 | zidovudine, lamivudine and nevirapine |
| J05AR09 | emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat |
| J05AX21 | pentanedioic acid imidazolyl ethanamide |
| J06A | IMMUNE SERA |
| J06AA04 | botulinum antitoxin |
| J06BB03 | varicella/zoster immunoglobulin |
| J06BB19 | anthrax immunoglobulin |
| J06BD01 | palivizumab |
| J07AC01 | anthrax antigen |
| J07AE01 | cholera, inactivated, whole cell |
| J07AF | Diphtheria vaccines |
| J07AG53 | haemophilus influenzae B, combinations with meningococcus C, conjugated |
| J07AH | Meningococcal vaccines |
| J07AJ01 | pertussis, inactivated, whole cell |
| J07AL52 | pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated |
| J07AM51 | tetanus toxoid, combinations with diphtheria toxoid |
| J07AP01 | typhoid, oral, live attenuated |
| J07AP03 | typhoid, purified polysaccharide antigen |
| J07BA01 | encephalitis, tick borne, inactivated, whole virus |
| J07BA02 | encephalitis, Japanese, inactivated, whole virus |
| J07BD51 | measles, combinations with mumps, live attenuated |
| J07BK03 | zoster, purified antigen |
| J07BN02 | covid-19, viral vector, non-replicating |
| J07BN04 | covid-19, protein subunit |
| J07CA | Bacterial and viral vaccines, combined |
| J07CA02 | diphtheria-pertussis-poliomyelitis-tetanus |
| J07CA10 | typhoid-hepatitis A |
| J07CA11 | diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B |
| J07CA12 | diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B |
| L01 | ANTINEOPLASTIC AGENTS |
| L01AA10 | melphalan flufenamide |
| L01AB | Alkyl sulfonates |
| L01AD05 | fotemustine |
| L01AX03 | temozolomide |
| L01BB03 | tioguanine |
| L01BC02 | fluorouracil |
| L01CA | Vinca alkaloids and analogues |
| L01CC | Colchicine derivatives |
| L01CE02 | irinotecan |
| L01DB04 | aclarubicin |
| L01E | PROTEIN KINASE INHIBITORS |
| L01EA03 | nilotinib |
| L01EB07 | dacomitinib |
| L01EB10 | mobocertinib |
| L01EB11 | aumolertinib |
| L01EE02 | cobimetinib |
| L01EG03 | ridaforolimus |
| L01EH01 | lapatinib |
| L01EH02 | neratinib |
| L01EJ01 | ruxolitinib |
| L01EK02 | cediranib |
| L01EL02 | acalabrutinib |
| L01EM01 | idelalisib |
| L01EM05 | parsaclisib |
| L01EX03 | pazopanib |
| L01EX05 | regorafenib |
| L01EX06 | masitinib |
| L01EX14 | entrectinib |
| L01EX18 | avapritinib |
| L01EX23 | pralsetinib |
| L01FE01 | cetuximab |
| L01FF13 | toripalimab |
| L01FX08 | elotuzumab |
| L01FX12 | tafasitamab |
| L01FX21 | naxitamab |
| L01FX24 | teclistamab |
| L01FY03 | prolgolimab and nurulimab |
| L01X | OTHER ANTINEOPLASTIC AGENTS |
| L01XF01 | tretinoin |
| L01XJ | Hedgehog pathway inhibitors |
| L01XJ03 | glasdegib |
| L01XL05 | ciltacabtagene autoleucel |
| L01XX01 | amsacrine |
| L01XX05 | hydroxycarbamide |
| L01XX11 | estramustine |
| L01XX18 | tiazofurine |
| L01XX41 | eribulin |
| L01XX67 | tagraxofusp |
| L01XY01 | cytarabine and daunorubicin |
| L02AE | Gonadotropin releasing hormone analogues |
| L02BB | Anti-androgens |
| L02BG06 | exemestane |
| L02BX | Other hormone antagonists and related agents |
| L02BX02 | degarelix |
| L03 | IMMUNOSTIMULANTS |
| L03AA | Colony stimulating factors |
| L03AA03 | molgramostim |
| L03AB09 | interferon alfacon-1 |
| L03AB13 | peginterferon beta-1a |
| L03AB16 | peginterferon alfacon-2 |
| L03AB17 | sampeginterferon beta-1a |
| L03AB60 | peginterferon alfa-2b, combinations |
| L03AX05 | pidotimod |
| L03AX14 | histamine dihydrochloride |
| L03AX17 | sipuleucel-T |
| L03AX18 | cridanimod |
| L04A | IMMUNOSUPPRESSANTS |
| L04AA40 | cladribine |
| L04AC09 | briakinumab |
| L04AC10 | secukinumab |
| L04AC14 | sarilumab |
| L04AC18 | risankizumab |
| L04AC19 | satralizumab |
| L04AC24 | mirikizumab |
| L04AD | Calcineurin inhibitors |
| L04AE | Sphingosine-1-phosphate (S1P) receptor modulators |
| L04AE02 | ozanimod |
| L04AE05 | etrasimod |
| L04AF01 | tofacitinib |
| L04AF04 | filgotinib |
| L04AF06 | peficitinib |
| L04AF08 | ritlecitinib |
| L04AG02 | efalizumab |
| L04AG08 | ocrelizumab |
| L04AG12 | ofatumumab |
| M01AB06 | alclofenac |
| M01AB10 | fentiazac |
| M01AB13 | oxametacin |
| M01AB16 | aceclofenac |
| M01AB51 | indometacin, combinations |
| M01AC01 | piroxicam |
| M01AE13 | ibuproxam |
| M01AG04 | meclofenamic acid |
| M01AH03 | valdecoxib |
| M01AH07 | polmacoxib |
| M01C | SPECIFIC ANTIRHEUMATIC AGENTS |
| M02AA29 | esflurbiprofen |
| M02AA31 | loxoprofen |
| M02AB | Capsaicin and similar agents |
| M02AX05 | idrocilamide |
| M03BX03 | pridinol |
| M03BX06 | mephenesin |
| M03BX07 | tetrazepam |
| M03CA | Dantrolene and derivatives |
| M04AA03 | febuxostat |
| M04AA51 | allopurinol, combinations |
| M04AC51 | colchicine and probenecid |
| M04AX01 | urate oxidase |
| M05BA08 | zoledronic acid |
| M05BB06 | alendronic acid and alfacalcidol, sequential |
| M09AA | Quinine and derivatives |
| M09AA72 | quinine, combinations with psycholeptics |
| M09AX14 | givinostat |
| N01AA01 | diethyl ether |
| N01AB05 | trichloroethylene |
| N01AF01 | methohexital |
| N01BA | Esters of aminobenzoic acid |
| N01BA03 | tetracaine |
| N01BB | Amides |
| N01BB08 | articaine |
| N01BB09 | ropivacaine |
| N01BB54 | prilocaine, combinations |
| N01BB59 | bupivacaine and meloxicam |
| N02AA04 | nicomorphine |
| N02AA10 | papaveretum |
| N02AA51 | morphine, combinations |
| N02AB01 | ketobemidone |
| N02AB03 | fentanyl |
| N02AB72 | pethidine, combinations with psycholeptics |
| N02AC03 | piritramide |
| N02AC54 | dextropropoxyphene, combinations excl. psycholeptics |
| N02AF | Morphinan derivatives |
| N02AF01 | butorphanol |
| N02AG | Opioids in combination with antispasmodics |
| N02AG01 | morphine and antispasmodics |
| N02AJ03 | dihydrocodeine and other non-opioid analgesics |
| N02AX06 | tapentadol |
| N02AX07 | oliceridine |
| N02BA02 | aloxiprin |
| N02BA03 | choline salicylate |
| N02BA07 | ethenzamide |
| N02BA08 | morpholine salicylate |
| N02BA11 | diflunisal |
| N02BA14 | guacetisal |
| N02BA71 | acetylsalicylic acid, combinations with psycholeptics |
| N02BB01 | phenazone |
| N02BB54 | propyphenazone, combinations excl. psycholeptics |
| N02BG06 | nefopam |
| N02BG09 | methoxyflurane |
| N02CA | Ergot alkaloids |
| N02CA07 | lisuride |
| N02CC05 | almotriptan |
| N02CC08 | lasmiditan |
| N02CD | Calcitonin gene-related peptide (CGRP) antagonists |
| N02CX02 | clonidine |
| N03AA01 | methylphenobarbital |
| N03AF | Carboxamide derivatives |
| N03AX24 | cannabidiol |
| N04AA04 | procyclidine |
| N04AA08 | dexetimide |
| N04AA10 | mazaticol |
| N04AC01 | benzatropine |
| N04BB01 | amantadine |
| N04BC08 | piribedil |
| N04BD01 | selegiline |
| N04CX | Other antiparkinson drugs |
| N05AA03 | promazine |
| N05AC | Phenothiazines with piperidine structure |
| N05AC03 | mesoridazine |
| N05AD01 | haloperidol |
| N05AD04 | moperone |
| N05AD08 | droperidol |
| N05AD09 | fluanisone |
| N05AE01 | oxypertine |
| N05AE03 | sertindole |
| N05AH02 | clozapine |
| N05AH53 | olanzapine and samidorphan |
| N05AX14 | iloperidone |
| N05BA18 | ethyl loflazepate |
| N05BA19 | etizolam |
| N05BB02 | captodiame |
| N05BC03 | emylcamate |
| N05CA01 | pentobarbital |
| N05CC05 | paraldehyde |
| N05CM09 | Valerianae radix |
| N05CX05 | emepronium, combinations |
| N06AA12 | doxepin |
| N06AA19 | amineptine |
| N06AB | Selective serotonin reuptake inhibitors |
| N06AB06 | sertraline |
| N06AB07 | alaproclate |
| N06AF03 | phenelzine |
| N06AX13 | medifoxamine |
| N06AX17 | milnacipran |
| N06AX24 | vilazodone |
| N06AX29 | brexanolone |
| N06B | PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS |
| N06BX01 | meclofenoxate |
| N06BX02 | pyritinol |
| N06BX07 | oxiracetam |
| N06BX12 | acetylcarnitine |
| N06BX14 | prolintane |
| N06CA | Antidepressants in combination with psycholeptics |
| N06CA02 | melitracen and psycholeptics |
| N06DA53 | donepezil, memantine and Ginkgo folium |
| N07AA30 | ambenonium |
| N07BB | Drugs used in alcohol dependence |
| N07CA02 | cinnarizine |
| N07XX05 | amifampridine |
| N07XX06 | tetrabenazine |
| N07XX14 | edaravone |
| N07XX16 | deutetrabenazine |
| N07XX23 | troriluzole |
| P01AB05 | propenidazole |
| P01AB52 | metronidazole and diloxanide |
| P01AC04 | teclozan |
| P01AR | Arsenic compounds |
| P01AR02 | difetarsone |
| P01AR03 | glycobiarsol |
| P01AR53 | glycobiarsol, combinations |
| P01AX06 | atovaquone |
| P01AX09 | dehydroemetine |
| P01BA | Aminoquinolines |
| P01BF04 | artesunate, sulfalene and pyrimethamine |
| P01BF09 | artesunate, sulfadoxine and pyrimethamine |
| P01CC01 | nifurtimox |
| P01CD | Arsenic compounds |
| P01CX | Other agents against leishmaniasis and trypanosomiasis |
| P01CX01 | pentamidine isethionate |
| P01CX03 | eflornithine |
| P01CX04 | miltefosine |
| P02BA01 | praziquantel |
| P02BX03 | stibophen |
| P02CA03 | albendazole |
| P02CA51 | mebendazole, combinations |
| P02DX | Other anticestodals |
| P03AA03 | mesulfen |
| P03AB | Chlorine containing products |
| P03AC04 | permethrin |
| P03AX03 | malathion |
| P03AX04 | quassia |
| P03AX05 | dimeticone |
| P03BA03 | decamethrin |
| R01AA02 | cyclopentamine |
| R01AA04 | phenylephrine |
| R01AA05 | oxymetazoline |
| R01AB02 | naphazoline |
| R01AB06 | xylometazoline |
| R01AB08 | tuaminoheptane |
| R01BA01 | phenylpropanolamine |
| R01BA03 | phenylephrine |
| R02AA11 | chlorquinaldol |
| R02AA15 | povidone-iodine |
| R03A | ADRENERGICS, INHALANTS |
| R03AA | Alpha- and beta-adrenoreceptor agonists |
| R03AC14 | clenbuterol |
| R03AH | Combinations of adrenergics |
| R03AK15 | salbutamol and budesonide |
| R03AL | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids |
| R03BB03 | stramoni preparations |
| R03CC04 | fenoterol |
| R03CC06 | isoetarine |
| R03DB05 | aminophylline and adrenergics |
| R03DC04 | ibudilast |
| R03DC53 | montelukast, combinations |
| R03DX08 | reslizumab |
| R03DX11 | tezepelumab |
| R05 | COUGH AND COLD PREPARATIONS |
| R05CA01 | tyloxapol |
| R05CB04 | eprazinone |
| R05CB07 | sobrerol |
| R05CB09 | letosteine |
| R05DA05 | opium alkaloids with morphine |
| R05DB14 | fedrilate |
| R05FB01 | cough suppressants and mucolytics |
| R05FB02 | cough suppressants and expectorants |
| R06AA01 | bromazine |
| R06AA02 | diphenhydramine |
| R06AA61 | dimenhydrinate, combinations |
| R06AB03 | dimetindene |
| R06AC53 | chloropyramine, combinations |
| R06AD | Phenothiazine derivatives |
| R06AD06 | thiazinam |
| R06AE03 | cyclizine |
| R06AK | Combinations of antihistamines |
| R06AX03 | thenalidine |
| R07AA | Lung surfactants |
| R07AB52 | nikethamide, combinations |
| R07AX01 | nitric oxide |
| S01AA16 | rifamycin |
| S01AD | Antivirals |
| S01AD01 | idoxuridine |
| S01AE02 | norfloxacin |
| S01AX02 | silver compounds |
| S01AX03 | zinc compounds |
| S01AX05 | bibrocathol |
| S01AX18 | povidone-iodine |
| S01BA | Corticosteroids, plain |
| S01BA02 | hydrocortisone |
| S01BA06 | betamethasone |
| S01BA15 | fluocinolone acetonide |
| S01BB03 | fluorometholone and mydriatics |
| S01BC | Antiinflammatory agents, non-steroids |
| S01BC05 | ketorolac |
| S01BC09 | pranoprofen |
| S01C | ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION |
| S01CA02 | prednisolone and antiinfectives |
| S01CA04 | fluocortolone and antiinfectives |
| S01CA10 | fluocinolone acetonide and antiinfectives |
| S01EA | Sympathomimetics in glaucoma therapy |
| S01EB | Parasympathomimetics |
| S01EB04 | demecarium |
| S01EB05 | physostigmine |
| S01EC54 | brinzolamide, combinations |
| S01EE05 | tafluprost |
| S01FA56 | tropicamide, combinations |
| S01GA | Sympathomimetics used as decongestants |
| S01GA02 | tetryzoline |
| S01GA56 | oxedrine, combinations |
| S01GX51 | cromoglicic acid, combinations |
| S01KA01 | hyaluronic acid |
| S01KX02 | trypan blue |
| S01LA05 | aflibercept |
| S01XA | Other ophthalmologicals |
| S01XA07 | alum |
| S01XA13 | alteplase |
| S01XA21 | mercaptamine |
| S01XA25 | lifitegrast |
| S01XA27 | voretigene neparvovec |
| S01XA29 | sepofarsen |
| S02AA01 | chloramphenicol |
| S02AA02 | nitrofural |
| S02AA03 | boric acid |
| S02CA02 | flumetasone and antiinfectives |
| S02CA04 | triamcinolone and antiinfectives |
| S02DA | Analgesics and anesthetics |
| S02DA01 | lidocaine |
| S02DA03 | phenazone |
| S03A | ANTIINFECTIVES |
| S03AA02 | tetracycline |
| S03AA06 | gentamicin |
| S03BA | Corticosteroids |
| V01A | ALLERGENS |
| V03AB04 | pralidoxime |
| V03AB08 | sodium nitrite |
| V03AB32 | glutathione |
| V03AB38 | andexanet alfa |
| V03AE03 | lanthanum carbonate |
| V03AE05 | sucroferric oxyhydroxide |
| V03AE06 | colestilan |
| V03AE09 | patiromer calcium |
| V03AF05 | amifostine |
| V03AF12 | trilaciclib |
| V03AG | Drugs for treatment of hypercalcemia |
| V03AH01 | diazoxide |
| V03AN02 | carbon dioxide |
| V04C | OTHER DIAGNOSTIC AGENTS |
| V04CC03 | sincalide |
| V04CD05 | somatorelin |
| V04CF01 | tuberculin |
| V04CG01 | cation exchange resins |
| V04CH01 | inulin and other polyfructosans |
| V04CH02 | indigo carmine |
| V04CH04 | alsactide |
| V04CJ | Tests for thyreoidea function |
| V04CK02 | pancreozymin (cholecystokinin) |
| V06DC01 | glucose |
| V07 | ALL OTHER NON-THERAPEUTIC PRODUCTS |
| V07AD | Blood tests, auxiliary products |
| V07AX | Washing agents etc. |
| V07AY | Other non-therapeutic auxiliary products |
| V08AA05 | ioxitalamic acid |
| V08AA10 | diodone |
| V08AB09 | iodixanol |
| V08AB12 | ioxilan |
| V08CA04 | gadoteridol |
| V08CA06 | gadoversetamide |
| V08CA10 | gadoxetic acid |
| V08CX01 | perflubron |
| V08DA03 | perflenapent |
| V09 | DIAGNOSTIC RADIOPHARMACEUTICALS |
| V09B | SKELETON |
| V09CA03 | technetium (99mTc) mertiatide |
| V09DA04 | technetium (99mTc) mebrofenin |
| V09DB02 | technetium (99mTc) microcolloid |
| V09DB06 | technetium (99mTc) rheniumsulfide colloid |
| V09EA | Technetium (99mTc), inhalants |
| V09EB | Technetium (99mTc), particles for injection |
| V09GB01 | fibrinogen (125I) |
| V09GB02 | iodine (125I) human albumin |
| V09GX05 | ammonia (13N) |
| V09HA | Technetium (99mTc) compounds |
| V09IA03 | technetium (99mTc) pentavalent succimer |
| V09IB03 | indium (111In) antiovariumcarcinoma antibody |
| V09IX07 | fluorocholine (18F) |
| V09IX14 | gallium (68Ga) gozetotide |
| V09IX16 | piflufolastat (18F) |
| V09XX02 | cobalt (58Co) cyanocobalamine |
| V10AX | Other antiinflammatory therapeutic radiopharmaceuticals |
| V10AX01 | phosphorous (32P) chromicphosphate colloid |
| V10XA01 | sodium iodide (131I) |
| V10XA02 | iobenguane (131I) |
| A01AA02 | sodium monofluorophosphate |
| A01AB17 | metronidazole |
| A01AB22 | doxycycline |
| A02AB03 | aluminium phosphate |
| A02AB04 | dihydroxialumini sodium carbonate |
| A02AD01 | ordinary salt combinations |
| A02BA01 | cimetidine |
| A02BC03 | lansoprazole |
| A02BC08 | vonoprazan |
| A02BD09 | lansoprazole, clarithromycin and tinidazole |
| A02BX15 | teprenone |
| A03A | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| A03AB01 | benzilone |
| A03AB04 | penthienate |
| A03AB05 | propantheline |
| A03AB07 | methantheline |
| A03AB11 | poldine |
| A03AX03 | chlorbenzoxamine |
| A03AX07 | proxazole |
| A03AX08 | alverine |
| A03B | BELLADONNA AND DERIVATIVES, PLAIN |
| A03BA04 | belladonna total alkaloids |
| A03C | ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS |
| A03CA04 | otilonium bromide and psycholeptics |
| A03CA08 | diphemanil and psycholeptics |
| A03EA | Antispasmodics, psycholeptics and analgesics in combination |
| A03F | PROPULSIVES |
| A04AA04 | dolasetron |
| A05B | LIVER THERAPY, LIPOTROPICS |
| A05BA10 | phospholipids |
| A06AB01 | oxyphenisatine |
| A06AB02 | bisacodyl |
| A06AB07 | cascara |
| A06AB30 | contact laxatives in combination with belladonna alkaloids |
| A06AC02 | ethulose |
| A06AC03 | sterculia |
| A06AC05 | linseed |
| A06AC53 | sterculia, combinations |
| A06AD16 | mannitol |
| A06AG06 | oil |
| A06AX | Other drugs for constipation |
| A06AX02 | carbon dioxide producing drugs |
| A06AX05 | prucalopride |
| A06AX06 | tegaserod |
| A07AB | Sulfonamides |
| A07AC | Imidazole derivatives |
| A07AX04 | nifurzide |
| A07BC54 | attapulgite, combinations |
| A07DA52 | morphine, combinations |
| A07E | INTESTINAL ANTIINFLAMMATORY AGENTS |
| A07EA | Corticosteroids acting locally |
| A07EA03 | prednisone |
| A08AA02 | fenfluramine |
| A08AA03 | amfepramone |
| A08AA05 | mazindol |
| A08AA09 | mefenorex |
| A08AA11 | lorcaserin |
| A08AA62 | bupropion and naltrexone |
| A10AD | Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting |
| A10AD03 | insulin (pork) |
| A10AF01 | insulin (human) |
| A10BB11 | glisoxepide |
| A10BD05 | metformin and pioglitazone |
| A10BD15 | metformin and dapagliflozin |
| A10BD19 | linagliptin and empagliflozin |
| A10BD20 | metformin and empagliflozin |
| A10BH52 | gemigliptin and rosuvastatin |
| A10BJ | Glucagon-like peptide-1 (GLP-1) analogues |
| A10BK | Sodium-glucose co-transporter 2 (SGLT2) inhibitors |
| A10BK05 | ipragliflozin |
| A10BK06 | sotagliflozin |
| A10BK07 | luseogliflozin |
| A10BX | Other blood glucose lowering drugs, excl. insulins |
| A10BX02 | repaglinide |
| A10BX08 | mitiglinide |
| A11A | MULTIVITAMINS, COMBINATIONS |
| A11BA | Multivitamins, plain |
| A11C | VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO |
| A11CC20 | combinations |
| A11CC55 | colecalciferol, combinations |
| A11D | VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 |
| A11E | VITAMIN B-COMPLEX, INCL. COMBINATIONS |
| A11GA | Ascorbic acid (vitamin C), plain |
| A11GB | Ascorbic acid (vitamin C), combinations |
| A11HA | Other plain vitamin preparations |
| A11JB | Vitamins with minerals |
| A12 | MINERAL SUPPLEMENTS |
| A12AA03 | calcium gluconate |
| A12AA04 | calcium carbonate |
| A12CC01 | magnesium chloride |
| A12CE02 | sodium selenite |
| A14AA06 | quinbolone |
| A14AB02 | ethylestrenol |
| A14AB03 | oxabolone cipionate |
| A16A | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| A16AB03 | agalsidase alfa |
| A16AB07 | alglucosidase alfa |
| A16AB10 | velaglucerase alfa |
| A16AB12 | elosulfase alfa |
| A16AB22 | avalglucosidase alfa |
| A16AX12 | trientine |
| A16AX18 | lumasiran |
| B01AA | Vitamin K antagonists |
| B01AA11 | tioclomarol |
| B01AB01 | heparin |
| B01AB04 | dalteparin |
| B01AB11 | sulodexide |
| B01AC08 | carbasalate calcium |
| B01AC21 | treprostinil |
| B01AC22 | prasugrel |
| B01AC26 | vorapaxar |
| B01AD07 | reteplase |
| B01AE01 | desirudin |
| B01AF | Direct factor Xa inhibitors |
| B01AX01 | defibrotide |
| B01AX05 | fondaparinux |
| B02 | ANTIHEMORRHAGICS |
| B02AA02 | tranexamic acid |
| B02BC03 | tetragalacturonic acid hydroxymethylester |
| B02BD14 | susoctocog alfa |
| B02BD15 | valoctocogene roxaparvovec |
| B02BD30 | thrombin |
| B02BX07 | lusutrombopag |
| B03AA06 | ferrous succinate |
| B03AB03 | sodium feredetate |
| B03AB05 | ferric oxide polymaltose complexes |
| B03B | VITAMIN B12 AND FOLIC ACID |
| B03XA03 | methoxy polyethylene glycol-epoetin beta |
| B03XA04 | peginesatide |
| B05AA03 | fluorocarbon blood substitutes |
| B05AA09 | hemoglobin raffimer |
| B05BB01 | electrolytes |
| B05BB02 | electrolytes with carbohydrates |
| B05BC | Solutions producing osmotic diuresis |
| B05CA07 | noxytiolin |
| B05CA08 | ethacridine lactate |
| B05CB04 | sodium bicarbonate |
| B05CX | Other irrigating solutions |
| B05XA01 | potassium chloride |
| B05XA04 | ammonium chloride |
| B05XA10 | magnesium phosphate |
| B05XA19 | calcium gluconate |
| B05XX | Other i.v. solution additives |
| B06AB01 | hemin |
| B06AC04 | conestat alfa |
| B06AC05 | lanadelumab |
| B06AX01 | crizanlizumab |
| B06AX04 | mitapivat |
| C | CARDIOVASCULAR SYSTEM |
| C01AA | Digitalis glycosides |
| C01AC | Strophanthus glycosides |
| C01BA13 | hydroquinidine |
| C01BC07 | lorcainide |
| C01BC08 | encainide |
| C01BD01 | amiodarone |
| C01BD03 | bunaftine |
| C01BD06 | tedisamil |
| C01CA02 | isoprenaline |
| C01CA07 | dobutamine |
| C01CA18 | octopamine |
| C01CA25 | amezinium metilsulfate |
| C01DA57 | propatylnitrate, combinations |
| C01DX06 | hexobendine |
| C01DX16 | nicorandil |
| C01DX19 | nesiritide |
| C01E | OTHER CARDIAC PREPARATIONS |
| C01EB06 | fosfocreatine |
| C01EB11 | tiracizine |
| C01EB13 | acadesine |
| C01EB24 | mavacamten |
| C02 | ANTIHYPERTENSIVES |
| C02A | ANTIADRENERGIC AGENTS, CENTRALLY ACTING |
| C02AA02 | reserpine |
| C02AA05 | deserpidine |
| C02AA52 | reserpine, combinations |
| C02AB01 | methyldopa (levorotatory) |
| C02CA01 | prazosin |
| C02CA02 | indoramin |
| C02DC01 | minoxidil |
| C02DG01 | pinacidil |
| C02KA01 | veratrum |
| C02KC01 | pargyline |
| C02KD01 | ketanserin |
| C02LA08 | rauwolfia alkaloids, whole root and diuretics |
| C02LC51 | clonidine and diuretics, combinations with other drugs |
| C02LE | Alpha-adrenoreceptor antagonists and diuretics |
| C02LG | Hydrazinophthalazine derivatives and diuretics |
| C02LX01 | pinacidil and diuretics |
| C03AX | Thiazides, combinations with other drugs |
| C03BA02 | quinethazone |
| C03BA10 | xipamide |
| C03CA03 | piretanide |
| C03CA04 | torasemide |
| C03CB | Sulfonamides and potassium in combination |
| C03CX01 | etozolin |
| C03DA01 | spironolactone |
| C03DA02 | potassium canrenoate |
| C03DB | Other potassium-sparing agents |
| C03EB01 | furosemide and potassium-sparing agents |
| C03XA | Vasopressin antagonists |
| C04AA01 | isoxsuprine |
| C04AB | Imidazoline derivatives |
| C04AB02 | tolazoline |
| C04AE51 | ergoloid mesylates, combinations |
| C04AX02 | phenoxybenzamine |
| C04AX28 | ifenprodil |
| C04AX32 | fasudil |
| C05AA04 | prednisolone |
| C05AA12 | triamcinolone |
| C05AD05 | procaine |
| C05AD07 | pramocaine |
| C05AX05 | tribenoside |
| C05BB | Sclerosing agents for local injection |
| C05BB02 | polidocanol |
| C05BB56 | glucose, combinations |
| C05BX | Other sclerosing agents |
| C05CA | Bioflavonoids |
| C05CA03 | diosmin |
| C05CA04 | troxerutin |
| C05CA51 | rutoside, combinations |
| C07 | BETA BLOCKING AGENTS |
| C07AA16 | tertatolol |
| C07AA23 | penbutolol |
| C07AB13 | talinolol |
| C07AG02 | carvedilol |
| C07BA07 | sotalol and thiazides |
| C07BB | Beta blocking agents, selective, and thiazides |
| C07BB07 | bisoprolol and thiazides |
| C07CA17 | bopindolol and other diuretics |
| C07CB02 | metoprolol and other diuretics |
| C07D | BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS |
| C07E | BETA BLOCKING AGENTS AND VASODILATORS |
| C07FB02 | metoprolol and felodipine |
| C07FB03 | atenolol and nifedipine |
| C07FX02 | sotalol and acetylsalicylic acid |
| C08CA06 | nimodipine |
| C08CA12 | barnidipine |
| C08CA13 | lercanidipine |
| C08CA16 | clevidipine |
| C08D | SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS |
| C08GA | Calcium channel blockers and diuretics |
| C09AA08 | cilazapril |
| C09AA15 | zofenopril |
| C09BA02 | enalapril and diuretics |
| C09BA07 | benazepril and diuretics |
| C09BA09 | fosinopril and diuretics |
| C09BB03 | lisinopril and amlodipine |
| C09BB06 | enalapril and nitrendipine |
| C09CA06 | candesartan |
| C09CA09 | azilsartan medoxomil |
| C09DA01 | losartan and diuretics |
| C09DB | Angiotensin II receptor blockers (ARBs) and calcium channel blockers |
| C09DX05 | valsartan and nebivolol |
| C09XA01 | remikiren |
| C10A | LIPID MODIFYING AGENTS, PLAIN |
| C10AB | Fibrates |
| C10AB11 | choline fenofibrate |
| C10AC02 | colestipol |
| C10AC03 | colextran |
| C10AC04 | colesevelam |
| C10AX09 | ezetimibe |
| C10AX14 | alirocumab |
| C10B | LIPID MODIFYING AGENTS, COMBINATIONS |
| C10BA12 | pravastatin, ezetimibe and fenofibrate |
| C10BX06 | atorvastatin, acetylsalicylic acid and ramipril |
| C10BX12 | atorvastatin, acetylsalicylic acid and perindopril |
| C10BX15 | atorvastatin and perindopril |
| C10BX21 | rosuvastatin and perindopril |
| D01AA02 | natamycin |
| D01AA06 | mepartricin |
| D01AC20 | imidazoles/triazoles in combination with corticosteroids |
| D01AE02 | methylrosaniline |
| D01AE11 | haloprogin |
| D01AE13 | selenium sulfide |
| D01AE16 | amorolfine |
| D01AE20 | combinations |
| D02BB01 | betacarotene |
| D03AX | Other cicatrizants |
| D03AX03 | dexpanthenol |
| D03AX04 | calcium pantothenate |
| D03AX11 | sodium chlorite |
| D03BA52 | collagenase, combinations |
| D04AA13 | dimetindene |
| D04AA32 | diphenhydramine |
| D04AA34 | chlorphenoxamine |
| D04AB | Anesthetics for topical use |
| D04AB03 | oxybuprocaine |
| D05AX55 | tazarotene and ulobetasol |
| D05BB | Retinoids for treatment of psoriasis |
| D05BB02 | acitretin |
| D06A | ANTIBIOTICS FOR TOPICAL USE |
| D06BA | Sulfonamides |
| D06BA04 | sulfamethizole |
| D06BA06 | sulfamerazine |
| D06BB04 | podophyllotoxin |
| D06BB07 | lysozyme |
| D07 | CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS |
| D07AA01 | methylprednisolone |
| D07AB09 | triamcinolone |
| D07AC01 | betamethasone |
| D07AC13 | mometasone |
| D07B | CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS |
| D07BB | Corticosteroids, moderately potent, combinations with antiseptics |
| D07BC02 | fluocinolone acetonide and antiseptics |
| D07CA03 | prednisolone and antibiotics |
| D07CB02 | fluprednidene and antibiotics |
| D07CC05 | fluocinonide and antibiotics |
| D07XB03 | fluprednidene |
| D07XB30 | combinations of corticosteroids |
| D07XC | Corticosteroids, potent, other combinations |
| D08AA | Acridine derivatives |
| D08AA02 | aminoacridine |
| D08AE06 | biphenylol |
| D08AG04 | diiodohydroxypropane |
| D08AJ10 | decamethoxine |
| D08AL30 | silver |
| D09AA03 | nitrofural |
| D10 | ANTI-ACNE PREPARATIONS |
| D10AB01 | bithionol |
| D10AB02 | sulfur |
| D10AD03 | adapalene |
| D10AD53 | adapalene, combinations |
| D10AF | Antiinfectives for treatment of acne |
| D10AF07 | minocycline |
| D10AX30 | various combinations |
| D11AC02 | cadmium compounds |
| D11AC30 | others |
| D11AE | Androgens for topical use |
| D11AH01 | tacrolimus |
| D11AH02 | pimecrolimus |
| D11AX | Other dermatologicals |
| D11AX02 | gamolenic acid |
| G01A | ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS |
| G01AA08 | carfecillin |
| G01AF08 | tioconazole |
| G01AF14 | propenidazole |
| G01AF19 | sertaconazole |
| G01AF55 | econazole, combinations |
| G01AX05 | nifuratel |
| G01AX14 | lactobacillus |
| G01AX17 | dapivirine |
| G01B | ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS |
| G01BD | Antiseptics and corticosteroids |
| G01BF | Imidazole derivatives and corticosteroids |
| G02AC01 | methylergometrine and oxytocin |
| G02AD02 | dinoprostone |
| G02AD05 | sulprostone |
| G02AD06 | misoprostol |
| G02BA02 | plastic IUD with copper |
| G02BA03 | plastic IUD with progestogen |
| G02BB01 | vaginal ring with progestogen and estrogen |
| G02CA02 | buphenine |
| G02CB01 | bromocriptine |
| G02CX02 | flibanserin |
| G03AA07 | levonorgestrel and ethinylestradiol |
| G03AA10 | gestodene and ethinylestradiol |
| G03AA13 | norelgestromin and ethinylestradiol |
| G03AB08 | dienogest and estradiol |
| G03AC03 | levonorgestrel |
| G03BA | 3-oxoandrosten (4) derivatives |
| G03BB01 | mesterolone |
| G03CA01 | ethinylestradiol |
| G03CB02 | diethylstilbestrol |
| G03CC02 | dienestrol |
| G03CX | Other estrogens |
| G03CX01 | tibolone |
| G03DB05 | demegestone |
| G03DC06 | etynodiol |
| G03EK01 | methyltestosterone |
| G03FA03 | ethisterone and estrogen |
| G03FB04 | megestrol and estrogen |
| G03FB05 | norethisterone and estrogen |
| G03FB09 | levonorgestrel and estrogen |
| G03GA02 | human menopausal gonadotrophin |
| G03GA07 | lutropin alfa |
| G03GA10 | follitropin delta |
| G03GB | Ovulation stimulants, synthetic |
| G03HB | Antiandrogens and estrogens |
| G03XA02 | gestrinone |
| G03XC03 | lasofoxifene |
| G04B | UROLOGICALS |
| G04BD02 | flavoxate |
| G04BD08 | solifenacin |
| G04BD13 | desfesoterodine |
| G04BE10 | avanafil |
| G04BX | Other urologicals |
| H01BA02 | desmopressin |
| H01C | HYPOTHALAMIC HORMONES |
| H01CA | Gonadotropin-releasing hormones |
| H01CA02 | nafarelin |
| H01CC03 | elagolix |
| H02A | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
| H02AB03 | fluocortolone |
| H02BX01 | methylprednisolone, combinations |
| H02CA01 | trilostane |
| H03AA | Thyroid hormones |
| H03BA03 | benzylthiouracil |
| H05AA05 | palopegteriparatide |
| H05B | ANTI-PARATHYROID AGENTS |
| H05BX02 | paricalcitol |
| J01AA | Tetracyclines |
| J01CA05 | carindacillin |
| J01CA10 | mezlocillin |
| J01CE | Beta-lactamase sensitive penicillins |
| J01CE07 | clometocillin |
| J01CE09 | procaine benzylpenicillin |
| J01CF02 | cloxacillin |
| J01CF06 | nafcillin |
| J01CR03 | ticarcillin and beta-lactamase inhibitor |
| J01DB01 | cefalexin |
| J01DB10 | cefacetrile |
| J01DC07 | cefotiam |
| J01DC14 | flomoxef |
| J01DD09 | cefodizime |
| J01DE02 | cefpirome |
| J01DE03 | cefozopran |
| J01DH03 | ertapenem |
| J01DH52 | meropenem and vaborbactam |
| J01EA | Trimethoprim and derivatives |
| J01EB07 | sulfathiazole |
| J01EC01 | sulfamethoxazole |
| J01EE04 | sulfamoxole and trimethoprim |
| J01FA02 | spiramycin |
| J01FA03 | midecamycin |
| J01FA05 | oleandomycin |
| J01FA10 | azithromycin |
| J01FF01 | clindamycin |
| J01FF02 | lincomycin |
| J01G | AMINOGLYCOSIDE ANTIBACTERIALS |
| J01GA01 | streptomycin |
| J01GB01 | tobramycin |
| J01GB08 | sisomicin |
| J01GB14 | plazomicin |
| J01MA | Fluoroquinolones |
| J01MA13 | trovafloxacin |
| J01MA24 | levonadifloxacin |
| J01MB03 | piromidic acid |
| J01RA | Combinations of antibacterials |
| J01RA02 | sulfonamides, combinations with other antibacterials (excl. trimethoprim) |
| J01RA03 | cefuroxime and metronidazole |
| J01RA10 | ciprofloxacin and metronidazole |
| J01XD | Imidazole derivatives |
| J02AC03 | voriconazole |
| J02AX06 | anidulafungin |
| J02AX08 | rezafungin acetate |
| J04 | ANTIMYCOBACTERIALS |
| J04AB04 | rifabutin |
| J04AK03 | terizidone |
| J04AK07 | thioacetazone |
| J04B | DRUGS FOR TREATMENT OF LEPRA |
| J04BA | Drugs for treatment of lepra |
| J04BA51 | dapsone, rifampicin and clofazimine |
| J05AB06 | ganciclovir |
| J05AB09 | famciclovir |
| J05AE08 | atazanavir |
| J05AF03 | zalcitabine |
| J05AF10 | entecavir |
| J05AJ04 | cabotegravir |
| J05AP52 | dasabuvir, ombitasvir, paritaprevir and ritonavir |
| J05AP57 | glecaprevir and pibrentasvir |
| J05AR12 | lamivudine and tenofovir disoproxil |
| J05AR14 | darunavir and cobicistat |
| J05AR22 | emtricitabine, tenofovir alafenamide, darunavir and cobicistat |
| J05AX05 | inosine pranobex |
| J05AX07 | enfuvirtide |
| J05AX26 | amenamevir |
| J05AX29 | fostemsavir |
| J06B | IMMUNOGLOBULINS |
| J06BB | Specific immunoglobulins |
| J06BB13 | pertussis immunoglobulin |
| J06BD08 | nirsevimab |
| J07AE | Cholera vaccines |
| J07AG01 | haemophilus influenzae B, purified antigen conjugated |
| J07AH02 | other meningococcal monovalent purified polysaccharides antigen |
| J07AL | Pneumococcal vaccines |
| J07AL01 | pneumococcus, purified polysaccharides antigen |
| J07AM01 | tetanus toxoid |
| J07AN | Tuberculosis vaccines |
| J07AP | Typhoid vaccines |
| J07AR01 | typhus exanthematicus, inactivated, whole cell |
| J07AX01 | leptospira vaccines |
| J07BC20 | combinations |
| J07BD52 | measles, combinations with mumps and rubella, live attenuated |
| J07BE01 | mumps, live attenuated |
| J07BK02 | zoster, live attenuated |
| J07BM02 | papillomavirus (human types 16, 18) |
| J07BM03 | papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) |
| J07BX04 | dengue virus vaccines |
| J07CA04 | haemophilus influenzae B and poliomyelitis |
| L01AA03 | melphalan |
| L01AA06 | ifosfamide |
| L01AD02 | lomustine |
| L01BB06 | clofarabine |
| L01BC05 | gemcitabine |
| L01BC07 | azacitidine |
| L01BC53 | tegafur, combinations |
| L01CD03 | paclitaxel poliglumex |
| L01CX01 | trabectedin |
| L01DA | Actinomycines |
| L01DB02 | daunorubicin |
| L01DB03 | epirubicin |
| L01DB10 | amrubicin |
| L01DB11 | pixantrone |
| L01DC04 | ixabepilone |
| L01EA05 | ponatinib |
| L01EB01 | gefitinib |
| L01EB02 | erlotinib |
| L01EC | B-Raf serine-threonine kinase (BRAF) inhibitors |
| L01EC01 | vemurafenib |
| L01EH03 | tucatinib |
| L01EJ02 | fedratinib |
| L01EK | Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors |
| L01EL | Bruton's tyrosine kinase (BTK) inhibitors |
| L01EN02 | pemigatinib |
| L01EX13 | gilteritinib |
| L01EX22 | selpercatinib |
| L01EX27 | capivasertib |
| L01FA03 | obinutuzumab |
| L01FD03 | trastuzumab emtansine |
| L01FE02 | panitumumab |
| L01FF01 | nivolumab |
| L01FG | VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors |
| L01FX | Other monoclonal antibodies and antibody drug conjugates |
| L01FX18 | amivantamab |
| L01FX19 | sabatolimab |
| L01FX26 | mirvetuximab soravtansine |
| L01FY02 | nivolumab and relatlimab |
| L01XA | Platinum compounds |
| L01XA01 | cisplatin |
| L01XA04 | satraplatin |
| L01XD03 | methyl aminolevulinate |
| L01XD05 | temoporfin |
| L01XH03 | panobinostat |
| L01XK04 | talazoparib |
| L01XL02 | talimogene laherparepvec |
| L01XL03 | axicabtagene ciloleucel |
| L01XL07 | idecabtagene vicleucel |
| L01XX62 | ivosidenib |
| L01XX79 | eflornithine |
| L02 | ENDOCRINE THERAPY |
| L02AX | Other hormones |
| L02BB01 | flutamide |
| L03AA13 | pegfilgrastim |
| L03AA17 | pegteograstim |
| L03AA18 | efbemalenograstim alfa |
| L03AB01 | interferon alfa natural |
| L03AB11 | peginterferon alfa-2a |
| L03AB61 | peginterferon alfa-2a, combinations |
| L03AC02 | oprelvekin |
| L03AX12 | melanoma vaccine |
| L03AX13 | glatiramer acetate |
| L03AX15 | mifamurtide |
| L04AA03 | antilymphocyte immunoglobulin (horse) |
| L04AA04 | antithymocyte immunoglobulin (rabbit) |
| L04AA22 | abetimus |
| L04AA32 | apremilast |
| L04AA48 | belumosudil |
| L04AB04 | adalimumab |
| L04AC03 | anakinra |
| L04AC04 | rilonacept |
| L04AC21 | bimekizumab |
| L04AE04 | ponesimod |
| L04AF03 | upadacitinib |
| L04AG01 | muromonab-CD3 |
| L04AG03 | natalizumab |
| L04AG04 | belimumab |
| L04AJ06 | zilucoplan |
| L04AJ09 | danicopan |
| L04AX01 | azathioprine |
| L04AX04 | lenalidomide |
| L04AX08 | darvadstrocel |
| M01A | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS |
| M01AA05 | clofezone |
| M01AB04 | zomepirac |
| M01AB09 | lonazolac |
| M01AB55 | diclofenac, combinations |
| M01AE02 | naproxen |
| M01AE07 | suprofen |
| M01AE09 | flurbiprofen |
| M01AE15 | flunoxaprofen |
| M01AE52 | naproxen and esomeprazole |
| M01AH01 | celecoxib |
| M01AH04 | parecoxib |
| M01AX02 | niflumic acid |
| M01AX04 | azapropazone |
| M01AX24 | oxaceprol |
| M01BA | Antiinflammatory/antirheumatic agents in combination with corticosteroids |
| M01CB04 | aurothioglucose |
| M01CC01 | penicillamine |
| M02AA01 | phenylbutazone |
| M02AA08 | felbinac |
| M02AA18 | meclofenamic acid |
| M02AX02 | tolazoline |
| M02AX03 | dimethyl sulfoxide |
| M03AC09 | rocuronium bromide |
| M03B | MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
| M03BA | Carbamic acid esters |
| M03BC51 | orphenadrine, combinations |
| M03BX | Other centrally acting agents |
| M03BX05 | thiocolchicoside |
| M03CA01 | dantrolene |
| M04AC | Preparations with no effect on uric acid metabolism |
| M05BB | Bisphosphonates, combinations |
| M05BB04 | risedronic acid, calcium and colecalciferol, sequential |
| M05BB05 | alendronic acid, calcium and colecalciferol, sequential |
| M05BC02 | eptotermin alfa |
| M05BX07 | vosoritide |
| M09 | OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM |
| M09AX02 | chondrocytes, autologous |
| M09AX04 | drisapersen |
| M09AX13 | casimersen |
| N01AB07 | desflurane |
| N01AX14 | esketamine |
| N01B | ANESTHETICS, LOCAL |
| N01BB53 | mepivacaine, combinations |
| N01BC | Esters of benzoic acid |
| N02AA01 | morphine |
| N02AA08 | dihydrocodeine |
| N02AB | Phenylpiperidine derivatives |
| N02AC04 | dextropropoxyphene |
| N02AX01 | tilidine |
| N02AX51 | tilidine and naloxone |
| N02BA55 | salicylamide, combinations excl. psycholeptics |
| N02BA75 | salicylamide, combinations with psycholeptics |
| N02BB53 | aminophenazone, combinations excl. psycholeptics |
| N02BE | Anilides |
| N02BE03 | phenacetin |
| N02BE05 | propacetamol |
| N02BE53 | phenacetin, combinations excl. psycholeptics |
| N02BE54 | bucetin, combinations excl. psycholeptics |
| N02BE73 | phenacetin, combinations with psycholeptics |
| N02BG04 | floctafenine |
| N02BG12 | tanezumab |
| N02C | ANTIMIGRAINE PREPARATIONS |
| N02CA72 | ergotamine, combinations with psycholeptics |
| N02CC | Selective serotonin (5HT1) agonists |
| N02CC51 | sumatriptan and naproxen |
| N02CX03 | iprazochrome |
| N03AA30 | metharbital |
| N03AB54 | mephenytoin, combinations |
| N03AE | Benzodiazepine derivatives |
| N03AF03 | rufinamide |
| N03AG01 | valproic acid |
| N03AG03 | aminobutyric acid |
| N03AX | Other antiepileptics |
| N03AX13 | pheneturide |
| N03AX18 | lacosamide |
| N03AX27 | ganaxolone |
| N03AX30 | beclamide |
| N04AB01 | etanautine |
| N04BC | Dopamine agonists |
| N05AA01 | chlorpromazine |
| N05AA02 | levomepromazine |
| N05AA06 | cyamemazine |
| N05AB | Phenothiazines with piperazine structure |
| N05AB03 | perphenazine |
| N05AB07 | acetophenazine |
| N05AB09 | butaperazine |
| N05AB10 | perazine |
| N05AC04 | pipotiazine |
| N05AF | Thioxanthene derivatives |
| N05AG | Diphenylbutylpiperidine derivatives |
| N05AL01 | sulpiride |
| N05AL05 | amisulpride |
| N05B | ANXIOLYTICS |
| N05BA09 | clobazam |
| N05BA21 | clotiazepam |
| N05BB51 | hydroxyzine, combinations |
| N05BE01 | buspirone |
| N05CA05 | aprobarbital |
| N05CA08 | vinylbital |
| N05CA22 | proxibarbal |
| N05CD09 | brotizolam |
| N05CF02 | zolpidem |
| N05CJ | Orexin receptor antagonists |
| N05CM01 | methaqualone |
| N05CM02 | clomethiazole |
| N05CM08 | ethchlorvynol |
| N05CM11 | bromides |
| N06 | PSYCHOANALEPTICS |
| N06AA01 | desipramine |
| N06AA14 | melitracen |
| N06AF05 | iproniazide |
| N06AX07 | minaprine |
| N06BA09 | atomoxetine |
| N06BX05 | fipexide |
| N06BX13 | idebenone |
| N06BX17 | adrafinil |
| N06DA02 | donepezil |
| N07BC04 | lofexidine |
| N07XA | Gangliosides and ganglioside derivatives |
| P | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS |
| P01AB | Nitroimidazole derivatives |
| P01AX | Other agents against amoebiasis and other protozoal diseases |
| P01AX08 | tenonitrozole |
| P01BA02 | hydroxychloroquine |
| P01BA07 | tafenoquine |
| P01BD01 | pyrimethamine |
| P01BD51 | pyrimethamine, combinations |
| P01BE05 | artenimol |
| P01BF06 | artesunate and pyronaridine |
| P01CC | Nitrofuran derivatives |
| P02 | ANTHELMINTICS |
| P02B | ANTITREMATODALS |
| P02BA | Quinoline derivatives and related substances |
| P02CA01 | mebendazole |
| P02CA04 | ciclobendazole |
| P02CB | Piperazine and derivatives |
| P02CC02 | oxantel |
| P02CF | Avermectines |
| P02CF01 | ivermectin |
| P03AA01 | dixanthogen |
| P03AC02 | bioallethrin |
| P03BX03 | dibutylphthalate |
| R01AA15 | indanazoline |
| R01AB | Sympathomimetics, combinations excl. corticosteroids |
| R01AB01 | phenylephrine |
| R01AC03 | azelastine |
| R01AD53 | dexamethasone, combinations |
| R01AD59 | mometasone, combinations |
| R01AX | Other nasal preparations |
| R01AX09 | hyaluronic acid |
| R01BA02 | pseudoephedrine |
| R01BA52 | pseudoephedrine, combinations |
| R02AA10 | myristyl-benzalkonium |
| R02AD02 | lidocaine |
| R02AD05 | ambroxol |
| R02AX01 | flurbiprofen |
| R03AB02 | isoprenaline |
| R03AB03 | orciprenaline |
| R03AC | Selective beta-2-adrenoreceptor agonists |
| R03AC04 | fenoterol |
| R03AC16 | procaterol |
| R03AK | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics |
| R03AK05 | reproterol and sodium cromoglicate |
| R03AK07 | formoterol and budesonide |
| R03AL09 | formoterol, glycopyrronium bromide and beclometasone |
| R03AL10 | formoterol and tiotropium bromide |
| R03BA01 | beclometasone |
| R03BA08 | ciclesonide |
| R03BX01 | fenspiride |
| R03CB51 | isoprenaline, combinations |
| R03CB53 | orciprenaline, combinations |
| R03CC53 | terbutaline, combinations |
| R03CC63 | clenbuterol and ambroxol |
| R03DA74 | theophylline, combinations with psycholeptics |
| R03DB02 | choline theophyllinate and adrenergics |
| R03DB06 | etamiphylline and adrenergics |
| R03DC | Leukotriene receptor antagonists |
| R03DC01 | zafirlukast |
| R03DX02 | eprozinol |
| R03DX07 | roflumilast |
| R05CA05 | altheae radix |
| R05CA10 | combinations |
| R05CB01 | acetylcysteine |
| R05CB08 | domiodol |
| R05CB14 | neltenexine |
| R05CB16 | mannitol |
| R05DA | Opium alkaloids and derivatives |
| R05DA04 | codeine |
| R05DA10 | thebacon |
| R05DB | Other cough suppressants |
| R05DB02 | benproperine |
| R05DB25 | morclofone |
| R06AB02 | dexchlorpheniramine |
| R06AB06 | dexbrompheniramine |
| R06AB54 | chlorphenamine, combinations |
| R06AD03 | thiethylperazine |
| R06AD08 | oxomemazine |
| R06AE01 | buclizine |
| R06AE51 | buclizine, combinations |
| R06AE55 | meclozine, combinations |
| R06AX04 | phenindamine |
| R06AX16 | deptropine |
| R06AX21 | tritoqualine |
| R06AX22 | ebastine |
| R06AX23 | pimethixene |
| R07AA01 | colfosceril palmitate |
| S01AA01 | chloramphenicol |
| S01AA04 | oxytetracycline |
| S01AA09 | tetracycline |
| S01AA23 | netilmicin |
| S01AA28 | vancomycin |
| S01AB04 | sulfacetamide |
| S01AD05 | interferon |
| S01AE09 | tosufloxacin |
| S01AX10 | sodium propionate |
| S01B | ANTIINFLAMMATORY AGENTS |
| S01BA05 | triamcinolone |
| S01BA09 | clobetasone |
| S01BA13 | rimexolone |
| S01BA14 | loteprednol |
| S01BB04 | betamethasone and mydriatics |
| S01CA01 | dexamethasone and antiinfectives |
| S01CA05 | betamethasone and antiinfectives |
| S01CA07 | fluorometholone and antiinfectives |
| S01CC02 | indometacin and antiinfectives |
| S01EB03 | ecothiopate |
| S01EB09 | acetylcholine |
| S01EC01 | acetazolamide |
| S01ED52 | betaxolol, combinations |
| S01EE03 | bimatoprost |
| S01EE06 | latanoprostene bunod |
| S01FA02 | scopolamine |
| S01FA03 | methylscopolamine |
| S01FA04 | cyclopentolate |
| S01GA06 | oxedrine |
| S01GX | Other antiallergics |
| S01GX05 | lodoxamide |
| S01GX07 | azelastine |
| S01HA | Local anesthetics |
| S01HA02 | oxybuprocaine |
| S01HA03 | tetracaine |
| S01JX | Other ophthalmological diagnostic agents |
| S01KA | Viscoelastic substances |
| S01LA06 | brolucizumab |
| S01LA08 | bevacizumab |
| S01XA03 | sodium chloride, hypertonic |
| S01XA04 | potassium iodide |
| S01XA05 | sodium edetate |
| S01XA10 | inosine |
| S01XA15 | ascorbic acid |
| S01XA18 | ciclosporin |
| S01XA23 | sirolimus |
| S02AA | Antiinfectives |
| S02AA09 | chlorhexidine |
| S02B | CORTICOSTEROIDS |
| S02BA01 | hydrocortisone |
| S02BA03 | prednisolone |
| S02CA01 | prednisolone and antiinfectives |
| S02CA07 | fludrocortisone and antiinfectives |
| S02DA02 | cocaine |
| S03CA01 | dexamethasone and antiinfectives |
| S03CA04 | hydrocortisone and antiinfectives |
| V01AA02 | grass pollen |
| V03AB14 | protamine |
| V03AB16 | ethanol |
| V03AB18 | potassium permanganate |
| V03AB19 | physostigmine |
| V03AB33 | hydroxocobalamin |
| V03AE | Drugs for treatment of hyperkalemia and hyperphosphatemia |
| V03AF01 | mesna |
| V03AG01 | sodium cellulose phosphate |
| V03AN | Medical gases |
| V03AN04 | nitrogen |
| V04CD | Tests for pituitary function |
| V04CD06 | macimorelin |
| V04CK03 | bentiromide |
| V06 | GENERAL NUTRIENTS |
| V06CA | Nutrients without phenylalanine |
| V06D | OTHER NUTRIENTS |
| V08AA | Watersoluble, nephrotropic, high osmolar X-ray contrast media |
| V08AB07 | ioversol |
| V08AC05 | iobenzamic acid |
| V08AC07 | iocetamic acid |
| V08AC10 | calcium iopodate |
| V08AD01 | ethyl esters of iodised fatty acids |
| V08AD04 | iofendylate |
| V08BA | Barium sulfate containing X-ray contrast media |
| V08CA01 | gadopentetic acid |
| V08D | ULTRASOUND CONTRAST MEDIA |
| V08DA04 | perflutren, phospholipid microspheres |
| V09AX04 | flutemetamol (18F) |
| V09AX05 | florbetapir (18F) |
| V09AX07 | flortaucipir (18F) |
| V09BA03 | technetium (99mTc) pyrophosphate |
| V09BA04 | technetium (99mTc) butedronic acid |
| V09CA02 | technetium (99mTc) succimer |
| V09CA04 | technetium (99mTc) gluceptate |
| V09CA05 | technetium (99mTc) gluconate |
| V09CX02 | sodium iodohippurate (131I) |
| V09DA01 | technetium (99mTc) disofenin |
| V09EB02 | technetium (99mTc) microspheres |
| V09EX02 | xenon (127Xe) gas |
| V09GA04 | technetium (99mTc) human albumin |
| V09GX02 | indium (111In) imciromab |
| V09GX03 | chromium (51Cr) chromate labelled cells |
| V09GX04 | rubidium (82Rb) chloride |
| V09IX05 | fluorodopa (18F) |
| V09XA01 | iodine (131I) norcholesterol |
| V10AA | Yttrium (90Y) compounds |
| V10AA01 | yttrium (90Y) citrate colloid |
| V10AX02 | samarium (153Sm) hydroxyapatite colloid |
| V10AX06 | gold (198Au) colloidal |
| A | ALIMENTARY TRACT AND METABOLISM |
| A01AA30 | combinations |
| A01AB02 | hydrogen peroxide |
| A01AB04 | amphotericin B |
| A01AB11 | various |
| A01AB13 | tetracycline |
| A01AB53 | chlorhexidine and cetylpyridinium |
| A01AC02 | dexamethasone |
| A01AC03 | hydrocortisone |
| A02AB | Aluminium compounds |
| A02AF | Antacids with antiflatulents |
| A02BA05 | niperotidine |
| A02BA53 | famotidine, combinations |
| A02BD | Combinations for eradication of Helicobacter pylori |
| A02BD10 | lansoprazole, amoxicillin and levofloxacin |
| A02BD12 | rabeprazole, amoxicillin and clarithromycin |
| A02BX10 | zolimidine |
| A02BX14 | rebamipide |
| A02BX71 | carbenoxolone, combinations with psycholeptics |
| A03AA01 | oxyphencyclimine |
| A03AA04 | mebeverine |
| A03AA08 | dihexyverine |
| A03AB06 | otilonium bromide |
| A03AB08 | tridihexethyl |
| A03AB16 | (2-benzhydryloxyethyl)diethyl-methylammonium iodide |
| A03AC02 | dimethylaminopropionylphenothiazine |
| A03AC05 | tiropramide |
| A03AX05 | fenoverine |
| A03AX09 | trepibutone |
| A03AX30 | trimethyldiphenylpropylamine |
| A03CA01 | isopropamide and psycholeptics |
| A03CA30 | emepronium and psycholeptics |
| A03DA03 | bevonium and analgesics |
| A03DA05 | camylofin and analgesics |
| A03DA07 | tiemonium iodide and analgesics |
| A03ED | Antispasmodics in combination with other drugs |
| A04A | ANTIEMETICS AND ANTINAUSEANTS |
| A04AA55 | palonosetron, combinations |
| A04AD01 | scopolamine |
| A04AD51 | scopolamine, combinations |
| A04AD54 | chlorobutanol, combinations |
| A05AB | Preparations for biliary tract therapy |
| A05AB01 | nicotinyl methylamide |
| A05AX01 | piprozolin |
| A05AX04 | maralixibat chloride |
| A05C | DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION |
| A06AB03 | dantron |
| A06AB04 | phenolphthalein |
| A06AD19 | magnesium citrate |
| A06AD65 | macrogol, combinations |
| A06AG11 | sodium lauryl sulfoacetate, incl. combinations |
| A06AH03 | naloxegol |
| A06AH05 | naldemedine |
| A06AX04 | linaclotide |
| A06AX09 | elobixibat |
| A07AA02 | nystatin |
| A07AB04 | succinylsulfathiazole |
| A07AX02 | acetarsol |
| A07DA53 | loperamide, combinations |
| A07EA04 | betamethasone |
| A07EC | Aminosalicylic acid and similar agents |
| A07XA03 | calcium compounds |
| A07XA06 | crofelemer |
| A08AA51 | phentermine and topiramate |
| A09A | DIGESTIVES, INCL. ENZYMES |
| A09AA02 | multienzymes (lipase, protease etc.) |
| A09AB03 | hydrochloric acid |
| A09AC | Enzyme and acid preparations, combinations |
| A09AC02 | multienzymes and acid preparations |
| A10AB | Insulins and analogues for injection, fast-acting |
| A10AB30 | combinations |
| A10AC | Insulins and analogues for injection, intermediate-acting |
| A10AC02 | insulin (beef) |
| A10AD05 | insulin aspart |
| A10BD01 | phenformin and sulfonylureas |
| A10BD02 | metformin and sulfonylureas |
| A10BD07 | metformin and sitagliptin |
| A10BD08 | metformin and vildagliptin |
| A10BD17 | metformin and acarbose |
| A10BG02 | rosiglitazone |
| A10BG03 | pioglitazone |
| A10BJ03 | lixisenatide |
| A10BK04 | ertugliflozin |
| A10BX03 | nateglinide |
| A11AA01 | multivitamins and iron |
| A11DB | Vitamin B1 in combination with vitamin B6 and/or vitamin B12 |
| A11HA01 | nicotinamide |
| A11HA03 | tocopherol (vit E) |
| A12AA02 | calcium glubionate |
| A12BA01 | potassium chloride |
| A12BA03 | potassium hydrogentartrate |
| A12C | OTHER MINERAL SUPPLEMENTS |
| A12CC | Magnesium |
| A12CC05 | magnesium aspartate |
| A14 | ANABOLIC AGENTS FOR SYSTEMIC USE |
| A14AA02 | stanozolol |
| A14B | OTHER ANABOLIC AGENTS |
| A15 | APPETITE STIMULANTS |
| A16AA07 | metreleptin |
| A16AB06 | sacrosidase |
| A16AX01 | thioctic acid |
| A16AX08 | teduglutide |
| A16AX13 | uridine triacetate |
| A16AX17 | triheptanoin |
| A16AX21 | elivaldogene autotemcel |
| A16AX30 | sodium benzoate and sodium phenylacetate |
| B01AA12 | fluindione |
| B01AB09 | danaparoid |
| B01AC16 | eptifibatide |
| B01AC25 | cangrelor |
| B01AC27 | selexipag |
| B01AC30 | combinations |
| B01AE06 | bivalirudin |
| B01AX07 | caplacizumab |
| B02AA03 | aminomethylbenzoic acid |
| B02AB02 | alfa1 antitrypsin |
| B02AB05 | ulinastatin |
| B02BC06 | thrombin |
| B02BD01 | coagulation factor IX, II, VII and X in combination |
| B02BD02 | coagulation factor VIII |
| B02BD06 | von Willebrand factor and coagulation factor VIII in combination |
| B02BD08 | coagulation factor VIIa |
| B02BD10 | von Willebrand factor |
| B02BX08 | avatrombopag |
| B02BX10 | concizumab |
| B03A | IRON PREPARATIONS |
| B03AA07 | ferrous sulfate |
| B03AA08 | ferrous tartrate |
| B03AB01 | ferric sodium citrate |
| B03AB09 | ferric proteinsuccinylate |
| B03AB10 | ferric maltol |
| B03BA04 | cobamamide |
| B03BA05 | mecobalamin |
| B03XA | Other antianemic preparations |
| B05AX03 | blood plasma |
| B05BA | Solutions for parenteral nutrition |
| B05CB02 | sodium citrate |
| B05XA12 | zinc chloride |
| B05XA30 | combinations of electrolytes |
| B06A | OTHER HEMATOLOGICAL AGENTS |
| C01AX | Other cardiac glycosides |
| C01BA | Antiarrhythmics, class Ia |
| C01BD | Antiarrhythmics, class III |
| C01BD04 | dofetilide |
| C01CA01 | etilefrine |
| C01CA15 | gepefrine |
| C01CA16 | ibopamine |
| C01CX06 | angiotensinamide |
| C01D | VASODILATORS USED IN CARDIAC DISEASES |
| C01DA54 | methylpropylpropanediol dinitrate, combinations |
| C01DA58 | isosorbide dinitrate, combinations |
| C01DA59 | trolnitrate, combinations |
| C01DA70 | organic nitrates in combination with psycholeptics |
| C02AA04 | rauwolfia alkaloids, whole root |
| C02CA04 | doxazosin |
| C02CC04 | debrisoquine |
| C02CC05 | guanoclor |
| C02DB02 | hydralazine |
| C02K | OTHER ANTIHYPERTENSIVES |
| C02KA | Alkaloids, excl. rauwolfia |
| C02KC | MAO inhibitors |
| C02L | ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION |
| C02LA01 | reserpine and diuretics |
| C02LA02 | rescinnamine and diuretics |
| C02LA51 | reserpine and diuretics, combinations with other drugs |
| C02LF | Guanidine derivatives and diuretics |
| C02LG01 | dihydralazine and diuretics |
| C02LL | MAO inhibitors and diuretics |
| C03 | DIURETICS |
| C03AA02 | hydroflumethiazide |
| C03AA05 | polythiazide |
| C03AA08 | methyclothiazide |
| C03AB | Thiazides and potassium in combination |
| C03AB04 | chlorothiazide and potassium |
| C03AB08 | methyclothiazide and potassium |
| C03BK | Sulfonamides, combinations with other drugs |
| C03BX | Other low-ceiling diuretics |
| C03DA04 | eplerenone |
| C03DB01 | amiloride |
| C03EA14 | butizide and potassium-sparing agents |
| C03EB02 | bumetanide and potassium-sparing agents |
| C03X | OTHER DIURETICS |
| C03XA02 | conivaptan |
| C04AA02 | buphenine |
| C04AC | Nicotinic acid and derivatives |
| C04AD | Purine derivatives |
| C04AX33 | clazosentan |
| C05A | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
| C05AA05 | betamethasone |
| C05AX01 | aluminium preparations |
| C05BA51 | heparinoid, combinations |
| C05BB03 | invert sugar |
| C05C | CAPILLARY STABILIZING AGENTS |
| C07A | BETA BLOCKING AGENTS |
| C07AA05 | propranolol |
| C07BA | Beta blocking agents, non-selective, and thiazides |
| C07BA02 | oxprenolol and thiazides |
| C07BA06 | timolol and thiazides |
| C07BA12 | nadolol and thiazides |
| C07BA68 | metipranolol and thiazides, combinations |
| C07C | BETA BLOCKING AGENTS AND OTHER DIURETICS |
| C07FB13 | metoprolol and amlodipine |
| C08CA10 | nilvadipine |
| C08E | NON-SELECTIVE CALCIUM CHANNEL BLOCKERS |
| C08EA02 | bepridil |
| C09AA07 | benazepril |
| C09BA04 | perindopril and diuretics |
| C09BB12 | delapril and manidipine |
| C09BX03 | ramipril, amlodipine and hydrochlorothiazide |
| C09CA01 | losartan |
| C09CA07 | telmisartan |
| C09DB06 | losartan and amlodipine |
| C09DB09 | fimasartan and amlodipine |
| C10AA02 | lovastatin |
| C10AA07 | rosuvastatin |
| C10AB02 | bezafibrate |
| C10AB03 | aluminium clofibrate |
| C10AB05 | fenofibrate |
| C10AX01 | dextrothyroxine |
| C10AX03 | tiadenol |
| C10AX12 | lomitapide |
| C10BA01 | lovastatin and nicotinic acid |
| C10BA03 | pravastatin and fenofibrate |
| C10BX04 | simvastatin, acetylsalicylic acid and ramipril |
| C10BX13 | rosuvastatin, perindopril and indapamide |
| C10BX16 | rosuvastatin and fimasartan |
| D01A | ANTIFUNGALS FOR TOPICAL USE |
| D01AC14 | sertaconazole |
| D01AE | Other antifungals for topical use |
| D01AE04 | undecylenic acid |
| D01AE06 | 2-(4-chlorphenoxy)-ethanol |
| D01AE12 | salicylic acid |
| D01AE21 | flucytosine |
| D01B | ANTIFUNGALS FOR SYSTEMIC USE |
| D02A | EMOLLIENTS AND PROTECTIVES |
| D02AX | Other emollients and protectives |
| D02BB02 | afamelanotide |
| D03AX01 | cadexomer iodine |
| D03AX06 | becaplermin |
| D03AX15 | trafermin |
| D03BA | Proteolytic enzymes |
| D03BA03 | bromelains |
| D04AA03 | thenalidine |
| D04AA14 | clemastine |
| D05AD | Psoralens for topical use |
| D05AD01 | trioxysalen |
| D05BA03 | bergapten |
| D06AX02 | chloramphenicol |
| D06AX11 | rifaximin |
| D06AX14 | ozenoxacin |
| D06B | CHEMOTHERAPEUTICS FOR TOPICAL USE |
| D06BB06 | penciclovir |
| D06BB08 | ibacitabine |
| D06BB12 | sinecatechins |
| D06C | ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS |
| D07AB | Corticosteroids, moderately potent (group II) |
| D07AB07 | fluprednidene |
| D07AB08 | desonide |
| D07AB10 | alclometasone |
| D07AB30 | combinations of corticosteroids |
| D07AC06 | diflucortolone |
| D07AC10 | diflorasone |
| D07AC11 | amcinonide |
| D07AC15 | beclometasone |
| D07AC19 | difluprednate |
| D07AD01 | clobetasol |
| D07BB04 | hydrocortisone butyrate and antiseptics |
| D07BD | Corticosteroids, very potent, combinations with antiseptics |
| D07CA01 | hydrocortisone and antibiotics |
| D07CB04 | dexamethasone and antibiotics |
| D07CB05 | flumetasone and antibiotics |
| D07XA01 | hydrocortisone |
| D07XB01 | flumetasone |
| D07XC01 | betamethasone |
| D07XC05 | fluocortolone |
| D08A | ANTISEPTICS AND DISINFECTANTS |
| D08AC04 | hexamidine |
| D08AH02 | chlorquinaldol |
| D08AJ01 | benzalkonium |
| D08AJ57 | octenidine, combinations |
| D08AK02 | phenylmercuric borate |
| D08AK04 | merbromin |
| D08AL | Silver compounds |
| D08AX05 | isopropanol |
| D09 | MEDICATED DRESSINGS |
| D10A | ANTI-ACNE PREPARATIONS FOR TOPICAL USE |
| D10AA03 | dexamethasone |
| D10AB | Preparations containing sulfur |
| D10AD51 | tretinoin, combinations |
| D10AF05 | nadifloxacin |
| D10AF51 | clindamycin, combinations |
| D10AX03 | azelaic acid |
| D10AX05 | dapsone |
| D11AH | Agents for dermatitis, excluding corticosteroids |
| D11AX01 | minoxidil |
| D11AX24 | deoxycholic acid |
| D11AX25 | hydrogen peroxide |
| D11AX52 | gamolenic acid, combinations |
| D11AX57 | collagen, combinations |
| G01AA09 | mepartricin |
| G01AA11 | pentamycin |
| G01AA51 | nystatin, combinations |
| G01AB | Arsenic compounds |
| G01AC05 | dequalinium |
| G01AD03 | ascorbic acid |
| G01AE | Sulfonamides |
| G01AE01 | sulfatolamide |
| G01AF01 | metronidazole |
| G01AF02 | clotrimazole |
| G01AF07 | isoconazole |
| G01AX02 | inosine |
| G01BE | Sulfonamides and corticosteroids |
| G02AB03 | ergometrine |
| G02AD03 | gemeprost |
| G03AA16 | dienogest and ethinylestradiol |
| G03AB05 | desogestrel and ethinylestradiol |
| G03AB09 | norgestimate and ethinylestradiol |
| G03AC | Progestogens |
| G03AC10 | drospirenone |
| G03B | ANDROGENS |
| G03BA03 | testosterone |
| G03CA53 | estradiol, combinations |
| G03CC | Estrogens, combinations with other drugs |
| G03DA | Pregnen (4) derivatives |
| G03DB07 | promegestone |
| G03FA01 | norethisterone and estrogen |
| G03FA06 | etynodiol and estrogen |
| G03GA06 | follitropin beta |
| G03XC04 | ormeloxifene |
| G04BE | Drugs used in erectile dysfunction |
| G04BE11 | udenafil |
| G04BX06 | phenazopyridine |
| G04BX10 | succinimide |
| G04CA | Alpha-adrenoreceptor antagonists |
| G04CX04 | fexapotide |
| H | SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS |
| H01 | PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES |
| H01AC02 | somatrem |
| H01B | POSTERIOR PITUITARY LOBE HORMONES |
| H01BB | Oxytocin and analogues |
| H01CA01 | gonadorelin |
| H01CB04 | vapreotide |
| H01CB05 | pasireotide |
| H01CC | Anti-gonadotropin-releasing hormones |
| H01CC54 | relugolix, estradiol and norethisterone |
| H02AA03 | desoxycortone |
| H02AB08 | triamcinolone |
| H02AB10 | cortisone |
| H02AB11 | prednylidene |
| H03AA01 | levothyroxine sodium |
| H03BB52 | thiamazole, combinations |
| H04 | PANCREATIC HORMONES |
| H05BA03 | calcitonin (human synthetic) |
| H05BA04 | elcatonin |
| H05BX04 | etelcalcetide |
| H05BX06 | evocalcet |
| J01AA20 | combinations of tetracyclines |
| J01BA52 | thiamphenicol, combinations |
| J01CA02 | pivampicillin |
| J01CA06 | bacampicillin |
| J01CA08 | pivmecillinam |
| J01CE08 | benzathine benzylpenicillin |
| J01CF01 | dicloxacillin |
| J01CF05 | flucloxacillin |
| J01CR01 | ampicillin and beta-lactamase inhibitor |
| J01CR50 | combinations of penicillins |
| J01DB03 | cefalotin |
| J01DC09 | cefmetazole |
| J01DC11 | ceforanide |
| J01DD02 | ceftazidime |
| J01DD05 | cefmenoxime |
| J01DD15 | cefdinir |
| J01DD62 | cefoperazone and beta-lactamase inhibitor |
| J01DE01 | cefepime |
| J01DE51 | cefepime and beta-lactamase inhibitor |
| J01DF02 | carumonam |
| J01DH04 | doripenem |
| J01DI | Other cephalosporins and penems |
| J01EB04 | sulfapyridine |
| J01EB05 | sulfafurazole |
| J01EC02 | sulfadiazine |
| J01EE02 | sulfadiazine and trimethoprim |
| J01EE07 | sulfamerazine and trimethoprim |
| J01F | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| J01FF | Lincosamides |
| J01MA08 | fleroxacin |
| J01MA17 | prulifloxacin |
| J01MA23 | delafloxacin |
| J01RA04 | spiramycin and metronidazole |
| J01RA16 | cefixime and azithromycin |
| J01X | OTHER ANTIBACTERIALS |
| J01XA02 | teicoplanin |
| J01XB | Polymyxins |
| J01XE | Nitrofuran derivatives |
| J01XX | Other antibacterials |
| J02AB01 | miconazole |
| J04AA | Aminosalicylic acid and derivatives |
| J04AC | Hydrazides |
| J04AD | Thiocarbamide derivatives |
| J04AD01 | protionamide |
| J04AK04 | morinamide |
| J04AK05 | bedaquiline |
| J04AM05 | rifampicin, pyrazinamide and isoniazid |
| J05AA01 | metisazone |
| J05AB01 | aciclovir |
| J05AB12 | cidofovir |
| J05AB16 | remdesivir |
| J05AB18 | molnupiravir |
| J05AC | Cyclic amines |
| J05AE05 | amprenavir |
| J05AE07 | fosamprenavir |
| J05AF | Nucleoside and nucleotide reverse transcriptase inhibitors |
| J05AG01 | nevirapine |
| J05AG05 | rilpivirine |
| J05AJ03 | dolutegravir |
| J05AP02 | telaprevir |
| J05AP03 | boceprevir |
| J05AP06 | asunaprevir |
| J05AP08 | sofosbuvir |
| J05AP12 | coblopasvir |
| J05AP13 | ravidasvir |
| J05AR | Antivirals for treatment of HIV infections, combinations |
| J05AR08 | emtricitabine, tenofovir disoproxil and rilpivirine |
| J05AR15 | atazanavir and cobicistat |
| J05AR19 | emtricitabine, tenofovir alafenamide and rilpivirine |
| J05AX23 | ibalizumab |
| J05AX24 | tecovirimat |
| J05AX31 | lenacapavir |
| J06AA | Immune sera |
| J06BB07 | vaccinia immunoglobulin |
| J06BB10 | diphtheria immunoglobulin |
| J06BB15 | mumps immunoglobulin |
| J06BC | Antibacterial monoclonal antibodies |
| J06BC04 | obiltoxaximab |
| J06BD02 | motavizumab |
| J06BD05 | sotrovimab |
| J06BD07 | casirivimab and imdevimab |
| J07 | VACCINES |
| J07AD | Brucellosis vaccines |
| J07AH03 | meningococcus A,C, bivalent purified polysaccharides antigen |
| J07AH04 | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen |
| J07AJ52 | pertussis, purified antigen, combinations with toxoids |
| J07AM | Tetanus vaccines |
| J07AM52 | tetanus toxoid, combinations with tetanus immunoglobulin |
| J07B | VIRAL VACCINES |
| J07BB04 | influenza, virus like particles |
| J07BC02 | hepatitis A, inactivated, whole virus |
| J07BF03 | poliomyelitis, trivalent, inactivated, whole virus |
| J07BK | Varicella zoster vaccines |
| J07BK01 | varicella, live attenuated |
| J07BX02 | ebola vaccines |
| J07C | BACTERIAL AND VIRAL VACCINES, COMBINED |
| L | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
| L01AB01 | busulfan |
| L01AB03 | mannosulfan |
| L01BA03 | raltitrexed |
| L01BB02 | mercaptopurine |
| L01BC03 | tegafur |
| L01CB02 | teniposide |
| L01CE03 | etirinotecan pegol |
| L01CE04 | belotecan |
| L01DB | Anthracyclines and related substances |
| L01DC | Other cytotoxic antibiotics |
| L01EA06 | asciminib |
| L01EC02 | dabrafenib |
| L01ED04 | brigatinib |
| L01EE01 | trametinib |
| L01EG01 | temsirolimus |
| L01EK03 | tivozanib |
| L01EK04 | fruquintinib |
| L01EL03 | zanubrutinib |
| L01EN | Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors |
| L01EN01 | erdafitinib |
| L01EX07 | cabozantinib |
| L01EX08 | lenvatinib |
| L01EX21 | tepotinib |
| L01FD02 | pertuzumab |
| L01FD06 | margetuximab |
| L01FE | EGFR (Epidermal Growth Factor Receptor) inhibitors |
| L01FF03 | durvalumab |
| L01FF05 | atezolizumab |
| L01FX02 | gemtuzumab ozogamicin |
| L01FX09 | mogamulizumab |
| L01FX22 | loncastuximab tesirine |
| L01FX23 | tisotumab vedotin |
| L01FX25 | mosunetuzumab |
| L01FX29 | talquetamab |
| L01XA02 | carboplatin |
| L01XB | Methylhydrazines |
| L01XB01 | procarbazine |
| L01XF | Retinoids for cancer treatment |
| L01XF03 | bexarotene |
| L01XG01 | bortezomib |
| L01XH | Histone deacetylase (HDAC) inhibitors |
| L01XH02 | romidepsin |
| L01XK02 | niraparib |
| L01XK06 | pamiparib |
| L01XL10 | nadofaragene firadenovec |
| L01XX29 | denileukin diftitox |
| L01XX33 | celecoxib |
| L01XX36 | oblimersen |
| L02AB03 | gestonorone |
| L02BB03 | bicalutamide |
| L02BG02 | formestane |
| L03AA10 | lenograstim |
| L03AA12 | ancestim |
| L03AB | Interferons |
| L03AB04 | interferon alfa-2a |
| L03AB06 | interferon alfa-n1 |
| L03AB12 | albinterferon alfa-2b |
| L03AB14 | cepeginterferon alfa-2b |
| L03AC | Interleukins |
| L03AX08 | poly ICLC |
| L03AX09 | thymopentin |
| L03AX16 | plerixafor |
| L04AA | Selective immunosuppressants |
| L04AA41 | imlifidase |
| L04AC01 | daclizumab |
| L04AC13 | ixekizumab |
| L04AC16 | guselkumab |
| L04AC20 | netakimab |
| L04AD03 | voclosporin |
| L04AE01 | fingolimod |
| L04AE03 | siponimod |
| L04AF07 | deucravacitinib |
| L04AG | Monoclonal antibodies |
| L04AG07 | begelomab |
| L04AJ03 | pegcetacoplan |
| M01 | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS |
| M01AA03 | oxyphenbutazone |
| M01AB03 | tolmetin |
| M01AB07 | bumadizone |
| M01AB17 | bufexamac |
| M01AE03 | ketoprofen |
| M01AE12 | oxaprozin |
| M01AE56 | naproxen and misoprostol |
| M01AX01 | nabumetone |
| M01AX14 | orgotein |
| M01AX17 | nimesulide |
| M01B | ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION |
| M01CB02 | sodium aurotiosulfate |
| M01CC02 | bucillamine |
| M02AA10 | ketoprofen |
| M02AA11 | bendazac |
| M02AA19 | flurbiprofen |
| M02AA28 | piketoprofen |
| M02AX10 | various |
| M03AA04 | dimethyltubocurarine |
| M03AB01 | suxamethonium |
| M03BB02 | chlormezanone |
| M03BB52 | chlormezanone, combinations excl. psycholeptics |
| M03BB73 | chlorzoxazone, combinations with psycholeptics |
| M03BX01 | baclofen |
| M03BX08 | cyclobenzaprine |
| M04AB | Preparations increasing uric acid excretion |
| M04AB01 | probenecid |
| M04AC02 | cinchophen |
| M05BA | Bisphosphonates |
| M05BB07 | risedronic acid and colecalciferol |
| M05BC | Bone morphogenetic proteins |
| M05BX08 | menatetrenone |
| M09A | OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM |
| M09AX09 | onasemnogene abeparvovec |
| M09AX10 | risdiplam |
| M09AX15 | delandistrogene moxeparvovec |
| N01A | ANESTHETICS, GENERAL |
| N01AF | Barbiturates, plain |
| N01BA01 | metabutethamine |
| N01BA52 | procaine, combinations |
| N01BB10 | levobupivacaine |
| N01BX02 | dyclonine |
| N02AA02 | opium |
| N02AA58 | dihydrocodeine, combinations |
| N02AA59 | codeine, combinations excl. psycholeptics |
| N02AF02 | nalbuphine |
| N02AJ09 | codeine and other non-opioid analgesics |
| N02AJ14 | tramadol and dexketoprofen |
| N02AJ19 | oxycodone and ibuprofen |
| N02AX03 | dezocine |
| N02BA04 | sodium salicylate |
| N02BA57 | ethenzamide, combinations excl. psycholeptics |
| N02BB02 | metamizole sodium |
| N02BB04 | propyphenazone |
| N02BB05 | nifenazone |
| N02BB72 | metamizole sodium, combinations with psycholeptics |
| N02BB74 | propyphenazone, combinations with psycholeptics |
| N02BE51 | paracetamol, combinations excl. psycholeptics |
| N02BG02 | rimazolium |
| N02CA04 | methysergide |
| N02CC06 | eletriptan |
| N02CD03 | fremanezumab |
| N03AD | Succinimide derivatives |
| N03AD51 | ethosuximide, combinations |
| N03AF02 | oxcarbazepine |
| N03AG05 | progabide |
| N04AA09 | phenglutarimide |
| N04B | DOPAMINERGIC AGENTS |
| N04BA04 | melevodopa |
| N04BC06 | cabergoline |
| N04BD02 | rasagiline |
| N04BX01 | tolcapone |
| N04BX03 | budipine |
| N05AD05 | pipamperone |
| N05AE | Indole derivatives |
| N05AF03 | chlorprothixene |
| N05AF04 | tiotixene |
| N05AH03 | olanzapine |
| N05AN01 | lithium |
| N05AX07 | prothipendyl |
| N05AX10 | mosapramine |
| N05BA03 | medazepam |
| N05BA04 | oxazepam |
| N05BA07 | adinazolam |
| N05BC01 | meprobamate |
| N05BE | Azaspirodecanedione derivatives |
| N05BX01 | mephenoxalone |
| N05BX04 | fabomotizole |
| N05CA | Barbiturates, plain |
| N05CA03 | butobarbital |
| N05CA04 | barbital |
| N05CA12 | reposal |
| N05CA21 | allobarbital |
| N05CD14 | remimazolam |
| N05CE03 | pyrithyldione |
| N05CH03 | tasimelteon |
| N05CM | Other hypnotics and sedatives |
| N05CM12 | apronal |
| N05CX06 | dipiperonylaminoethanol, combinations |
| N06AA07 | lofepramine |
| N06AA10 | nortriptyline |
| N06AA16 | dosulepin |
| N06AA21 | maprotiline |
| N06AA23 | quinupramine |
| N06AB02 | zimeldine |
| N06AB04 | citalopram |
| N06AF06 | iproclozide |
| N06AX01 | oxitriptan |
| N06AX08 | bifemelane |
| N06AX12 | bupropion |
| N06AX25 | Hyperici herba |
| N06DA05 | ipidacrine |
| N07A | PARASYMPATHOMIMETICS |
| N07AA01 | neostigmine |
| N07B | DRUGS USED IN ADDICTIVE DISORDERS |
| N07BA04 | cytisinicline |
| N07X | OTHER NERVOUS SYSTEM DRUGS |
| N07XX | Other nervous system drugs |
| N07XX07 | fampridine |
| N07XX11 | pitolisant |
| N07XX15 | inotersen |
| N07XX21 | eplontersen |
| P01AA02 | clioquinol |
| P01AA52 | clioquinol, combinations |
| P01AB04 | azanidazole |
| P01AB51 | metronidazole and furazolidone |
| P01AC01 | diloxanide |
| P01AX52 | emetine, combinations |
| P01BA03 | primaquine |
| P01BE02 | artemether |
| P01CA03 | fexinidazole |
| P01CB01 | meglumine antimonate |
| P02CA02 | tiabendazole |
| P02CB02 | diethylcarbamazine |
| P02D | ANTICESTODALS |
| P02DA | Salicylic acid derivatives |
| P03AA05 | thiram |
| P03AC | Pyrethrines, incl. synthetic compounds |
| P03AC03 | phenothrin |
| P03AX07 | abametapir |
| P03BA | Pyrethrines |
| P03BA01 | cyfluthrin |
| P03BA02 | cypermethrin |
| P03BX04 | dibutylsuccinate |
| R01A | DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE |
| R01AA08 | naphazoline |
| R01AA11 | tuaminoheptane |
| R01AB03 | tetryzoline |
| R01AC | Antiallergic agents, excl. corticosteroids |
| R01AC02 | levocabastine |
| R01AD06 | betamethasone |
| R01AD13 | ciclesonide |
| R01AX08 | framycetin |
| R01AX30 | combinations |
| R02AA | Antiseptics |
| R02AA13 | acriflavinium chloride |
| R02AA19 | phenol |
| R02AA20 | various |
| R02AX03 | benzydamine |
| R03AC09 | tretoquinol |
| R03AC15 | reproterol |
| R03AK02 | isoprenaline and other drugs for obstructive airway diseases |
| R03AL04 | indacaterol and glycopyrronium bromide |
| R03AL05 | formoterol and aclidinium bromide |
| R03AL11 | formoterol, glycopyrronium bromide and budesonide |
| R03BA02 | budesonide |
| R03BC | Antiallergic agents, excl. corticosteroids |
| R03CC02 | salbutamol |
| R03CC03 | terbutaline |
| R03CC10 | carbuterol |
| R03CC13 | clenbuterol |
| R03CC15 | formoterol |
| R03DA | Xanthines |
| R03DA55 | aminophylline, combinations |
| R03DB | Xanthines and adrenergics |
| R03DB04 | theophylline and adrenergics |
| R05CA06 | senega |
| R05CB03 | carbocisteine |
| R05CB05 | mesna |
| R05DA03 | hydrocodone |
| R05DB01 | benzonatate |
| R05DB04 | isoaminile |
| R06AA52 | diphenhydramine, combinations |
| R06AC52 | histapyrrodine, combinations |
| R06AD04 | methdilazine |
| R06AE06 | oxatomide |
| R06AX08 | pyrrobutamine |
| R06AX24 | epinastine |
| R06AX25 | mizolastine |
| R06AX27 | desloratadine |
| R06AX53 | thenalidine, combinations |
| R07AB08 | dimefline |
| R07AX02 | ivacaftor |
| R07AX31 | ivacaftor and tezacaftor |
| S01AA03 | neomycin |
| S01AA07 | framycetin |
| S01AA12 | tobramycin |
| S01AA14 | benzylpenicillin |
| S01AA18 | polymyxin B |
| S01AD06 | vidarabine |
| S01AD07 | famciclovir |
| S01AE04 | lomefloxacin |
| S01AX | Other antiinfectives |
| S01AX01 | mercury compounds |
| S01AX07 | sodium borate |
| S01AX08 | hexamidine |
| S01AX14 | dibrompropamidine |
| S01BA04 | prednisolone |
| S01BC04 | flurbiprofen |
| S01BC07 | bendazac |
| S01BC10 | nepafenac |
| S01CA | Corticosteroids and antiinfectives in combination |
| S01CA08 | methylprednisolone and antiinfectives |
| S01CB05 | fluorometholone |
| S01EA02 | dipivefrine |
| S01EC04 | brinzolamide |
| S01EC05 | methazolamide |
| S01ED05 | carteolol |
| S01EE01 | latanoprost |
| S01EE51 | latanoprost and netarsudil |
| S01FA01 | atropine |
| S01FA54 | cyclopentolate, combinations |
| S01FB01 | phenylephrine |
| S01FB02 | ephedrine |
| S01FB51 | phenylephrine and ketorolac |
| S01G | DECONGESTANTS AND ANTIALLERGICS |
| S01HA01 | cocaine |
| S01HA07 | lidocaine |
| S01HA30 | combinations |
| S01JA | Colouring agents |
| S01LA03 | pegaptanib |
| S01XA01 | guaiazulen |
| S01XA22 | ocriplasmin |
| S01XA24 | cenegermin |
| S02A | ANTIINFECTIVES |
| S02AA06 | hydrogen peroxide |
| S02AA11 | polymyxin B |
| S02AA14 | gentamicin |
| S02AA18 | cefmenoxime |
| S02BA08 | fluocinolone acetonide |
| S02CA03 | hydrocortisone and antiinfectives |
| S02CA06 | dexamethasone and antiinfectives |
| S03 | OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS |
| S03AA01 | neomycin |
| S03CA | Corticosteroids and antiinfectives in combination |
| S03CA06 | betamethasone and antiinfectives |
| V01AA01 | feather |
| V01AA05 | tree pollen |
| V03AB20 | copper sulfate |
| V03AB26 | methionine |
| V03AB29 | cholinesterase |
| V03AC | Iron chelating agents |
| V03AE04 | calcium acetate and magnesium carbonate |
| V03AE08 | ferric citrate |
| V03AF03 | calcium folinate |
| V03AF04 | calcium levofolinate |
| V03AF10 | sodium levofolinate |
| V03AG05 | sodium phosphate |
| V03AH | Drugs for treatment of hypoglycemia |
| V03AX04 | difelikefalin |
| V04 | DIAGNOSTIC AGENTS |
| V04CA02 | glucose |
| V04CC01 | sorbitol |
| V04CD01 | metyrapone |
| V04CK | Tests for pancreatic function |
| V04CM | Tests for fertility disturbances |
| V04CX04 | mannitol |
| V06DF | Milk substitutes |
| V07AC | Blood transfusion, auxiliary products |
| V07AS | Stomi equipment |
| V07AV | Technical disinfectants |
| V08 | CONTRAST MEDIA |
| V08AA02 | metrizoic acid |
| V08AC09 | tyropanoic acid |
| V08CA03 | gadodiamide |
| V08CA08 | gadobenic acid |
| V08CA09 | gadobutrol |
| V08CA11 | gadofosveset |
| V08DA06 | perflubutane, phospholipid microspheres |
| V09AA | Technetium (99mTc) compounds |
| V09AB | Iodine (123I) compounds |
| V09AB03 | iodine ioflupane (123I) |
| V09BA | Technetium (99mTc) compounds |
| V09BA02 | technetium (99mTc) medronic acid |
| V09DA05 | technetium (99mTc) galtifenin |
| V09FX02 | sodium iodide (123I) |
| V09GA06 | technetium (99mTc) stannous agent labelled cells |
| V09GB | Iodine (125I) compounds |
| V09HA04 | technetium (99mTc) sulesomab |
| V09HX | Other diagnostic radiopharmaceuticals for inflammation and infection detection |
| V09IA01 | technetium (99mTc) antiCarcinoEmbryonicAntigen antibody |
| V09IA04 | technetium (99mTc) votumumab |
| V09IX03 | iodine (125I) CC49-monoclonal antibody |
| V09IX04 | fludeoxyglucose (18F) |
| V09IX10 | fluoroethyl-L-tyrosine (18F) |
| V09XA | Iodine (131I) compounds |
| V09XX | Various diagnostic radiopharmaceuticals |
| V09XX04 | ferric (59Fe) citrate |
| V10 | THERAPEUTIC RADIOPHARMACEUTICALS |
| V10AX04 | erbium (169Er) citrate colloid |
| V10XA03 | iodine (131I) omburtamab |
| V10XX | Various therapeutic radiopharmaceuticals |
| A01A | STOMATOLOGICAL PREPARATIONS |
| A01AB06 | domiphen |
| A01AB10 | natamycin |
| A01AB24 | octenidine |
| A01AC54 | prednisolone, combinations |
| A02 | DRUGS FOR ACID RELATED DISORDERS |
| A02AA03 | magnesium peroxide |
| A02AA04 | magnesium hydroxide |
| A02AB01 | aluminium hydroxide |
| A02AB06 | aloglutamol |
| A02AC01 | calcium carbonate |
| A02AC02 | calcium silicate |
| A02AX | Antacids, other combinations |
| A02BA | H2-receptor antagonists |
| A02BA04 | nizatidine |
| A02BA51 | cimetidine, combinations |
| A02BC06 | dexlansoprazole |
| A02BD01 | omeprazole, amoxicillin and metronidazole |
| A02BD07 | lansoprazole, amoxicillin and clarithromycin |
| A02BX05 | bismuth subcitrate |
| A02BX08 | sulglicotide |
| A02BX13 | alginic acid |
| A03AA09 | difemerine |
| A03AB | Synthetic anticholinergics, quaternary ammonium compounds |
| A03AB17 | tiemonium iodide |
| A03AB19 | timepidium bromide |
| A03AD | Papaverine and derivatives |
| A03AD02 | drotaverine |
| A03AX13 | silicones |
| A03BA01 | atropine |
| A03BB | Belladonna alkaloids, semisynthetic, quaternary ammonium compounds |
| A03BB01 | butylscopolamine |
| A03BB04 | fentonium |
| A03FA04 | bromopride |
| A03FA08 | cinitapride |
| A03FA09 | mosapride |
| A04AA01 | ondansetron |
| A04AD | Other antiemetics |
| A04AD02 | cerium oxalate |
| A04AD12 | aprepitant |
| A05 | BILE AND LIVER THERAPY |
| A05AX02 | hymecromone |
| A05AX06 | elafibranor |
| A05BA | Liver therapy |
| A06AB56 | senna glycosides, combinations |
| A06AB57 | cascara, combinations |
| A06AC08 | polycarbophil calcium |
| A06AD13 | sodium sulfate |
| A06AG | Enemas |
| A06AG03 | dantron, incl. combinations |
| A06AH01 | methylnaltrexone bromide |
| A07AA12 | fidaxomicin |
| A07AA13 | rifamycin |
| A07AX03 | nifuroxazide |
| A07BA01 | medicinal charcoal |
| A07BC02 | kaolin |
| A07BC04 | attapulgite |
| A07D | ANTIPROPULSIVES |
| A07DA02 | opium |
| A07EA06 | budesonide |
| A07EA07 | beclometasone |
| A07EB01 | cromoglicic acid |
| A07EC01 | sulfasalazine |
| A07EC04 | balsalazide |
| A07XA02 | ceratonia |
| A08 | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS |
| A08A | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS |
| A08AA | Centrally acting antiobesity products |
| A09AA01 | diastase |
| A10A | INSULINS AND ANALOGUES |
| A10AB02 | insulin (beef) |
| A10AB06 | insulin glulisine |
| A10AE | Insulins and analogues for injection, long-acting |
| A10AE02 | insulin (beef) |
| A10AF | Insulins and analogues for inhalation |
| A10BD04 | glimepiride and rosiglitazone |
| A10BD13 | metformin and alogliptin |
| A10BD25 | metformin, saxagliptin and dapagliflozin |
| A10BG01 | troglitazone |
| A10BH02 | vildagliptin |
| A10BJ02 | liraglutide |
| A10BJ05 | dulaglutide |
| A10BX18 | dorzagliatin |
| A10XX | Other drugs used in diabetes |
| A10XX01 | teplizumab |
| A11AA | Multivitamins with minerals |
| A11CC03 | alfacalcidol |
| A11DA01 | thiamine (vit B1) |
| A11EB | Vitamin B-complex with vitamin C |
| A11HA08 | tocofersolan |
| A11JA | Combinations of vitamins |
| A12AA07 | calcium chloride |
| A12AA11 | calcium pangamate |
| A12B | POTASSIUM |
| A12CB | Zinc |
| A12CB03 | zinc protein complex |
| A14AA01 | androstanolone |
| A16AA | Amino acids and derivatives |
| A16AA05 | carglumic acid |
| A16AB08 | galsulfase |
| A16AB19 | pegvaliase |
| A16AB21 | atidarsagene autotemcel |
| A16AX06 | miglustat |
| A16AX23 | leriglitazone |
| B01AA01 | dicoumarol |
| B01AA07 | acenocoumarol |
| B01AA08 | ethyl biscoumacetate |
| B01AB06 | nadroparin |
| B01AB08 | reviparin |
| B01AC07 | dipyridamole |
| B01AD11 | tenecteplase |
| B01AE02 | lepirudin |
| B01AE04 | melagatran |
| B01AF51 | rivaroxaban and acetylsalicylic acid |
| B01AX04 | dermatan sulfate |
| B02B | VITAMIN K AND OTHER HEMOSTATICS |
| B02BB01 | fibrinogen, human |
| B02BD03 | factor VIII inhibitor bypassing activity |
| B02BX09 | fostamatinib |
| B03AA01 | ferrous glycine sulfate |
| B03AA02 | ferrous fumarate |
| B03AA10 | ferrous ascorbate |
| B03AB08 | ferric acetyl transferrin |
| B03AD01 | ferrous amino acid complex and folic acid |
| B03BA01 | cyanocobalamin |
| B03BA51 | cyanocobalamin, combinations |
| B05 | BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS |
| B05AA08 | hemoglobin crosfumaril |
| B05AX | Other blood products |
| B05B | I.V. SOLUTIONS |
| B05BB | Solutions affecting the electrolyte balance |
| B05BC02 | carbamide |
| B05CA04 | sulfamethizole |
| B05CB03 | magnesium citrate |
| B05CX02 | sorbitol |
| B05CX10 | combinations |
| B05DA | Isotonic solutions |
| B05DB | Hypertonic solutions |
| B05XA02 | sodium bicarbonate |
| B05XA06 | potassium phosphate, incl. combinations with other potassium salts |
| B05XA09 | sodium phosphate |
| B05XA18 | zinc sulfate |
| B05XA20 | sodium selenite |
| B05XA31 | electrolytes in combination with other drugs |
| B05XB | Amino acids |
| B05XC | Vitamins |
| B06AX05 | exagamglogene autotemcel |
| C01AB | Scilla glycosides |
| C01AC01 | g-strophanthin |
| C01BA04 | sparteine |
| C01BA51 | quinidine, combinations excl. psycholeptics |
| C01BD05 | ibutilide |
| C01BG01 | moracizine |
| C01CA03 | norepinephrine |
| C01CA12 | dimetofrine |
| C01CA28 | centhaquine |
| C01DA02 | glyceryl trinitrate |
| C01DX03 | oxyfedrine |
| C01DX07 | etafenone |
| C01DX12 | molsidomine |
| C01DX22 | vericiguat |
| C01DX54 | benziodarone, combinations |
| C01EB03 | indometacin |
| C01EB05 | creatinolfosfate |
| C01EB22 | meldonium |
| C02AC06 | rilmenidine |
| C02BB | Secondary and tertiary amines |
| C02D | ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON |
| C02DD01 | nitroprusside |
| C02LA50 | combination of rauwolfia alkaloids and diuretics incl. other combinations |
| C02LA52 | rescinnamine and diuretics, combinations with other drugs |
| C02LC05 | moxonidine and diuretics |
| C02LF01 | guanethidine and diuretics |
| C02LG02 | hydralazine and diuretics |
| C02N | COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02 |
| C03AA03 | hydrochlorothiazide |
| C03AA04 | chlorothiazide |
| C03AB02 | hydroflumethiazide and potassium |
| C03AB03 | hydrochlorothiazide and potassium |
| C03AB06 | trichlormethiazide and potassium |
| C03BA | Sulfonamides, plain |
| C03BA09 | meticrane |
| C03BB03 | clopamide and potassium |
| C03CA01 | furosemide |
| C03CC01 | etacrynic acid |
| C03CD01 | muzolimine |
| C03DA03 | canrenone |
| C03EA | Low-ceiling diuretics and potassium-sparing agents |
| C03EA01 | hydrochlorothiazide and potassium-sparing agents |
| C03EA13 | bendroflumethiazide and potassium-sparing agents |
| C04A | PERIPHERAL VASODILATORS |
| C04AC02 | nicotinyl alcohol (pyridylcarbinol) |
| C04AD02 | xantinol nicotinate |
| C04AX10 | moxisylyte |
| C05AA | Corticosteroids |
| C05AA10 | fluocinolone acetonide |
| C05AX03 | other preparations, combinations |
| C05AX06 | phenylephrine |
| C05BA03 | heparin |
| C05BA04 | pentosan polysulfate sodium |
| C05BB05 | phenol |
| C05CX03 | Hippocastani semen |
| C07AA17 | bopindolol |
| C07AA19 | bupranolol |
| C07AB01 | practolol |
| C07AB10 | epanolol |
| C07BB03 | atenolol and thiazides |
| C07BB52 | metoprolol and thiazides, combinations |
| C07BG | Alpha and beta blocking agents and thiazides |
| C07CA03 | pindolol and other diuretics |
| C07EA | Beta blocking agents, non-selective, and vasodilators |
| C07EB | Beta blocking agents, selective, and vasodilators |
| C07FX04 | bisoprolol and acetylsalicylic acid |
| C08CA04 | nicardipine |
| C08CA07 | nisoldipine |
| C08EA01 | fendiline |
| C08GA02 | amlodipine and diuretics |
| C09 | AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM |
| C09AA04 | perindopril |
| C09B | ACE INHIBITORS, COMBINATIONS |
| C09BA12 | delapril and diuretics |
| C09BA13 | moexipril and diuretics |
| C09BX05 | ramipril and bisoprolol |
| C09DA03 | valsartan and diuretics |
| C09X | OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM |
| C10AA05 | atorvastatin |
| C10AB08 | ciprofibrate |
| C10AB12 | pemafibrate |
| C10AX02 | probucol |
| C10AX06 | omega-3-triglycerides incl. other esters and acids |
| C10AX16 | inclisiran |
| C10BA05 | atorvastatin and ezetimibe |
| C10BA11 | pravastatin and ezetimibe |
| C10BX19 | atorvastatin, amlodipine and candesartan |
| C10BX20 | rosuvastatin and telmisartan |
| D01AA07 | pyrrolnitrin |
| D01AA08 | griseofulvin |
| D01AC16 | flutrimazole |
| D01AC60 | bifonazole, combinations |
| D01AE01 | bromochlorosalicylanilide |
| D01AE24 | tavaborole |
| D02AE51 | carbamide, combinations |
| D02BA01 | aminobenzoic acid |
| D03 | PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS |
| D03AX05 | hyaluronic acid |
| D03AX10 | enoxolone |
| D03BA01 | trypsin |
| D04AA12 | tolpropamine |
| D04AA15 | bamipine |
| D04AB04 | benzocaine |
| D04AB05 | quinisocaine |
| D05AX02 | calcipotriol |
| D05AX05 | tazarotene |
| D06AA02 | chlortetracycline |
| D06AA03 | oxytetracycline |
| D06AX13 | retapamulin |
| D06BA51 | silver sulfadiazine, combinations |
| D06BB09 | edoxudine |
| D06BX03 | tirbanibulin |
| D07AA | Corticosteroids, weak (group I) |
| D07AA02 | hydrocortisone |
| D07AC02 | fluclorolone |
| D07AC12 | halometasone |
| D07AC16 | hydrocortisone aceponate |
| D07AC17 | fluticasone |
| D07BC | Corticosteroids, potent, combinations with antiseptics |
| D07CA | Corticosteroids, weak, combinations with antibiotics |
| D07CA02 | methylprednisolone and antibiotics |
| D07CB | Corticosteroids, moderately potent, combinations with antibiotics |
| D07CB01 | triamcinolone and antibiotics |
| D07CC04 | beclometasone and antibiotics |
| D07CD | Corticosteroids, very potent, combinations with antibiotics |
| D07XB | Corticosteroids, moderately potent, other combinations |
| D07XC03 | mometasone |
| D08AC52 | chlorhexidine, combinations |
| D08AF | Nitrofuran derivatives |
| D08AJ03 | cetylpyridinium |
| D08AJ04 | cetrimide |
| D08AK05 | mercury, metallic |
| D09AA12 | chlorhexidine |
| D10AA02 | methylprednisolone |
| D10AB03 | tioxolone |
| D10AD | Retinoids for topical use in acne |
| D10AD02 | retinol |
| D10AD04 | isotretinoin |
| D10AD06 | trifarotene |
| D10AD54 | isotretinoin, combinations |
| D10AE01 | benzoyl peroxide |
| D10AE51 | benzoyl peroxide, combinations |
| D10BA | Retinoids for treatment of acne |
| D10BX01 | ichtasol |
| D11 | OTHER DERMATOLOGICAL PREPARATIONS |
| D11AH11 | delgocitinib |
| D11AX04 | lithium succinate |
| D11AX05 | magnesium sulfate |
| G01AA06 | hachimycin |
| G01AA10 | clindamycin |
| G01AB01 | acetarsol |
| G01AD01 | lactic acid |
| G01AD02 | acetic acid |
| G01AF06 | ornidazole |
| G01AF17 | oxiconazole |
| G01AF21 | tinidazole |
| G01AX | Other antiinfectives and antiseptics |
| G01BA | Antibiotics and corticosteroids |
| G02 | OTHER GYNECOLOGICALS |
| G02AD01 | dinoprost |
| G02CA03 | fenoterol |
| G02CB | Prolactine inhibitors |
| G02CB02 | lisuride |
| G02CB03 | cabergoline |
| G02CC01 | ibuprofen |
| G02CC04 | flunoxaprofen |
| G02CX06 | fezolinetant |
| G03AA15 | chlormadinone and ethinylestradiol |
| G03AB02 | lynestrenol and ethinylestradiol |
| G03AB07 | chlormadinone and ethinylestradiol |
| G03AC02 | lynestrenol |
| G03AC04 | quingestanol |
| G03AD01 | levonorgestrel |
| G03CA09 | promestriene |
| G03DA01 | gestonorone |
| G03DC31 | methylestrenolone |
| G03EK | Androgens and female sex hormones in combination with other drugs |
| G03F | PROGESTOGENS AND ESTROGENS IN COMBINATION |
| G03GA01 | chorionic gonadotrophin |
| G03HA | Antiandrogens, plain |
| G03X | OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM |
| G03XA01 | danazol |
| G03XC | Selective estrogen receptor modulators |
| G04BA | Acidifiers |
| G04BD03 | meladrazine |
| G04BD05 | terodiline |
| G04BD09 | trospium |
| G04BE04 | yohimbine |
| G04BX12 | phenyl salicylate |
| G04BX14 | dapoxetine |
| G04BX15 | pentosan polysulfate sodium |
| G04CA04 | silodosin |
| G04CA52 | tamsulosin and dutasteride |
| G04CA54 | tamsulosin and tadalafil |
| G04CX01 | Prunus africanae cortex |
| H01AC06 | tesamorelin |
| H01AC09 | lonapegsomatropin |
| H01AX | Other anterior pituitary lobe hormones and analogues |
| H01BA | Vasopressin and analogues |
| H01BA03 | lypressin |
| H01BB02 | oxytocin |
| H01CC02 | cetrorelix |
| H02CA02 | osilodrostat |
| H02CA03 | ketoconazole |
| H02CA04 | levoketoconazole |
| H03BA01 | methylthiouracil |
| H04A | GLYCOGENOLYTIC HORMONES |
| H04AA01 | glucagon |
| H05AA02 | teriparatide |
| J01CE02 | phenoxymethylpenicillin |
| J01CE03 | propicillin |
| J01CF | Beta-lactamase resistant penicillins |
| J01CG01 | sulbactam |
| J01CR04 | sultamicillin |
| J01DB11 | cefroxadine |
| J01DC06 | cefonicid |
| J01DC08 | loracarbef |
| J01DD04 | ceftriaxone |
| J01DD07 | ceftizoxime |
| J01DD11 | cefpiramide |
| J01DE | Fourth-generation cephalosporins |
| J01DH06 | tebipenem pivoxil |
| J01DH55 | panipenem and betamipron |
| J01EB | Short-acting sulfonamides |
| J01EB01 | sulfaisodimidine |
| J01EB03 | sulfadimidine |
| J01ED01 | sulfadimethoxine |
| J01EE06 | sulfadiazine and tetroxoprim |
| J01FA | Macrolides |
| J01FA09 | clarithromycin |
| J01GB03 | gentamicin |
| J01GB04 | kanamycin |
| J01MA05 | temafloxacin |
| J01MA06 | norfloxacin |
| J01MA09 | sparfloxacin |
| J01MA11 | grepafloxacin |
| J01MA15 | gemifloxacin |
| J01MA19 | garenoxacin |
| J01MB01 | rosoxacin |
| J01MB07 | flumequine |
| J01MB08 | nemonoxacin |
| J01RA11 | ciprofloxacin and tinidazole |
| J01XA01 | vancomycin |
| J01XD02 | tinidazole |
| J02AA01 | amphotericin B |
| J02AA02 | hachimycin |
| J02AC06 | oteseconazole |
| J02AX01 | flucytosine |
| J02AX04 | caspofungin |
| J04AB | Antibiotics |
| J04AB05 | rifapentine |
| J04AM08 | isoniazid, sulfamethoxazole, trimethoprim and pyridoxine |
| J04BA50 | dapsone and rifampicin |
| J05AA | Thiosemicarbazones |
| J05AB | Nucleosides and nucleotides excl. reverse transcriptase inhibitors |
| J05AB02 | idoxuridine |
| J05AD | Phosphonic acid derivatives |
| J05AD01 | foscarnet |
| J05AE02 | indinavir |
| J05AE04 | nelfinavir |
| J05AE16 | ensitrelvir |
| J05AF02 | didanosine |
| J05AF08 | adefovir dipivoxil |
| J05AH | Neuraminidase inhibitors |
| J05AH01 | zanamivir |
| J05AP58 | daclatasvir, asunaprevir and beclabuvir |
| J05AR02 | lamivudine and abacavir |
| J05AR04 | zidovudine, lamivudine and abacavir |
| J05AR26 | darunavir and ritonavir |
| J05AX13 | umifenovir |
| J06AA05 | gas-gangrene sera |
| J06BA02 | immunoglobulins, normal human, for intravascular adm. |
| J06BB04 | hepatitis B immunoglobulin |
| J06BC02 | raxibacumab |
| J07AD01 | brucella antigen |
| J07AF01 | diphtheria toxoid |
| J07AG52 | haemophilus influenzae B, combinations with pertussis and toxoids |
| J07AJ02 | pertussis, purified antigen |
| J07AJ51 | pertussis, inactivated, whole cell, combinations with toxoids |
| J07AK01 | plague, inactivated, whole cell |
| J07AR | Typhus (exanthematicus) vaccines |
| J07BB01 | influenza, inactivated, whole virus |
| J07BF02 | poliomyelitis oral, trivalent, live attenuated |
| J07BJ51 | rubella, combinations with mumps, live attenuated |
| J07BN01 | covid-19, RNA-based vaccine |
| J07BX01 | smallpox and monkeypox vaccines |
| J07CA13 | diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C |
| J07X | OTHER VACCINES |
| L01AA02 | chlorambucil |
| L01AA05 | chlormethine |
| L01AC01 | thiotepa |
| L01AC03 | carboquone |
| L01AD01 | carmustine |
| L01AX | Other alkylating agents |
| L01AX02 | pipobroman |
| L01AX04 | dacarbazine |
| L01BA01 | methotrexate |
| L01BB05 | fludarabine |
| L01BC01 | cytarabine |
| L01BC09 | floxuridine |
| L01BC52 | fluorouracil, combinations |
| L01CB | Podophyllotoxin derivatives |
| L01DA01 | dactinomycin |
| L01DC02 | plicamycin |
| L01EB04 | osimertinib |
| L01EM04 | duvelisib |
| L01EX02 | sorafenib |
| L01EX09 | nintedanib |
| L01EX10 | midostaurin |
| L01EX15 | pexidartinib |
| L01FC | CD38 (Clusters of Differentiation 38) inhibitors |
| L01FC02 | isatuximab |
| L01FD05 | trastuzumab duocarmazine |
| L01FF07 | dostarlimab |
| L01FX16 | oportuzumab monatox |
| L01FX17 | sacituzumab govitecan |
| L01XD07 | padeliporfin |
| L01XG | Proteasome inhibitors |
| L01XH05 | entinostat |
| L01XK05 | veliparib |
| L01XL04 | tisagenlecleucel |
| L01XL08 | lisocabtagene maraleucel |
| L01XL09 | tabelecleucel |
| L01XX16 | mitoguazone |
| L01XX66 | selinexor |
| L01XX69 | lurbinectedin |
| L01XX72 | tazemetostat |
| L01XX73 | sotorasib |
| L02A | HORMONES AND RELATED AGENTS |
| L02AA03 | ethinylestradiol |
| L02AB | Progestogens |
| L02AE02 | leuprorelin |
| L02BB04 | enzalutamide |
| L03A | IMMUNOSTIMULANTS |
| L03AA09 | sargramostim |
| L03AB08 | interferon beta-1b |
| L03AB10 | peginterferon alfa-2b |
| L03AX01 | lentinan |
| L03AX03 | BCG vaccine |
| L04AA19 | gusperimus |
| L04AF02 | baricitinib |
| L04AF05 | itacitinib |
| L04AG09 | emapalumab |
| L04AG11 | anifrolumab |
| L04AG13 | teprotumumab |
| L04AG16 | rozanolixizumab |
| L04AJ04 | sutimlimab |
| L04AJ05 | avacopan |
| L04AX05 | pirfenidone |
| M01AA02 | mofebutazone |
| M01AB | Acetic acid derivatives and related substances |
| M01AB02 | sulindac |
| M01AE05 | fenbufen |
| M01AE14 | dexibuprofen |
| M01AH05 | etoricoxib |
| M01AX | Other antiinflammatory and antirheumatic agents, non-steroids |
| M01AX12 | glucosaminoglycan polysulfate |
| M01AX22 | morniflumate |
| M01CB01 | sodium aurothiomalate |
| M01CC | Penicillamine and similar agents |
| M02AA06 | etofenamate |
| M02AA15 | diclofenac |
| M02AX06 | tolperisone |
| M03AC07 | doxacurium chloride |
| M03AC08 | fazadinium bromide |
| M03AX | Other muscle relaxants, peripherally acting agents |
| M03BA01 | phenprobamate |
| M03BA03 | methocarbamol |
| M03BA05 | febarbamate |
| M03BA51 | phenprobamate, combinations excl. psycholeptics |
| M04AB04 | isobromindione |
| M04AB05 | lesinurad |
| M05BA01 | etidronic acid |
| M05BA07 | risedronic acid |
| M05BB08 | zoledronic acid, calcium and colecalciferol, sequential |
| M05BC01 | dibotermin alfa |
| M05BX | Other drugs affecting bone structure and mineralization |
| M09AA01 | hydroquinine |
| M09AB52 | trypsin, combinations |
| M09AX | Other drugs for disorders of the musculo-skeletal system |
| M09AX03 | ataluren |
| M09AX06 | eteplirsen |
| N01 | ANESTHETICS |
| N01AH06 | remifentanil |
| N01AX15 | xenon |
| N01AX63 | nitrous oxide, combinations |
| N01BB07 | etidocaine |
| N01BC01 | cocaine |
| N01BX01 | ethyl chloride |
| N02A | OPIOIDS |
| N02AA | Natural opium alkaloids |
| N02AC01 | dextromoramide |
| N02AC74 | dextropropoxyphene, combinations with psycholeptics |
| N02AG04 | hydromorphone and antispasmodics |
| N02AJ13 | tramadol and paracetamol |
| N02BA | Salicylic acid and derivatives |
| N02BA05 | salicylamide |
| N02BA09 | dipyrocetyl |
| N02BA10 | benorilate |
| N02BF03 | mirogabalin |
| N02BG07 | flupirtine |
| N02BG08 | ziconotide |
| N02BG10 | cannabinoids |
| N02CA51 | dihydroergotamine, combinations |
| N02CC02 | naratriptan |
| N02CX06 | oxetorone |
| N03AB | Hydantoin derivatives |
| N03AB02 | phenytoin |
| N03AB03 | amino(diphenylhydantoin) valeric acid |
| N03AB05 | fosphenytoin |
| N03AB52 | phenytoin, combinations |
| N03AD02 | phensuximide |
| N03AD03 | mesuximide |
| N03AG02 | valpromide |
| N03AX21 | retigabine |
| N04AA03 | metixene |
| N04AA11 | bornaprine |
| N04AC30 | etybenzatropine |
| N04BC01 | bromocriptine |
| N05AB05 | thiopropazate |
| N05AB08 | thioproperazine |
| N05AD02 | trifluperidol |
| N05AD03 | melperone |
| N05AD07 | benperidol |
| N05AD10 | lumateperone |
| N05AE04 | ziprasidone |
| N05AF05 | zuclopenthixol |
| N05AG01 | fluspirilene |
| N05AH06 | clotiapine |
| N05AL | Benzamides |
| N05AL03 | tiapride |
| N05AX13 | paliperidone |
| N05BA02 | chlordiazepoxide |
| N05BA14 | pinazepam |
| N05BB | Diphenylmethane derivatives |
| N05BB01 | hydroxyzine |
| N05BC04 | mebutamate |
| N05BX | Other anxiolytics |
| N05CA19 | thiopental |
| N05CB01 | combinations of barbiturates |
| N05CC | Aldehydes and derivatives |
| N05CC04 | dichloralphenazone |
| N05CD | Benzodiazepine derivatives |
| N05CD05 | triazolam |
| N05CF01 | zopiclone |
| N05CM03 | bromisoval |
| N05CM06 | propiomazine |
| N05CM10 | hexapropymate |
| N05CM15 | methylpentynol |
| N05CX | Hypnotics and sedatives in combination, excl. barbiturates |
| N06AG02 | moclobemide |
| N06AX | Other antidepressants |
| N06AX05 | trazodone |
| N06AX23 | desvenlafaxine |
| N06BA05 | pemoline |
| N06BA15 | dexmethylphenidate and serdexmethylphenidate |
| N06BC01 | caffeine |
| N06BX09 | linopirdine |
| N06BX10 | nizofenone |
| N06BX18 | vinpocetine |
| N06BX21 | temgicoluril |
| N06C | PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION |
| N06DX30 | combinations |
| N07AB | Choline esters |
| N07BB01 | disulfiram |
| N07BB02 | calcium carbimide |
| N07BB05 | nalmefene |
| N07C | ANTIVERTIGO PREPARATIONS |
| N07XX01 | tirilazad |
| N07XX02 | riluzole |
| P01AA01 | broxyquinoline |
| P01AA04 | chlorquinaldol |
| P01AA05 | tilbroquinol |
| P01AA30 | tilbroquinol and tiliquinol |
| P01AB03 | ornidazole |
| P01AC02 | clefamide |
| P01AX02 | emetine |
| P01BC01 | quinine |
| P01BC02 | mefloquine |
| P01BE01 | artemisinin |
| P01BF05 | artenimol and piperaquine |
| P01CB | Antimony compounds |
| P01CC02 | nitrofural |
| P01CX02 | suramin sodium |
| P02BA03 | arpraziquantel |
| P02BX01 | bithionol |
| P02BX02 | niridazole |
| P02BX04 | triclabendazole |
| P02CB01 | piperazine |
| P02CC01 | pyrantel |
| P02CE01 | levamisole |
| P02CX | Other antinematodals |
| P02DX01 | desaspidin |
| P03A | ECTOPARASITICIDES, INCL. SCABICIDES |
| P03AA02 | potassium polysulfide |
| P03AA04 | disulfiram |
| P03AC51 | pyrethrum, combinations |
| P03AC54 | permethrin, combinations |
| P03AX02 | copper oleinate |
| P03BA04 | tetramethrin |
| R01AD04 | flunisolide |
| R01B | NASAL DECONGESTANTS FOR SYSTEMIC USE |
| R02 | THROAT PREPARATIONS |
| R02A | THROAT PREPARATIONS |
| R02AA06 | cetylpyridinium |
| R02AA09 | benzethonium |
| R02AA17 | cetrimonium |
| R02AB03 | fusafungine |
| R02AD | Anesthetics, local |
| R03AC17 | bitolterol |
| R03AK04 | salbutamol and sodium cromoglicate |
| R03AK08 | formoterol and beclometasone |
| R03AK11 | formoterol and fluticasone |
| R03AK13 | salbutamol and beclometasone |
| R03AK14 | indacaterol and mometasone |
| R03AL08 | vilanterol, umeclidinium bromide and fluticasone furoate |
| R03BA | Glucocorticoids |
| R03BA06 | triamcinolone |
| R03BB07 | umeclidinium bromide |
| R03C | ADRENERGICS FOR SYSTEMIC USE |
| R03CB02 | methoxyphenamine |
| R03DA02 | choline theophyllinate |
| R03DA06 | etamiphylline |
| R03DA10 | bufylline |
| R03DA57 | theobromine, combinations |
| R03DB01 | diprophylline and adrenergics |
| R03DC03 | montelukast |
| R03DX01 | amlexanox |
| R03DX05 | omalizumab |
| R05C | EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS |
| R05CA08 | creosote |
| R05CA12 | Hederae helicis folium |
| R05CB06 | ambroxol |
| R05CB15 | erdosteine |
| R05D | COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS |
| R05DA01 | ethylmorphine |
| R05DB07 | oxolamine |
| R05DB12 | bibenzonium bromide |
| R05DB15 | zipeprol |
| R05DB19 | dropropizine |
| R05DB20 | combinations |
| R05FA02 | opium derivatives and expectorants |
| R05X | OTHER COLD PREPARATIONS |
| R06AA06 | chlorphenoxamine |
| R06AA07 | diphenylpyraline |
| R06AB | Substituted alkylamines |
| R06AB07 | talastine |
| R06AD05 | hydroxyethylpromethazine |
| R06AE04 | chlorcyclizine |
| R06AE05 | meclozine |
| R06AX07 | triprolidine |
| R06AX28 | rupatadine |
| R06AX29 | bilastine |
| R06AX31 | quifenadine |
| R07 | OTHER RESPIRATORY SYSTEM PRODUCTS |
| R07A | OTHER RESPIRATORY SYSTEM PRODUCTS |
| R07AB03 | pentetrazol |
| S01AA05 | tyrothricin |
| S01AA20 | antibiotics in combination with other drugs |
| S01AA21 | amikacin |
| S01AA22 | micronomicin |
| S01AA30 | combinations of different antibiotics |
| S01AB02 | sulfafurazole |
| S01AE07 | moxifloxacin |
| S01AX16 | picloxydine |
| S01AX24 | polihexanide |
| S01BA11 | desonide |
| S01BA16 | difluprednate |
| S01BB | Corticosteroids and mydriatics in combination |
| S01BC01 | indometacin |
| S01CA09 | chloroprednisone and antiinfectives |
| S01CA11 | clobetasone and antiinfectives |
| S01CB03 | hydrocortisone |
| S01EA03 | apraclonidine |
| S01EA05 | brimonidine |
| S01EB01 | pilocarpine |
| S01EB08 | aceclidine |
| S01EE | Prostaglandin analogues |
| S01EE04 | travoprost |
| S01EX | Other antiglaucoma preparations |
| S01EX06 | omidenepag |
| S01FA | Anticholinergics |
| S01GA03 | xylometazoline |
| S01GX13 | bilastine |
| S01H | LOCAL ANESTHETICS |
| S01HA05 | procaine |
| S01K | SURGICAL AIDS |
| S01KA02 | hypromellose |
| S01KX | Other surgical aids |
| S01KX01 | chymotrypsin |
| S01LA07 | abicipar pegol |
| S01XA02 | retinol |
| S01XA06 | ethylmorphine |
| S01XA11 | nandrolone |
| S01XA14 | heparin |
| S03AA04 | chlorhexidine |
| V01AA03 | house dust mites |
| V03 | ALL OTHER THERAPEUTIC PRODUCTS |
| V03AB | Antidotes |
| V03AB09 | dimercaprol |
| V03AB27 | 4-dimethylaminophenol |
| V03AB31 | prussian blue |
| V03AB34 | fomepizole |
| V03AB35 | sugammadex |
| V03AE02 | sevelamer |
| V03AM | Drugs for embolisation |
| V03AX | Other therapeutic products |
| V03AX02 | nalfurafine |
| V04CE02 | sulfobromophthalein |
| V04CJ01 | thyrotropin |
| V04CL | Tests for allergic diseases |
| V04CM01 | gonadorelin |
| V04CX | Other diagnostic agents |
| V04CX03 | methacholine |
| V04CX10 | pafolacianine |
| V06B | PROTEIN SUPPLEMENTS |
| V06DB | Fat/carbohydrates/proteins/minerals/vitamins, combinations |
| V07AA | Plasters |
| V07AB | Solvents and diluting agents, incl. irrigating solutions |
| V07AZ | Chemicals and reagents for analysis |
| V08AA07 | acetrizoic acid |
| V08AB02 | iohexol |
| V08AB03 | ioxaglic acid |
| V08AB05 | iopromide |
| V08AB11 | iobitridol |
| V08AC | Watersoluble, hepatotropic X-ray contrast media |
| V08CA | Paramagnetic contrast media |
| V08DA05 | sulfur hexafluoride, phospholipid microspheres |
| V09A | CENTRAL NERVOUS SYSTEM |
| V09AA01 | technetium (99mTc) exametazime |
| V09AX01 | indium (111In) pentetic acid |
| V09AX06 | florbetaben (18F) |
| V09CA01 | technetium (99mTc) pentetic acid |
| V09CX01 | sodium iodohippurate (123I) |
| V09DA02 | technetium (99mTc) etifenin |
| V09DB01 | technetium (99mTc) nanocolloid |
| V09DB07 | technetium (99mTc) phytate |
| V09E | RESPIRATORY SYSTEM |
| V09EB01 | technetium (99mTc) macrosalb |
| V09EX | Other respiratory system diagnostic radiopharmaceuticals |
| V09EX03 | xenon (133Xe) gas |
| V09GX | Other cardiovascular system diagnostic radiopharmaceuticals |
| V09HB01 | indium (111In) oxinate labelled cells |
| V09HB02 | indium (111In) tropolonate labelled cells |
| V09IA02 | technetium (99mTc) antimelanoma antibody |
| V09IA06 | technetium (99mTc) arcitumomab |
| V09IX11 | fluoroestradiol (18F) |
| V09XA02 | iodocholesterol (131I) |
| V10AX03 | dysprosium (165Dy) colloid |
| V10X | OTHER THERAPEUTIC RADIOPHARMACEUTICALS |
| V20 | SURGICAL DRESSINGS |
| A01 | STOMATOLOGICAL PREPARATIONS |
| A01AA51 | sodium fluoride, combinations |
| A01AB05 | polynoxylin |
| A01AB07 | oxyquinoline |
| A01AB15 | tibezonium iodide |
| A01AB16 | mepartricin |
| A01AB18 | clotrimazole |
| A01AB19 | sodium perborate |
| A01AC04 | prednisolone |
| A01AD01 | epinephrine |
| A01AD05 | acetylsalicylic acid |
| A01AD06 | adrenalone |
| A01AD07 | amlexanox |
| A02AD05 | almasilate |
| A02B | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) |
| A02BB01 | misoprostol |
| A02BD14 | vonoprazan, amoxicillin and clarithromycin |
| A02BD17 | vonoprazan and amoxicillin |
| A02BX | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) |
| A02BX12 | bismuth subnitrate |
| A02BX77 | gefarnate, combinations with psycholeptics |
| A03AA07 | dicycloverine |
| A03AB03 | oxyphenonium |
| A03AB14 | pipenzolate |
| A03AX04 | pinaverium |
| A03AX14 | valethamate |
| A03AX15 | menthae piperitae aetheroleum |
| A03AX58 | alverine, combinations |
| A03BB05 | cimetropium bromide |
| A03CA34 | propantheline and psycholeptics |
| A03CB | Belladonna and derivatives in combination with psycholeptics |
| A03CB02 | belladonna total alkaloids and psycholeptics |
| A03CB31 | hyoscyamine and psycholeptics |
| A03DA | Synthetic anticholinergic agents in combination with analgesics |
| A03DB | Belladonna and derivatives in combination with analgesics |
| A03DB04 | butylscopolamine and analgesics |
| A03DC | Other antispasmodics in combination with analgesics |
| A03FA10 | acotiamide |
| A04 | ANTIEMETICS AND ANTINAUSEANTS |
| A04AD13 | casopitant |
| A05AA | Bile acids and derivatives |
| A05BA01 | arginine glutamate |
| A05BA03 | silymarin |
| A05BA05 | epomediol |
| A05BA08 | glycyrrhizic acid |
| A05BA09 | metadoxine |
| A06AA | Softeners, emollients |
| A06AB09 | bisoxatin |
| A06AD01 | magnesium carbonate |
| A06AD10 | mineral salts in combination |
| A06AD15 | macrogol |
| A06AD17 | sodium phosphate |
| A06AD18 | sorbitol |
| A06AG10 | docusate sodium, incl. combinations |
| A06AH02 | alvimopan |
| A07 | ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS |
| A07AA03 | natamycin |
| A07AA07 | amphotericin B |
| A07AA51 | neomycin, combinations |
| A07AB02 | phthalylsulfathiazole |
| A07B | INTESTINAL ADSORBENTS |
| A07CA | Oral rehydration salt formulations |
| A07DA | Antipropulsives |
| A07DA04 | difenoxin |
| A07EA05 | tixocortol |
| A07EC03 | olsalazine |
| A07FA03 | escherichia coli |
| A07X | OTHER ANTIDIARRHEALS |
| A07XA | Other antidiarrheals |
| A07XA04 | racecadotril |
| A08AA06 | etilamfetamine |
| A08AA10 | sibutramine |
| A08AX | Other antiobesity drugs |
| A09AA03 | pepsin |
| A09AA04 | tilactase |
| A09AC01 | pepsin and acid preparations |
| A10 | DRUGS USED IN DIABETES |
| A10AE04 | insulin glargine |
| A10B | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| A10BA01 | phenformin |
| A10BB07 | glipizide |
| A10BB10 | metahexamide |
| A10BB12 | glimepiride |
| A10BD06 | glimepiride and pioglitazone |
| A10BD14 | metformin and repaglinide |
| A10BD16 | metformin and canagliflozin |
| A10BD22 | metformin and evogliptin |
| A10BD26 | metformin and lobeglitazone |
| A10BD28 | metformin and teneligliptin |
| A10BF02 | miglitol |
| A10BG | Thiazolidinediones |
| A10BJ04 | albiglutide |
| A10BK03 | empagliflozin |
| A10BX05 | pramlintide |
| A11 | VITAMINS |
| A11CB | Vitamin A and D in combination |
| A11CC04 | calcitriol |
| A11CC06 | calcifediol |
| A11EX | Vitamin B-complex, other combinations |
| A11GB01 | ascorbic acid (vit C) and calcium |
| A11H | OTHER PLAIN VITAMIN PREPARATIONS |
| A11HA02 | pyridoxine (vit B6) |
| A11HA05 | biotin |
| A11HA30 | dexpanthenol |
| A11JC | Vitamins, other combinations |
| A12A | CALCIUM |
| A12AA09 | calcium citrate lysine complex |
| A12AA20 | calcium (different salts in combination) |
| A12BA | Potassium |
| A12CA01 | sodium chloride |
| A12CB01 | zinc sulfate |
| A12CB02 | zinc gluconate |
| A12CC04 | magnesium citrate |
| A16 | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| A16AB15 | velmanase alfa |
| A16AB25 | olipudase alfa |
| A16AX10 | eliglustat |
| A16AX14 | migalastat |
| A16AX20 | lonafarnib |
| A16AX22 | tiomolibdic acid |
| B01 | ANTITHROMBOTIC AGENTS |
| B01AA09 | clorindione |
| B01AC | Platelet aggregation inhibitors excl. heparin |
| B01AC09 | epoprostenol |
| B01AC11 | iloprost |
| B01AC18 | triflusal |
| B01AC23 | cilostazol |
| B01AD08 | saruplase |
| B01AD10 | drotrecogin alfa (activated) |
| B01AD13 | apadamtase alfa and cinaxadamtase alfa |
| B01AE03 | argatroban |
| B01AF01 | rivaroxaban |
| B01AF04 | betrixaban |
| B02BC02 | oxidized cellulose |
| B02BC07 | collagen |
| B02BC09 | epinephrine |
| B02BD11 | catridecacog |
| B03 | ANTIANEMIC PREPARATIONS |
| B03AA | Iron bivalent, oral preparations |
| B03AA03 | ferrous gluconate |
| B03AB02 | saccharated iron oxide |
| B03AD02 | ferrous fumarate and folic acid |
| B03AE02 | iron, multivitamins and folic acid |
| B03XA02 | darbepoetin alfa |
| B05AA02 | other plasma protein fractions |
| B05AA06 | gelatin agents |
| B05BA01 | amino acids |
| B05CA | Antiinfectives |
| B05CA05 | taurolidine |
| B05CA06 | mandelic acid |
| B05CX01 | glucose |
| B05XA03 | sodium chloride |
| B05ZB | Hemofiltrates |
| B06 | OTHER HEMATOLOGICAL AGENTS |
| B06AA02 | fibrinolysin and desoxyribonuclease |
| B06AX03 | voxelotor |
| C01AA03 | digitalis leaves |
| C01AX02 | peruvoside |
| C01BA05 | ajmaline |
| C01BC | Antiarrhythmics, class Ic |
| C01BG11 | vernakalant |
| C01CA04 | dopamine |
| C01CA06 | phenylephrine |
| C01CA24 | epinephrine |
| C01CA30 | combinations |
| C01CE01 | amrinone |
| C01CX09 | angiotensin II |
| C01DA04 | methylpropylpropanediol dinitrate |
| C01DA52 | glyceryl trinitrate, combinations |
| C01DX | Other vasodilators used in cardiac diseases |
| C01DX21 | serelaxin |
| C01DX51 | itramin tosilate, combinations |
| C01EA | Prostaglandins |
| C01EB | Other cardiac preparations |
| C02AA01 | rescinnamine |
| C02AA03 | combinations of rauwolfia alkaloids |
| C02AA06 | methoserpidine |
| C02BA | Sulfonium derivatives |
| C02BC | Bisquaternary ammonium compounds |
| C02CA03 | trimazosin |
| C02CA06 | urapidil |
| C02DB01 | dihydralazine |
| C02DD | Nitroferricyanide derivatives |
| C02KB | Tyrosine hydroxylase inhibitors |
| C02KD | Serotonin antagonists |
| C02KX01 | bosentan |
| C02LA04 | methoserpidine and diuretics |
| C02LA07 | bietaserpine and diuretics |
| C02LB01 | methyldopa (levorotatory) and diuretics |
| C02LG73 | picodralazine and diuretics, combinations with psycholeptics |
| C03AA01 | bendroflumethiazide |
| C03AA09 | cyclothiazide |
| C03AH | Thiazides, combinations with psycholeptics and/or analgesics |
| C03BA04 | chlortalidone |
| C03BA07 | clofenamide |
| C03BA11 | indapamide |
| C03BB02 | quinethazone and potassium |
| C03BB04 | chlortalidone and potassium |
| C03BC | Mercurial diuretics |
| C03BD | Xanthine derivatives |
| C03CX | Other high-ceiling diuretics |
| C03EA07 | cyclopenthiazide and potassium-sparing agents |
| C03EA12 | metolazone and potassium-sparing agents |
| C04AA31 | bamethan |
| C04AE02 | nicergoline |
| C04AE54 | dihydroergocristine, combinations |
| C04AF | Enzymes |
| C04AX23 | butalamine |
| C04AX27 | cinepazide |
| C05AB | Antibiotics |
| C05AD01 | lidocaine |
| C05AD03 | benzocaine |
| C05AE | Muscle relaxants |
| C05B | ANTIVARICOSE THERAPY |
| C05BB04 | sodium tetradecyl sulfate |
| C05BX51 | calcium dobesilate, combinations |
| C05CA54 | troxerutin, combinations |
| C05CX01 | tribenoside |
| C05CX02 | naftazone |
| C05XX01 | beperminogene perplasmid |
| C07AA01 | alprenolol |
| C07AA06 | timolol |
| C07AB11 | s-atenolol |
| C07AB14 | landiolol |
| C07AG | Alpha and beta blocking agents |
| C07CA | Beta blocking agents, non-selective, and other diuretics |
| C07CB03 | atenolol and other diuretics |
| C07DA | Beta blocking agents, non-selective, thiazides and other diuretics |
| C07DB | Beta blocking agents, selective, thiazides and other diuretics |
| C07DB01 | atenolol, thiazides and other diuretics |
| C07FX03 | metoprolol and acetylsalicylic acid |
| C08CA05 | nifedipine |
| C08CA09 | lacidipine |
| C08CA11 | manidipine |
| C08CA15 | benidipine |
| C08DB01 | diltiazem |
| C08EX02 | perhexiline |
| C09AA02 | enalapril |
| C09BB10 | trandolapril and verapamil |
| C09CA02 | eprosartan |
| C09CA03 | valsartan |
| C09CA04 | irbesartan |
| C09D | ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS |
| C09DA09 | azilsartan medoxomil and diuretics |
| C09DA10 | fimasartan and diuretics |
| C09DB01 | valsartan and amlodipine |
| C09DB05 | irbesartan and amlodipine |
| C09DX04 | valsartan and sacubitril |
| C09DX06 | candesartan, amlodipine and hydrochlorothiazide |
| C09DX07 | irbesartan, amlodipine and hydrochlorothiazide |
| C10AA01 | simvastatin |
| C10AA08 | pitavastatin |
| C10AB09 | etofibrate |
| C10AB10 | clofibride |
| C10AD | Nicotinic acid and derivatives |
| C10AD04 | aluminium nicotinate |
| C10AD06 | acipimox |
| C10AX05 | meglutol |
| C10BA07 | rosuvastatin and omega-3 fatty acids |
| C10BX | Lipid modifying agents in combination with other drugs |
| C10BX09 | rosuvastatin and amlodipine |
| C10BX14 | rosuvastatin, amlodipine and perindopril |
| D | DERMATOLOGICALS |
| D01AA | Antibiotics |
| D01AC01 | clotrimazole |
| D01AC11 | oxiconazole |
| D01AC12 | fenticonazole |
| D01AC21 | neticonazole |
| D01AC22 | lanoconazole |
| D01AE03 | tribromometacresol |
| D01AE07 | chlorphenesin |
| D01AE09 | sulbentine |
| D01AE17 | dimazole |
| D01AE18 | tolnaftate |
| D01AE23 | butenafine |
| D01AE25 | liranaftate |
| D01BA | Antifungals for systemic use |
| D01BA02 | terbinafine |
| D02AB | Zinc products |
| D04A | ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. |
| D04AA01 | thonzylamine |
| D04AA02 | mepyramine |
| D04AA04 | tripelennamine |
| D04AA09 | chloropyramine |
| D04AA16 | pheniramine |
| D04AA22 | isothipendyl |
| D04AA33 | diphenhydramine methylbromide |
| D04AB02 | cinchocaine |
| D05AA | Tars |
| D05BA | Psoralens for systemic use |
| D06AX | Other antibiotics for topical use |
| D06AX07 | gentamicin |
| D06BB | Antivirals |
| D06BB01 | idoxuridine |
| D06BB53 | aciclovir, combinations |
| D06BX01 | metronidazole |
| D06BX02 | ingenol mebutate |
| D07AB11 | hydrocortisone buteprate |
| D07AB19 | dexamethasone |
| D07AC05 | fluocortolone |
| D07AC07 | fludroxycortide |
| D07AC09 | budesonide |
| D07AC14 | methylprednisolone aceponate |
| D07BB02 | desonide and antiseptics |
| D07BC01 | betamethasone and antiseptics |
| D07CB03 | fluorometholone and antibiotics |
| D07X | CORTICOSTEROIDS, OTHER COMBINATIONS |
| D07XA02 | prednisolone |
| D07XC04 | diflucortolone |
| D08AC | Biguanides and amidines |
| D08AC01 | dibrompropamidine |
| D08AE01 | hexachlorophene |
| D08AF01 | nitrofural |
| D08AH01 | dequalinium |
| D08AJ06 | didecyldimethylammonium chloride |
| D08AX08 | ethanol |
| D09AB01 | zinc bandage without supplements |
| D09AX | Soft paraffin dressings |
| D10AA | Corticosteroids, combinations for treatment of acne |
| D11AE01 | metandienone |
| D11AH09 | ruxolitinib |
| D11AX12 | pyrithione zinc |
| D11AX18 | diclofenac |
| D11AX22 | ivermectin |
| D11AX23 | aminobenzoate potassium |
| G01AC01 | diiodohydroxyquinoline |
| G01AF | Imidazole derivatives |
| G01AF04 | miconazole |
| G01AF05 | econazole |
| G01AF11 | ketoconazole |
| G01AX01 | clodantoin |
| G01AX09 | methylrosaniline |
| G01AX13 | protiofate |
| G01AX15 | copper usnate |
| G01AX16 | hexetidine |
| G02A | UTEROTONICS |
| G02AD04 | carboprost |
| G02AX | Other uterotonics |
| G02BA | Intrauterine contraceptives |
| G02C | OTHER GYNECOLOGICALS |
| G02CA | Sympathomimetics, labour repressants |
| G02CB04 | quinagolide |
| G02CB05 | metergoline |
| G02CX01 | atosiban |
| G02CX04 | Cimicifugae rhizoma |
| G03AA11 | norgestimate and ethinylestradiol |
| G03AB03 | levonorgestrel and ethinylestradiol |
| G03AC06 | medroxyprogesterone |
| G03CA57 | conjugated estrogens |
| G03DB | Pregnadien derivatives |
| G03DB02 | megestrol |
| G03DC02 | norethisterone |
| G03EA03 | prasterone and estrogen |
| G03FB08 | dydrogesterone and estrogen |
| G03FB11 | trimegestone and estrogen |
| G03GA03 | serum gonadotrophin |
| G03GA04 | urofollitropin |
| G03HA01 | cyproterone |
| G03XB01 | mifepristone |
| G03XC05 | ospemifene |
| G04 | UROLOGICALS |
| G04BD04 | oxybutynin |
| G04BD10 | darifenacin |
| G04BX17 | sodium salicylate and methenamine |
| G04C | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| G04CA01 | alfuzosin |
| G04CA55 | doxazosin and finasteride |
| G04CB02 | dutasteride |
| H01AC07 | somapacitan |
| H01CB | Somatostatin and analogues |
| H01CC01 | ganirelix |
| H02AA | Mineralocorticoids |
| H02AA01 | aldosterone |
| H02AB02 | dexamethasone |
| H02AB05 | paramethasone |
| H02AB14 | cloprednol |
| H03 | THYROID THERAPY |
| H03A | THYROID PREPARATIONS |
| H03BA | Thiouracils |
| H03BX01 | diiodotyrosine |
| H04AA | Glycogenolytic hormones |
| H05AA | Parathyroid hormones and analogues |
| H05BA01 | calcitonin (salmon synthetic) |
| H05BX03 | doxercalciferol |
| J01 | ANTIBACTERIALS FOR SYSTEMIC USE |
| J01AA10 | penimepicycline |
| J01B | AMPHENICOLS |
| J01CA01 | ampicillin |
| J01CA04 | amoxicillin |
| J01CF03 | meticillin |
| J01CF04 | oxacillin |
| J01CG | Beta-lactamase inhibitors |
| J01CR | Combinations of penicillins, incl. beta-lactamase inhibitors |
| J01CR02 | amoxicillin and beta-lactamase inhibitor |
| J01DB | First-generation cephalosporins |
| J01DC | Second-generation cephalosporins |
| J01DC03 | cefamandole |
| J01DC10 | cefprozil |
| J01DD | Third-generation cephalosporins |
| J01DD08 | cefixime |
| J01DD10 | cefetamet |
| J01DD14 | ceftibuten |
| J01DD16 | cefditoren |
| J01DD52 | ceftazidime and beta-lactamase inhibitor |
| J01DD63 | ceftriaxone and beta-lactamase inhibitor |
| J01DF | Monobactams |
| J01DF01 | aztreonam |
| J01DH | Carbapenems |
| J01DI01 | ceftobiprole medocaril |
| J01EC | Intermediate-acting sulfonamides |
| J01ED | Long-acting sulfonamides |
| J01EE | Combinations of sulfonamides and trimethoprim, incl. derivatives |
| J01FA13 | dirithromycin |
| J01FA14 | flurithromycin |
| J01FG | Streptogramins |
| J01GB12 | arbekacin |
| J01MA01 | ofloxacin |
| J01MA03 | pefloxacin |
| J01MA14 | moxifloxacin |
| J01MA25 | lascufloxacin |
| J01RA01 | penicillins, combinations with other antibacterials |
| J01RA07 | azithromycin, fluconazole and secnidazole |
| J01RA12 | ciprofloxacin and ornidazole |
| J01XB01 | colistin |
| J01XB02 | polymyxin B |
| J01XD01 | metronidazole |
| J01XE01 | nitrofurantoin |
| J01XX02 | xibornol |
| J01XX07 | nitroxoline |
| J02AA | Antibiotics |
| J02AC05 | isavuconazole |
| J04AA03 | calcium aminosalicylate |
| J04AB02 | rifampicin |
| J04AD03 | ethionamide |
| J04AM03 | ethambutol and isoniazid |
| J04BA03 | aldesulfone sodium |
| J05A | DIRECT ACTING ANTIVIRALS |
| J05AB13 | penciclovir |
| J05AB14 | valganciclovir |
| J05AB15 | brivudine |
| J05AE | Protease inhibitors |
| J05AF01 | zidovudine |
| J05AF13 | tenofovir alafenamide |
| J05AP | Antivirals for treatment of HCV infections |
| J05AP07 | daclatasvir |
| J05AP54 | elbasvir and grazoprevir |
| J05AR18 | emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat |
| J05AR23 | atazanavir and ritonavir |
| J05AR27 | lamivudine, tenofovir disoproxil and dolutegravir |
| J05AX01 | moroxydine |
| J05AX09 | maraviroc |
| J06BA01 | immunoglobulins, normal human, for extravascular adm. |
| J06BB01 | anti-D (rh) immunoglobulin |
| J06BB05 | rabies immunoglobulin |
| J06BB06 | rubella immunoglobulin |
| J06BB14 | measles immunoglobulin |
| J07AC | Anthrax vaccines |
| J07AG | Haemophilus influenzae B vaccines |
| J07AG54 | haemophilus influenza B, combinations with meningococcus C,Y, conjugated |
| J07AJ | Pertussis vaccines |
| J07AK | Plague vaccines |
| J07AL02 | pneumococcus, purified polysaccharides antigen conjugated |
| J07AN01 | tuberculosis, live attenuated |
| J07BB | Influenza vaccines |
| J07BB02 | influenza, inactivated, split virus or surface antigen |
| J07BC | Hepatitis vaccines |
| J07BD01 | measles, live attenuated |
| J07BG01 | rabies, inactivated, whole virus |
| J07BH02 | rota virus, pentavalent, live, reassorted |
| J07BL01 | yellow fever, live attenuated |
| J07BX06 | enterovirus 71 vaccines |
| J07CA08 | haemophilus influenzae B and hepatitis B |
| L01A | ALKYLATING AGENTS |
| L01AC02 | triaziquone |
| L01AD | Nitrosoureas |
| L01AD04 | streptozocin |
| L01AG01 | etoglucid |
| L01AX01 | mitobronitol |
| L01B | ANTIMETABOLITES |
| L01BB | Purine analogues |
| L01BC58 | decitabine, combinations |
| L01CA03 | vindesine |
| L01CB01 | etoposide |
| L01DB06 | idarubicin |
| L01DB08 | pirarubicin |
| L01EA | BCR-ABL tyrosine kinase inhibitors |
| L01EA01 | imatinib |
| L01EB09 | lazertinib |
| L01ED01 | crizotinib |
| L01EE | Mitogen-activated protein kinase (MEK) inhibitors |
| L01EE04 | selumetinib |
| L01EF01 | palbociclib |
| L01EG | Mammalian target of rapamycin (mTOR) kinase inhibitors |
| L01EJ | Janus-associated kinase (JAK) inhibitors |
| L01EJ03 | pacritinib |
| L01EL01 | ibrutinib |
| L01EM | Phosphatidylinositol-3-kinase (Pi3K) inhibitors |
| L01EN04 | futibatinib |
| L01EX19 | ripretinib |
| L01EX25 | umbralisib |
| L01FA | CD20 (Clusters of Differentiation 20) inhibitors |
| L01FB | CD22 (Clusters of Differentiation 22) inhibitors |
| L01FB02 | moxetumomab pasudotox |
| L01FF | PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
| L01FF06 | cemiplimab |
| L01FF10 | retifanlimab |
| L01FF11 | sugemalimab |
| L01FF12 | serplulimab |
| L01FX01 | edrecolomab |
| L01FX11 | bermekimab |
| L01XD | Sensitizers used in photodynamic/radiation therapy |
| L01XG02 | carfilzomib |
| L01XG03 | ixazomib |
| L01XH01 | vorinostat |
| L01XL | Antineoplastic cell and gene therapy |
| L01XX08 | pentostatin |
| L01XX10 | masoprocol |
| L01XX24 | pegaspargase |
| L01XX35 | anagrelide |
| L01XX40 | omacetaxine mepesuccinate |
| L01XX57 | plitidepsin |
| L01XX59 | enasidenib |
| L01XX75 | tebentafusp |
| L01XY | Combinations of antineoplastic agents |
| L02AA02 | polyestradiol phosphate |
| L02AE51 | leuprorelin and bicalutamide |
| L02BA01 | tamoxifen |
| L02BA04 | elacestrant |
| L02BG01 | aminoglutethimide |
| L02BX01 | abarelix |
| L03AB05 | interferon alfa-2b |
| L03AX11 | tasonermin |
| L03AX19 | dasiprotimut-T |
| L03AX22 | leniolisib |
| L04AA15 | alefacept |
| L04AA24 | abatacept |
| L04AA58 | efgartigimod alfa |
| L04AB07 | opinercept |
| L04AC07 | tocilizumab |
| L04AC11 | siltuximab |
| L04AC12 | brodalumab |
| L04AC15 | sirukumab |
| L04AC23 | olokizumab |
| L04AC25 | levilimab |
| L04AD02 | tacrolimus |
| L04AG05 | vedolizumab |
| L04AG10 | inebilizumab |
| L04AG14 | ublituximab |
| L04AH | Mammalian target of rapamycin (mTOR) kinase inhibitors |
| L04AH02 | everolimus |
| M01AB01 | indometacin |
| M01AB14 | proglumetacin |
| M01AC | Oxicams |
| M01AC56 | meloxicam, combinations |
| M01AE01 | ibuprofen |
| M01AE04 | fenoprofen |
| M01AE10 | indoprofen |
| M01AE18 | naproxcinod |
| M01AE51 | ibuprofen, combinations |
| M01AG | Fenamates |
| M01AX23 | tenidap |
| M01AX25 | chondroitin sulfate |
| M01AX26 | avocado and soyabean oil, unsaponifiables |
| M01BA01 | phenylbutazone and corticosteroids |
| M02 | TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN |
| M02AA02 | mofebutazone |
| M02AA25 | aceclofenac |
| M02AA26 | nimesulide |
| M02AA27 | dexketoprofen |
| M02AB02 | zucapsaicin |
| M02AX | Other topical products for joint and muscular pain |
| M03AA01 | alcuronium |
| M03AA02 | tubocurarine |
| M03AC | Other quaternary ammonium compounds |
| M03AC04 | atracurium |
| M03BA52 | carisoprodol, combinations excl. psycholeptics |
| M03BA53 | methocarbamol, combinations excl. psycholeptics |
| M03BA71 | phenprobamate, combinations with psycholeptics |
| M03BB03 | chlorzoxazone |
| M03BX53 | pridinol, combinations |
| M03BX55 | thiocolchicoside, combinations |
| M04AA | Preparations inhibiting uric acid production |
| M04AB03 | benzbromarone |
| M04AC01 | colchicine |
| M04AX | Other antigout preparations |
| M04AX02 | pegloticase |
| M05BA03 | pamidronic acid |
| M05BX06 | romosozumab |
| M09AB02 | collagenase clostridium histolyticum |
| M09AX08 | golodirsen |
| N | NERVOUS SYSTEM |
| N01AA | Ethers |
| N01AB | Halogenated hydrocarbons |
| N01AG01 | narcobarbital |
| N01AH01 | fentanyl |
| N01AH03 | sufentanil |
| N01AH05 | anileridine |
| N01AH51 | fentanyl, combinations |
| N01AX03 | ketamine |
| N01AX04 | propanidid |
| N01BA05 | benzocaine |
| N01BA53 | tetracaine, combinations |
| N01BB06 | cinchocaine |
| N01BB57 | etidocaine, combinations |
| N02AJ17 | oxycodone and paracetamol |
| N02B | OTHER ANALGESICS AND ANTIPYRETICS |
| N02BA01 | acetylsalicylic acid |
| N02BA15 | carbasalate calcium |
| N02BA79 | dipyrocetyl, combinations with psycholeptics |
| N02BB | Pyrazolones |
| N02BF01 | gabapentin |
| N02CB | Corticosteroid derivatives |
| N02CD02 | galcanezumab |
| N02CD07 | atogepant |
| N03A | ANTIEPILEPTICS |
| N03AA02 | phenobarbital |
| N03AC01 | paramethadione |
| N03AC03 | ethadione |
| N03AE01 | clonazepam |
| N03AG | Fatty acid derivatives |
| N03AX03 | sultiame |
| N03AX19 | carisbamate |
| N03AX23 | brivaracetam |
| N04 | ANTI-PARKINSON DRUGS |
| N04AA05 | profenamine |
| N04AA12 | tropatepine |
| N04AB02 | orphenadrine (chloride) |
| N04BA07 | foslevodopa and decarboxylase inhibitor |
| N04BB | Adamantane derivatives |
| N04BD | Monoamine oxidase B inhibitors |
| N04CX01 | istradefylline |
| N05A | ANTIPSYCHOTICS |
| N05AA | Phenothiazines with aliphatic side-chain |
| N05AA04 | acepromazine |
| N05AB04 | prochlorperazine |
| N05AE05 | lurasidone |
| N05AF02 | clopenthixol |
| N05AG02 | pimozide |
| N05AH05 | asenapine |
| N05AL07 | levosulpiride |
| N05AN | Lithium |
| N05AX | Other antipsychotics |
| N05BA06 | lorazepam |
| N05BA12 | alprazolam |
| N05BA13 | halazepam |
| N05BC | Carbamates |
| N05BD | Dibenzo-bicyclo-octadiene derivatives |
| N05CA09 | vinbarbital |
| N05CA15 | methohexital |
| N05CD03 | flunitrazepam |
| N05CD06 | lormetazepam |
| N05CD07 | temazepam |
| N05CD08 | midazolam |
| N05CD13 | cinolazepam |
| N05CD15 | nimetazepam |
| N05CE02 | methyprylon |
| N05CF03 | zaleplon |
| N05CJ03 | daridorexant |
| N06AA | Non-selective monoamine reuptake inhibitors |
| N06AA03 | imipramine oxide |
| N06AA04 | clomipramine |
| N06AA09 | amitriptyline |
| N06AA17 | amoxapine |
| N06AB05 | paroxetine |
| N06AB08 | fluvoxamine |
| N06AX03 | mianserin |
| N06AX06 | nefazodone |
| N06AX22 | agomelatine |
| N06BA01 | amfetamine |
| N06BA08 | fenozolone |
| N06BA12 | lisdexamfetamine |
| N06BX03 | piracetam |
| N06BX22 | phenibut |
| N06DA | Anticholinesterases |
| N06DA52 | donepezil and memantine |
| N06DX02 | Ginkgo folium |
| N07AX02 | choline alfoscerate |
| N07BA | Drugs used in nicotine dependence |
| N07BA03 | varenicline |
| N07CA | Antivertigo preparations |
| N07CA04 | acetylleucine |
| N07XX03 | xaliproden |
| N07XX12 | patisiran |
| P01 | ANTIPROTOZOALS |
| P01A | AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES |
| P01AC | Dichloroacetamide derivatives |
| P01AC03 | etofamide |
| P01BB02 | cycloguanil embonate |
| P01BB51 | proguanil and atovaquone |
| P01BB52 | chloroquine and proguanil |
| P01BC | Methanolquinolines |
| P01BE03 | artesunate |
| P01BF03 | artesunate and amodiaquine |
| P01BX | Other antimalarials |
| P01CB02 | sodium stibogluconate |
| P02BB01 | metrifonate |
| P02CE | Imidazothiazole derivatives |
| P02CX02 | bephenium |
| P02CX03 | moxidectin |
| P02DA01 | niclosamide |
| P03 | ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS |
| P03AX | Other ectoparasiticides, incl. scabicides |
| P03BX02 | dimethylphthalate |
| R01AA | Sympathomimetics, plain |
| R01AA07 | xylometazoline |
| R01AB05 | ephedrine |
| R01AC06 | thonzylamine |
| R01AD02 | prednisolone |
| R01AD05 | budesonide |
| R01AD08 | fluticasone |
| R01AD11 | triamcinolone |
| R01AD58 | fluticasone, combinations |
| R01AX01 | calcium hexamine thiocyanate |
| R01AX03 | ipratropium bromide |
| R01AX07 | hexamidine |
| R01BA51 | phenylpropanolamine, combinations |
| R02AA02 | dequalinium |
| R02AA14 | oxyquinoline |
| R02AA16 | benzalkonium |
| R02AB02 | tyrothricin |
| R02AD03 | cocaine |
| R03 | DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| R03AC02 | salbutamol |
| R03AC07 | isoetarine |
| R03AL01 | fenoterol and ipratropium bromide |
| R03AL06 | olodaterol and tiotropium bromide |
| R03AL07 | formoterol and glycopyrronium bromide |
| R03BA03 | flunisolide |
| R03BA09 | fluticasone furoate |
| R03BB | Anticholinergics |
| R03BB02 | oxitropium bromide |
| R03BB06 | glycopyrronium bromide |
| R03DA03 | proxyphylline |
| R03DA11 | doxofylline |
| R03DA51 | diprophylline, combinations |
| R03DB03 | proxyphylline and adrenergics |
| R05CA | Expectorants |
| R05CA03 | guaifenesin |
| R05CA09 | guaiacolsulfonate |
| R05CB11 | stepronin |
| R05DA08 | pholcodine |
| R05DB13 | butamirate |
| R05F | COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS |
| R05FA | Opium derivatives and expectorants |
| R05FB | Other cough suppressants and expectorants |
| R06 | ANTIHISTAMINES FOR SYSTEMIC USE |
| R06A | ANTIHISTAMINES FOR SYSTEMIC USE |
| R06AA04 | clemastine |
| R06AA54 | clemastine, combinations |
| R06AB52 | dexchlorpheniramine, combinations |
| R06AC04 | tripelennamine |
| R06AD07 | mequitazine |
| R06AE09 | levocetirizine |
| R06AX13 | loratadine |
| R06AX17 | ketotifen |
| R06AX32 | sequifenadine |
| R07AB01 | doxapram |
| R07AB05 | bemegride |
| R07AB09 | mepixanox |
| R07AB53 | pentetrazol, combinations |
| R07AX | Other respiratory system products |
| R07AX32 | ivacaftor, tezacaftor and elexacaftor |
| S01AA02 | chlortetracycline |
| S01AA11 | gentamicin |
| S01AA27 | cefuroxime |
| S01AA29 | dibekacin |
| S01AB | Sulfonamides |
| S01AD02 | trifluridine |
| S01AE08 | besifloxacin |
| S01AX04 | nitrofural |
| S01AX15 | propamidine |
| S01BA01 | dexamethasone |
| S01BA07 | fluorometholone |
| S01BA12 | formocortal |
| S01BB02 | prednisolone and mydriatics |
| S01BC02 | oxyphenbutazone |
| S01BC06 | piroxicam |
| S01BC08 | salicylic acid |
| S01CB01 | dexamethasone |
| S01CC | Antiinflammatory agents, non-steroids and antiinfectives in combination |
| S01E | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| S01EC02 | diclofenamide |
| S01EC03 | dorzolamide |
| S01ED01 | timolol |
| S01ED04 | metipranolol |
| S01ED06 | befunolol |
| S01EX01 | guanethidine |
| S01EX05 | netarsudil |
| S01FB | Sympathomimetics excl. antiglaucoma preparations |
| S01GA01 | naphazoline |
| S01GA52 | tetryzoline, combinations |
| S01KA51 | hyaluronic acid, combinations |
| S02AA05 | clioquinol |
| S02AA07 | neomycin |
| S02AA15 | ciprofloxacin |
| S02AA17 | fosfomycin |
| S02BA07 | betamethasone |
| S02DC | Indifferent preparations |
| S03AA30 | antiinfectives, combinations |
| S03B | CORTICOSTEROIDS |
| S03CA02 | prednisolone and antiinfectives |
| S03D | OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS |
| V01AA | Allergen extracts |
| V01AA08 | food |
| V01AA20 | various |
| V03AB06 | thiosulfate |
| V03AB17 | methylthioninium chloride |
| V03AB22 | amyl nitrite |
| V03AB54 | pralidoxime and atropine |
| V03AE01 | polystyrene sulfonate |
| V03AE10 | sodium zirconium cyclosilicate |
| V03AF07 | rasburicase |
| V03AF11 | arginine and lysine |
| V03AZ | Nerve depressants |
| V03AZ01 | ethanol |
| V04CA01 | tolbutamide |
| V04CC02 | magnesium sulfate |
| V04CC04 | ceruletide |
| V04CE03 | methacetin (13C) |
| V04CF | Tuberculosis diagnostics |
| V04CG03 | histamine phosphate |
| V04CH | Tests for renal function and ureteral injuries |
| V04CX06 | hexaminolevulinate |
| V04CX11 | lithium chloride |
| V06AA | Low-energy diets |
| V06C | INFANT FORMULAS |
| V06DC02 | fructose |
| V07AT | Cosmetics |
| V08AA08 | iocarmic acid |
| V08AB | Watersoluble, nephrotropic, low osmolar X-ray contrast media |
| V08AB01 | metrizamide |
| V08AB10 | iomeprol |
| V08AC08 | sodium iopodate |
| V08B | X-RAY CONTRAST MEDIA, NON-IODINATED |
| V08CX | Other magnetic resonance imaging contrast media |
| V09AA02 | technetium (99mTc) bicisate |
| V09AX | Other central nervous system diagnostic radiopharmaceuticals |
| V09CX03 | sodium iothalamate (125I) |
| V09DB | Technetium (99mTc), particles and colloids |
| V09DB03 | technetium (99mTc) millimicrospheres |
| V09DX | Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals |
| V09EX01 | krypton (81mKr) gas |
| V09GA01 | technetium (99mTc) sestamibi |
| V09GA02 | technetium (99mTc) tetrofosmin |
| V09GX01 | thallium (201Tl) chloride |
| V09HX01 | gallium (67Ga) citrate |
| V09IA | Technetium (99mTc) compounds |
| V09IA05 | technetium (99mTc) depreotide |
| V09IB01 | indium (111In) pentetreotide |
| V09IX13 | methionine (11C) |
| V09IX15 | copper (64Cu) dotatate |
| V09IX17 | PSMA-1007 (18F) |
| V09XA03 | iodine (131I) human albumin |
| V10AA02 | yttrium (90Y) ferrihydroxide colloid |
| V10BX | Various pain palliation radiopharmaceuticals |
| V10BX03 | rhenium (186Re) etidronic acid |
| V10XA53 | tositumomab/iodine (131I) tositumomab |
| V10XX02 | ibritumomab tiuxetan (90Y) |
| V10XX03 | radium (223Ra) dichloride |
| A01AB25 | oxytetracycline |
| A07F | ANTIDIARRHEAL MICROORGANISMS |
| A10BX01 | guar gum |
| G | GENITO URINARY SYSTEM AND SEX HORMONES |
| L01FA01 | rituximab |
| N05CJ01 | suvorexant |
| N06AA06 | trimipramine |
| N06AX11 | mirtazapine |
| N07XX08 | tafamidis |
| P01BA01 | chloroquine |
| R03BB54 | tiotropium bromide, combinations |
| S01J | DIAGNOSTIC AGENTS |
| V09GA03 | technetium (99mTc) teboroxime |
| V09IX01 | iobenguane (123I) |
| C01BB02 | mexiletine |
| C02LK | Alkaloids, excl. rauwolfia, in combination with diuretics |
| C10AB07 | ronifibrate |
| D06BA02 | sulfathiazole |
| G03CC04 | estrone |
| L01XL11 | lifileucel |
| M01AB05 | diclofenac |
| M03AB | Choline derivatives |
| N06AG03 | toloxatone |
| V08CA05 | mangafodipir |
| B01AB07 | parnaparin |
| C09XA53 | aliskiren and amlodipine |
| J05AX18 | letermovir |
| L01EX04 | vandetanib |
| N02CC01 | sumatriptan |
| N05CD01 | flurazepam |
| A03CA03 | oxyphencyclimine and psycholeptics |
| A07XA51 | albumin tannate, combinations |
| B01AB10 | tinzaparin |
| B05XA15 | potassium lactate |
| C09AA09 | fosinopril |
| H01AC04 | sermorelin |
| L04AJ | Complement inhibitors |
| N02BA67 | magnesium salicylate, combinations excl. psycholeptics |
| N05CF | Benzodiazepine related drugs |
| N07BC05 | levomethadone |
| P03AA | Sulfur containing products |
| R05DB26 | nepinalone |
| B01AC28 | limaprost |
| L01XX58 | epacadostat |
| N01AX05 | alfaxalone |
| N05AC02 | thioridazine |
| N06BA04 | methylphenidate |
| N06CB | Psychostimulants in combination with psycholeptics |
| R05CB10 | combinations |
| R05DB24 | tipepidine |
| V03AF08 | palifermin |
| A03DA02 | pitofenone and analgesics |
| A14A | ANABOLIC STEROIDS |
| A14AA09 | norethandrolone |
| C09BA03 | lisinopril and diuretics |
| D06BB10 | imiquimod |
| D08AK | Mercurial products |
| G03AA02 | quingestanol and ethinylestradiol |
| H03BB01 | carbimazole |
| J04AK01 | pyrazinamide |
| N03AA | Barbiturates and derivatives |
| N05BX03 | etifoxine |
| R01AA13 | tymazoline |
| A05AA05 | ursodoxicoltaurine |
| G01 | GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS |
| G02CB06 | terguride |
| G03DC04 | ethisterone |
| G03FA02 | hydroxyprogesterone and estrogen |
| N02CC03 | zolmitriptan |
| R03DX03 | fenspiride |
| S03CA07 | methylprednisolone and antiinfectives |
| A08AB01 | orlistat |
| A10AC04 | insulin lispro |
| A16AB16 | idursulfase beta |
| C02AC05 | moxonidine |
| C02LA | Rauwolfia alkaloids and diuretics in combination |
| D05AX04 | tacalcitol |
| D06AX09 | mupirocin |
| D11AX21 | brimonidine |
| J01RA13 | norfloxacin and tinidazole |
| L01CA02 | vincristine |
| M01AA01 | phenylbutazone |
| M09AX01 | hyaluronic acid |
| N06AX02 | tryptophan |
Generated Narrative: ValueSet
Expansion based on codesystem WHO ATC version2020-05
This value set contains 1,000 concepts
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |